,0,1,2
0,"((5Z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4H-imidazol-4-one)",leucettine L41,1
1,17p13.3,17p13.3 deletions,1
2,1-Phosphatidylinositol 3-Kinase,phosphatidylinositol 3-kinase,3
3,1-Phosphatidylinositol 3-Kinase,PI3-kinase,4
4,1-Phosphatidylinositol 3-Kinase,phosphatidylinositol 3 kinase,1
5,1-Phosphatidylinositol 3-Kinase,putative phosphatidyl inositol 3-kinase,1
6,1-Phosphatidylinositol 3-Kinase,PI3-K,3
7,22q13,22q13,1
8,2-Dimensional,2D,1
9,3' Region,downstream regions,1
10,"3,4-Methylenedioxyamphetamine",MDa,1
11,3c,3c,1
12,4-dichlorobenzene,PDB,1
13,5-bromo-4-chloro-3-indolyl beta-galactoside,X-gal,1
14,A axonemal microtubule,tubule,1
15,A Codes,codes,1
16,AB Term Type,Ab,1
17,Abdominal aorta structure,abdominal aorta,1
18,Aberrant,aberrant,10
19,ABI1 wt Allele,Abi-1,2
20,ABI1 wt Allele,e3B1,1
21,Ability,abilities,1
22,Ability to Drive,driving,1
23,Ablation,ablation,2
24,Ablation,Ablation,1
25,Abnormal,abnormal,13
26,Abnormal,Abnormal,1
27,Abnormal behavior,neurobehavioral abnormalities,1
28,Abnormal degeneration,degenerated,1
29,Abnormal degeneration,degeneration,1
30,Abnormality,abnormality,1
31,Abnormality of mitochondrial metabolism,mitochondrial dysfunction,1
32,Abnormality of the vasculature,vascular abnormalities,1
33,Absence (morphologic abnormality),absence,18
34,Absolute,absolute,1
35,Abstract thinking ability,ideas,1
36,Abundance,abundance,10
37,Abundance,abundant,6
38,Accelerated,accelerates,2
39,acceptors,acceptor,1
40,Accident due to exposure to weather conditions,exposure,1
41,Accumulation,accumulation,10
42,Accumulation,accumulate,4
43,Accumulation,fat accumulation,1
44,Accurate (qualifier),accuracy,1
45,Acetyltransferase,protein acetyltransferases,1
46,acetyltransferase activity,acetyltransferase activity,3
47,Acids,acidic,1
48,ACP5 gene,tartrate-resistant acid phosphatase,1
49,Acquisition (action),acquisition,2
50,Act Class - investigation,investigation,4
51,Act Class - investigation,Investigation,1
52,Act Class - review,review,2
53,actin cytoskeleton reorganization,cytoskeleton reorganisation,1
54,actin filament polymerization,actin polymerization,4
55,actin nucleation,nucleation,1
56,Actin-Binding Protein,actin binding proteins,1
57,Actins,actin,1
58,Activating PI3K Mutation,PI3K activation,1
59,Activation action,activate,18
60,Activation action,activation,64
61,Activation action,activated,22
62,Activation action,activates,7
63,Activation action,Activation,3
64,Activation action,activating,10
65,Activation function,activation function,1
66,Activator Appliances,coactivator function,1
67,Active Site,catalytic site,1
68,Activities,activities,3
69,Activities,activity,44
70,activity-dependent neurotrophic factor,activity-dependent neurotrophic factor,1
71,ACTL6A gene,BAF53a,1
72,ACTL6B gene,BAF53b,1
73,"ACTN4 protein, human",actin cross-linking protein,1
74,ACTR2 gene,actin-related protein,1
75,Acute inflammation,acute inflammation,1
76,Acute leukemia,acute leukemias,1
77,Acute Undifferentiated Leukemia,Scl,3
78,Adaptation,adaptation,1
79,Adapter Device Component,adaptor,3
80,Adaptive Thermogenesis,adaptive thermogenesis,1
81,Adaptor Protein Complex 1,Golgi adaptor,1
82,Adaptor Protein Complex 2,adaptors,3
83,"adaptor protein complex 2, alpha 2 subunit",alpha-adaptin,1
84,Adaptor Protein Complex beta Subunits,Adaptins,1
85,Adaptor Protein Complex beta Subunits,beta-adaptins,2
86,Adaptor Protein Complex gamma Subunits,gamma-adaptin,4
87,Adaptor Protein Complex gamma Subunits,gamma-adaptins,1
88,"Adaptor Proteins, Signal Transducing",adaptor protein,1
89,"Adaptor Proteins, Signal Transducing",signaling adaptor,1
90,"Adaptor Proteins, Signal Transducing",adaptor proteins,2
91,Adenocarcinoma of lung (disorder),lung adenocarcinoma,2
92,Adenosine Triphosphatases,ATPase,1
93,Adenylate,adenylate,1
94,Adenylate Cyclase,adenylyl cyclase,1
95,ADENYLATE KINASE,Adenylate kinase,1
96,ADENYLATE KINASE,AK,1
97,adenylosuccinate,adenylosuccinate,1
98,Adipocytes,adipocytes,4
99,Adjacent,adjacent,8
100,Administration procedure,administration,1
101,Adrenal Cortex,cortical,13
102,ADSL gene,Adenylosuccinate lyase,2
103,ADSL gene,adenylosuccinate lyase,2
104,Adult,adult,53
105,Adult,adults,3
106,Adulthood,adulthood,1
107,Advanced phase,advanced entry,1
108,Adverse Event Associated with Vascular,vascular,3
109,AF-1 domain binding,AF-1 domain,1
110,AF-2,AF-2,2
111,Affecting,affecting,4
112,Affecting,affected,4
113,Afferent,afferent,1
114,Affinity,affinity,11
115,Afibrinogenemia,fibrinogen deficiency,1
116,Age of Onset,onset,1
117,Age:Time:Point in time:^Patient:Quantitative,age,1
118,Aggregate,aggregates,1
119,Aggregation,aggregation,1
120,Aging,aging,1
121,Agonist,agonist,2
122,agonists,agonists,2
123,Agreement,accord,1
124,AHSA1 gene,Aha1,1
125,AK3 gene,AK3,2
126,AK4 gene,AK4,9
127,AKAP10 gene,A-kinase anchoring protein 150,1
128,AKAP10 gene,AKAP150,3
129,AKAP13 gene,AKAP13,4
130,AKAP13 gene,Akap13,2
131,AKAP13 wt Allele,AKAP-Lbc,1
132,AKAP13 wt Allele,proto-Lbc,1
133,AKAP8 gene,Akap8,1
134,"A-Kinase Anchor Protein 10, Mitochondrial",protein kinase A-anchoring protein,1
135,"A-Kinase Anchor Protein 10, Mitochondrial",AKAP,1
136,AKT Signaling Pathway,Akt signaling pathway,1
137,AKT1 gene,Rac,8
138,AKT1 gene,Akt1,2
139,Alanine,alanine,3
140,"Albumin Human, USP",HSA,1
141,algorithm,algorithms,1
142,Alkalies,Alkali,1
143,Alkaline phosphatase stain,alkaline phosphatase,1
144,Alleles,allele,4
145,Alleles,allelic,2
146,Alleles,alleles,2
147,Allogeneic Hematopoietic Stem Cell Transplantation,HSC,7
148,Alpha 1,alpha 1,1
149,Alpha 2,alpha 2,1
150,Alpha Granule,platelet granule,1
151,Alpha subunit - qualifier value,alpha 1 subunit,2
152,Alpha subunit - qualifier value,alpha subunit,1
153,Alpha1 Significance,alpha1,1
154,Alpha2 Significance,alpha2,3
155,alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid,AMPA,3
156,alpha-Lactalbumin,alpha-lactalbumin,1
157,Alteration,alterations,2
158,Alteration,alteration,3
159,Alternating,alternating,1
160,Alternative,alternate,5
161,Alternative,alternative,8
162,Alternative Splicing,alternative splicing,4
163,Alternative Splicing,Alternative splicing,1
164,Aluminum,aluminium,1
165,Alzheimer's Disease,Alzheimer disease brains,1
166,Alzheimer's Disease,Alzheimer\'s disease,2
167,AMBRA1 gene,Ambra1,19
168,AMBRA1 gene,AMBRA1,42
169,Amino Acid Motifs,motifs,15
170,Amino Acid Sequence,amino acid sequence,15
171,Amino Acid Sequence,primary structure,1
172,Amino Acid Sequence,partial amino acid sequences,1
173,Amino Acid Sequence,amino acid sequences,2
174,Amino Acids,amino acid,14
175,Amino Acids,amino acids,25
176,AMINO ACIDS/PROTEINS,amino acid protein,1
177,aminoacid sequence of protein,peptide sequence,1
178,Amount type - Differential,differential,3
179,Amount type - Rate,rate,6
180,AMPA Receptors,AMPA receptors,5
181,"AMPH protein, human",AMP,1
182,Amphibians,amphibians,1
183,Amplification,amplification,3
184,Amplitude,amplitude,1
185,Amplitude,amplitudes,1
186,Amyloid,amyloid,1
187,Amyloid Beta Precursor Protein Measurement,amyloid-beta precursor protein,1
188,Amyloid beta-Peptides,beta-amyloid,1
189,Amyotrophic Lateral Sclerosis,amyotrophic lateral sclerosis,1
190,Amyotrophic Lateral Sclerosis,ALS,3
191,Anabolism,synthesis,2
192,Anabolism,biogenesis,2
193,Anabolism,Synthesis,1
194,Analysis,analyzed,11
195,analysis aspect,analysis,15
196,analysis aspect,Analysis,4
197,anatomical layer,layers,4
198,anatomical layer,layering,1
199,anatomical layer,players,4
200,Anatomical maturation,maturation,2
201,Anatomical segmentation,segment,4
202,"Anatomy, Regional",topology,3
203,Anchorage,anchorage,1
204,Anchoring procedure,anchoring,3
205,Androgen Receptor,androgen receptors,1
206,Angiogenic Process,angiogenesis,5
207,Angiogenic Process,active angiogenesis,1
208,Angiopoietin-1 Receptor Signaling Pathway,Tek signaling pathway,2
209,"Angiopoietin-1 Receptor, Human",endothelial receptor tyrosine kinase,1
210,"Angiopoietin-1 Receptor, Human",angiopoietin receptor,1
211,Angiopoietin-2,angiopoietin-2,1
212,Angiopoietin-2,Ang-2,5
213,Angiopoietins,angiopoietins,1
214,Angiopoietins,angiopoietin binding,2
215,Angiopoietins,angiopoietin,1
216,Angiopoietins,Ang,1
217,Angiotensin II,angiotensin 2,1
218,"ANGPT1 protein, human",Angiopoietin-1,2
219,"ANGPT1 protein, human",Ang-1,5
220,"ANGPT1 protein, human",angiopoietin-1,1
221,"ANGPT1 protein, human",Ang1,5
222,ANGPT1 wt Allele,Angpt1,1
223,ANGPT2 gene,Ang2,1
224,ANGPT4 wt Allele,Ang4,12
225,ANGPTL1 gene,Ang3,13
226,Animal Model,animal model,2
227,Animal Model,animal models,1
228,Animals,animal,1
229,Animals,animals,2
230,"Animals, Transgenic",transgenic,1
231,ANO2 gene,TMEM16B,5
232,Anomaly of placenta,placental abnormalities,1
233,Antagonist muscle action,antagonist,2
234,Anterior chamber of eye structure,anterior chamber,1
235,Anthropological Culture,cultures,2
236,Antiapoptotic Agent,antiapoptotic protein,1
237,antibiotic G 418,G418,1
238,"Antibodies, in vitro diagnostic",antibodies,8
239,"Antibodies, Phospho-Specific",phosphospecific,1
240,Antigen Presentation,antigen presentation,2
241,Antigens,antigens,3
242,Anti-inflammatory effect,anti-inflammatory drug,1
243,Antimicrobial susceptibility,sensitivities,1
244,Antimicrobial Susceptibility Result,susceptible,1
245,Antineoplastic Agents,antineoplastic,1
246,Antioxidant Response Elements,antioxidant response element,1
247,Antioxidant Response Elements,ARE,2
248,Antioxidant Response Elements,antioxidant response elements,1
249,Antisense Orientation,antisense orientation,1
250,Anxiety,anxiety,1
251,AP1 complex location,AP1 complex,1
252,AP1 complex location,AP-1 complex,1
253,AP1M2 gene,mu2,3
254,"APC protein, human",APC,1
255,"APC protein, human",Apc,1
256,APH1A gene,Aph-1a,3
257,APH1A gene,APH-1a,1
258,APH1B gene,Aph-1b,1
259,APH1B gene,APH-1b,1
260,Apical Ectodermal Ridge,apical ectodermal ridge,1
261,Apoptosis,programmed cell death,3
262,Apoptosis,apoptosis,20
263,Apoptosis,apoptotic cell death,1
264,Apoptosis,Apoptotic cell death,1
265,Apoptosis,apoptosis protein,1
266,apparent,apparent,4
267,Appearance,appearance,1
268,Application Dosing Unit,application,2
269,AraC Transcription Factor,transcriptional regulator,4
270,Architecture as Topic,architecture,1
271,Area,areas,1
272,ARF1 gene,Arf1,1
273,ARF6 gene,ARF6,1
274,Arginine,arginine,4
275,Arginine,Arginine,1
276,arginine methyltransferase,arginine methyltransferase,1
277,Argininosuccinate,argininosuccinate,1
278,arginyl-glycyl-aspartic acid,RGD,1
279,ARHGEF5 gene,p60,3
280,ARID1B wt Allele,Bright,1
281,Arm or Leg Response Group 4,group 4,1
282,ARNTL gene,BMAL1,2
283,Array,array,2
284,Arterial,arterial,1
285,Arteries,arteries,5
286,As Directed,directed,2
287,ASB2 gene,ASB2,1
288,Aspartic Acid,aspartic acid,1
289,Aspects of congenital malformations,malformations,1
290,Assay,assay,2
291,Assembly (construction),assembly,9
292,Assembly (construction),assemble,1
293,Assessed,assess,2
294,Assessed,assessed,1
295,Associate - assistant,associates,15
296,Associate - relationship,associate,4
297,Associated with,associated with,40
298,Asthma,asthma,1
299,astral microtubule organization,microtubule organization,1
300,Asymmetrical synapse,asymmetric synapses,1
301,ATAD1 gene,Thorase,2
302,Ataxia,ataxia,2
303,Ataxia Telangiectasia,ataxia telangiectasia,1
304,"Ataxia, Spinocerebellar",spinocerebellar ataxia,1
305,ATF2 gene,Atf2,1
306,ATG7 gene,ATG7,2
307,Atherogenesis,atherogenesis,1
308,"Atmosphere, unit of pressure",ATM,3
309,Atom (substance),atoms,2
310,ATP-dependent chromatin remodeling,ATP-dependent chromatin remodeling,1
311,ATR gene,ATR,2
312,Attention deficit hyperactivity disorder,hyperkinetic disorders,1
313,Attention deficit hyperactivity disorder,hyperkinetic disorder,1
314,Attention deficit hyperactivity disorder,attention-deficit hyperactivity disorder,1
315,Attenuated by (contextual qualifier),attenuated,1
316,Atypical,atypical,1
317,Auditory recruitment,recruitment,21
318,Auditory recruitment,Recruitment,1
319,Author,authors,1
320,Autism Spectrum Disorders,autism spectrum disorder,3
321,Autism Spectrum Disorders,ASD,5
322,Autism Spectrum Disorders,ASDs,2
323,Autism Spectrum Disorders,autism spectrum disorders,1
324,Autoimmune Diseases,autoimmune diseases,2
325,Autoimmune Diseases,autoimmune disease,2
326,autolysosome formation,autolysosome formation,1
327,Autophagosome,autophagosomes,1
328,autophagosome assembly,autophagosome formation,1
329,Autophagy,Autophagy,2
330,Autophagy,autophagy,38
331,Autophagy-Related Protein 5,autophagy protein,1
332,Autophagy-Related Proteins,autophagy-related proteins,1
333,Autosomal dominant inheritance,autosomal dominant,1
334,Auxilins,auxilin,1
335,Availability of,availability,1
336,Availability of,iron availability,1
337,Average of Value Derivation Technique,average,1
338,avoidance,avoidance,1
339,Awake,awake,1
340,Axial,axial,2
341,Axial skeleton structure,axial skeleton,1
342,AXIN2 gene,Axin2,1
343,Axon,axons,6
344,Axon,axon,1
345,Axon,axonal,2
346,Axon,axoneme structure,1
347,axon development,axoneme development,1
348,axon growth,axon growth,1
349,Axon Guidance,axon guidance,1
350,axonal guidance,axonal guidance,1
351,Axoneme,axoneme,2
352,B cell apoptotic process,cell apoptosis,1
353,B4GALT1 gene,GT1 gene,1
354,Background,BACKGROUND,1
355,Bacterial,bacterial,1
356,Bacterial Count Measurement,bacteria,1
357,Baculovirus,baculoviruses,1
358,Bad,Bad,3
359,Baker's Antifol,BAF,3
360,Bands,bands,1
361,Basal,basal,4
362,basal RNA polymerase II transcription machinery binding,RNA polymerase II transcription machinery,1
363,basal transcription machinery binding,basal transcription machinery,1
364,Base Pairing,base pairs,1
365,Base Sequence,nucleotide sequences,2
366,Base Sequence,nucleotide sequence,1
367,Baseline,baseline,2
368,Basement membrane,basement membrane,1
369,Basic Helix-Loop-Helix Transcription Factors,bHLH transcription factor,2
370,Basic Helix-Loop-Helix Transcription Factors,bHLH protein,1
371,Bay-K-8644,Bay K8644,1
372,BC-2 protein,chromatin-modifying proteins,1
373,b-cell proliferation,B cell proliferation,1
374,B-Cell Receptor Complex,B cell receptor,1
375,B-Cell Survival Pathway,cell survival pathways,1
376,BCL2 gene,BCL2,1
377,BCL2 gene,Bcl-2,1
378,"BCR protein, human",BCR,3
379,BCYRN1 gene,Brain cytoplasmic RNA 1,1
380,BCYRN1 gene,BC1,1
381,Bead Dosage Form,beads,1
382,Beck Lethality Scale,lethality,2
383,Beclin-1,Beclin1,1
384,Beclin-1,Beclin 1,5
385,BECN1 gene,Becn1,1
386,BECN1 gene,BECN1,3
387,Behavior,cell behavior,1
388,Behavior,behavior,2
389,Behavior,behaviors,1
390,Behavioral Domain,behavioral,4
391,Beneo Synergy 1,synergy,1
392,Best Case Imputation Technique,BC,1
393,beta catenin,beta-catenin,7
394,beta1-adrenergic receptor activity,beta1-adrenergic receptor,1
395,beta1-adrenergic receptor activity,beta1AR,3
396,beta-adrenergic receptor,beta-adrenergic receptors,1
397,beta-catenin binding,bind beta-catenin,1
398,beta-Chemokines,CC chemokine genes,1
399,Beta-defensin 2 Measurement,BD2,4
400,"Beta-Galactosidase, human",beta-galactosidase gene,1
401,beta-Sheet,beta-sheets,2
402,BHLHE22 gene,beta3,2
403,Bilateral Disease,bilateral disease,2
404,Binding (Molecular Function),physical interaction,3
405,Binding (Molecular Function),molecular interactions,1
406,Binding action,binding,43
407,Binding action,bind,29
408,Binding action,binds,15
409,Binding action,Binding,1
410,Binding Proteins,binding proteins,1
411,Binding Sites,binding site,6
412,Binding Sites,binding sites,4
413,Biochemical,biochemical,4
414,Biochemical Activity,biochemical activity,1
415,Biochemical Pathway,pathways,7
416,Biochemical Pathway,pathway,11
417,Biochemical Pathway,molecular pathways,1
418,Biochemistry,biochemistry,1
419,Bio-Informatics,bioinformatics,1
420,biological,biological,7
421,biological,biologically active,1
422,biological adaptation to stress,stress response,1
423,biological adaptation to stress,stress responses,2
424,Biological Evolution,evolution,2
425,Biological Markers,marker,1
426,Biological Markers,molecular markers,1
427,Biological Models,model system,3
428,Biological Processes,biological processes,5
429,Biological Processes,biological function,1
430,biological signaling,signaling,12
431,biological signaling,signalling,7
432,biological signaling,Signaling,1
433,biological signaling,Met signaling,1
434,biological signaling,Signalling,1
435,Biophysics,biophysical,2
436,Biopolymer Sequencing,sequencing,4
437,Biopolymer Sequencing,Sequencing,2
438,Biosynthetic Pathways,biosynthetic pathway,1
439,"BIRC4 protein, human",XIAP,7
440,BIRC5 gene,surviving,1
441,Birth,born,1
442,Birth Weight,birth weights,1
443,bis(2-hydroxybenzylidene)acetone,bis(2-hydroxybenzylidene)acetone,1
444,Bisulfite Sequencing,bisulfite genomic sequencing,1
445,"Blastocyst Implantation, natural",embryo implantation,1
446,Blastocyst structure,blastocysts,2
447,Block Dosage Form,block,1
448,Blockage (obstruction - finding),blockage,1
449,Blocking,blocking,4
450,blood phenylalanine measurement by Guthrie microbiologic assay,phenylalanine,3
451,Blood Platelets,platelet,1
452,Blood Platelets,platelets,3
453,Blood Pressure,blood pressure,1
454,blood pressure regulation,blood pressure regulation,1
455,Blood Transfusion,transfusion,1
456,Blood Vessel,blood vessels,1
457,Blood Vessel,vascular structures,2
458,Blood Vessel,blood vessel,1
459,Blood Vessel,vascular tone,1
460,blood vessel morphogenesis,blood vessel morphogenesis,1
461,Blunted,blunted,1
462,B-Lymphocytes,B cells,7
463,B-Lymphocytes,B lymphocytes,2
464,B-Lymphocytes,B-cell line,1
465,BMP1 gene,Bmp1,1
466,Body growth,body growth,1
467,Body structure,body,2
468,Body Surface Area,surface area,2
469,Body temperature measurement,temperature,1
470,Body tissue,tissues,29
471,Body tissue,tissue,9
472,Bone Development,bone development,1
473,Bone Marrow,bone marrow,1
474,Bone Marrow-Derived Cell,bone marrow-derived,1
475,Bone remodeling,remodeling,2
476,Bone remodeling,remodelling,1
477,Bone Resorption,osteoclastic bone,1
478,Bone Resorption,bone resorption,1
479,Bone structure of tibia,tibia,1
480,Borg Category-Ratio 10 Perceived Exertion Score 10,maximal,1
481,Bos taurus,bovine,1
482,Brachyury protein,brachyury,1
483,BRAHMA,Brm,1
484,Brain,brain,45
485,Brain,brains,3
486,brain development,developmental brain,3
487,brain development,brain development,9
488,brain function,brain function,2
489,Brain Gray Matter,brain gray matter,1
490,brain size,brain size,2
491,brain tissue surgical material,brain tissue,1
492,Brain-Derived Neurotrophic Factor Measurement,BDNF,3
493,Brain-Derived Neurotrophic Factor Measurement,brain-derived neurotrophic factor,1
494,Branched,branched,1
495,Branchial arch structure,pharyngeal arch,1
496,Branching (qualifier value),branching,2
497,BRCA1 gene,BRCA1,2
498,BRD4 gene,mitotic chromosome-associated protein,1
499,BRD4 gene,MCAP,7
500,BRD4 gene,Brd4 gene,1
501,BRD4 gene,Brd4,39
502,BRD4 gene,protein bromodomain-containing 4,1
503,Breast,breast,3
504,Breast Carcinoma,breast carcinoma,1
505,Breast Feeding,lactation,3
506,Brefeldin A,brefeldinA,1
507,Bromodeoxyuridine,BrdU,1
508,Bromodomain,bromodomains,8
509,Bromodomain,bromodomain,2
510,Bromodomain Containing Protein 2,BRD4,9
511,Bromodomain Containing Protein 2,Brd2,1
512,brown adipose tissue uncoupling protein,uncoupling,1
513,Brown color,brown,1
514,Brown Fat,brown fat,1
515,Brown Fat,brown adipose tissue,2
516,Brown Fat,BAT,1
517,Brucellosis,Mediterranean fever,1
518,BTB-POZ Domain,BTB/POZ domain,1
519,BTC gene,betacellulin,2
520,BTC gene,BTC,2
521,"BTK protein, human",Bruton\'s tyrosine kinase,2
522,C17orf96 gene,C17orf96,1
523,C2 Domains,C2 domain,2
524,C7orf49 gene,MRI,1
525,C9orf72 gene,C9orf72,12
526,CA3 Term Type,CA3,1
527,CACNA1C gene,Cav1.2,1
528,CACNA1C gene,CaV1.2,1
529,CADM1 gene,Synaptic cell adhesion molecules,1
530,Caenorhabditis elegans,C. elegans,3
531,Caenorhabditis elegans,Caenorhabditis elegans,1
532,Calcineurin,Calcineurin,1
533,Calcineurin,calcineurin,3
534,Calcineurin B,calcineurin B,1
535,Calcium Channel,calcium channels,1
536,calcium channel activity,calcium channel,6
537,calcium channel activity,Calcium channel,1
538,Calcium Signaling,calcium-mediated signaling,1
539,CALM1 wt Allele,CaM,1
540,Calmodulin,calcium-dependent,1
541,calorie unit of energy,CAL,11
542,"Calorimeters, Isothermal Titration",Isothermal titration calorimetry,1
543,Calvaria,calvaria,1
544,Calvarial skull defect,cranial defects,1
545,Cancer Biology,cancer cell biology,1
546,Cancer Pain,cancer-associated,1
547,cancer-predisposing genes,susceptibility gene,1
548,Candidate Disease Gene,candidate genes,2
549,Capacity,capacity,4
550,"CAP-Gly Domain-Containing Linker Protein 1, human",CLIP-170,10
551,Carboxy-Terminal Amino Acid,C-terminal region,2
552,Carboxy-Terminal Amino Acid,C-terminal portion,1
553,Carboxy-Terminal Amino Acid,C-terminal amino acids,1
554,Carboxy-Terminal Amino Acid,C-terminal,1
555,Cardiac - anatomy qualifier,cardiac,4
556,cardiac development,cardiac development,2
557,Cardiac dysfunction,cardiac dysfunction,1
558,Cardiac function,cardiac function,1
559,Cardiac Hypertrophy,cardiac hypertrophy,6
560,Cardiac Hypertrophy,Cardiac hypertrophy,1
561,cardiac muscle cell differentiation,cardiac muscle differentiation,1
562,Cardiomyocyte hypertrophy,cardiomyocyte hypertrophy,1
563,Cardiomyopathies,cardiomyopathy,1
564,Cardiovascular,cardiovascular,2
565,Cardiovascular Diseases,cardiovascular diseases,1
566,Cardiovascular stress testing,cardiac stress,2
567,cargo loading into vesicle,cargo selection,1
568,Case (situation),cases,5
569,Casein Kinase II,CK2,2
570,CASP14 gene,Mice,8
571,CASP14 gene,mice,96
572,CASP8-Associated Protein 2,FLICE-associated huge protein,1
573,CASP8-Associated Protein 2,FLASH,4
574,caspase,caspases,1
575,Catabolism,degradation,20
576,Catalytic activity property,catalytic activity,1
577,Catalytic Domain,catalytic domains,1
578,Catalytic Domain,catalytic domain,2
579,Catalytic Domain,catalytic subunits,6
580,Cataract,cataracts,1
581,Cation Exchange Resins,cation exchange,2
582,Caveolae,caveolae,1
583,caveolin 1,caveolin-1,2
584,CBFA2T3 wt Allele,Eto2,4
585,CCDC88A gene,KIAA1212,2
586,"CCL2 protein, human",HC11,2
587,CCND1 gene,cyclin D1,4
588,CCND2 gene,cyclin D2,1
589,CCV gene,CCV,1
590,CD300C gene,LIR,1
591,CD40 Antigens,CD40,1
592,CD40LG wt Allele,IgM,3
593,CDC2 Protein Kinase,cdc2 kinase,1
594,cdc42 GTP-Binding Protein,Cdc42,2
595,CDH5 gene,VE-cadherin,1
596,CDISC Events Class,events,1
597,CDISC Findings Class,findings,44
598,CDISC Relationship Class,relationship,2
599,CDISC SDTM Body Position Terminology,position,2
600,CDISC SDTM Lesion Complexity Terminology,complexity,1
601,CDISC SDTM Subject Status Response Terminology,SSTRs,1
602,CDISC SDTM Submission Domain Abbreviation Terminology,domain,16
603,CDISC SDTM Submission Domain Abbreviation Terminology,D,2
604,"CDK2 protein, human",CDK2,1
605,CDK4/6 Inhibition,CDK4/6 inhibitors,1
606,CDK5 gene,Cdk5,3
607,CDK5 gene,CDK5,1
608,"CDK6 protein, human",CDK6,2
609,"CDK6 protein, human",CDK4/6,6
610,CDK9 gene,Cdk9,1
611,cDNA Library,cDNA library,1
612,cDNA Library,cDNA libraries,2
613,CEL gene,cell,11
614,Cell Adhesion,cell adhesion,3
615,Cell Adhesion Molecules,CAMs,5
616,Cell Adhesion Molecules,cell adhesion molecules,1
617,Cell body of neuron,neuronal cell,1
618,cell cortex,cell cortex,1
619,Cell Count,Treg cell numbers,1
620,Cell Cycle,cell division cycle,1
621,Cell Cycle Arrest,cell cycle arrest,1
622,cell cycle phase transition,cell cycle transition,1
623,Cell Cycle Progression,cell cycle progression,1
624,cell cycle regulator,cell cycle regulators,1
625,Cell Death,cell death,5
626,Cell Differentiation process,cell differentiation,1
627,Cell division,cell division,9
628,cell fate,Cell fate,1
629,cell growth,B cell growth,1
630,cell growth,general cell growth,1
631,cell growth,cell growth,3
632,cell growth,expansion,3
633,Cell Invasion,cancer cell invasion,1
634,cell leading edge,leading edge,1
635,Cell metabolism,cell metabolism,1
636,cell motility,cell motility,3
637,cell motility,cellular motility,1
638,Cell Movement,cell movement,3
639,Cell Nucleolus,nucleoli,2
640,Cell Nucleus,cell nucleus,2
641,Cell Nucleus,nucleus,32
642,Cell of bone,bone cells,1
643,cell periphery,cell periphery,2
644,Cell physiology,cellular physiology,1
645,Cell physiology,cellular functions,4
646,Cell physiology,cell functions,2
647,Cell physiology,cellular function,1
648,Cell Polarity,cell polarity,1
649,Cell Proliferation,cell proliferation,12
650,Cell Proliferation,cellular proliferation,2
651,Cell Respiration,cellular respiration,1
652,Cell secretion,secreted,1
653,Cell secretion,secretory,2
654,Cell surface,cell surface,9
655,Cell Surface Extensions,membrane protrusions,1
656,Cell Surface Proteins,cell surface proteins,1
657,Cell Survival,cell survival,13
658,cell type,cell types,10
659,cell type,cell type,1
660,cell-cell adhesion,cell-cell adhesion,2
661,Cells,cells,49
662,Cells,ES cells,5
663,Cells,Cells,4
664,Cellular,cellular,3
665,cellular localization,cellular localizations,1
666,Cellular Morphology (discipline),cell morphology,1
667,cellular process,cellular processes,3
668,cellular process,cellular process,1
669,cellular response to DNA damage stimulus,genotoxic stress response,1
670,cellular response to DNA damage stimulus,DNA damage response,1
671,cellular response to DNA damage stimulus,DDR,4
672,cellular response to pH,cellular response,2
673,cellular targeting,targeting,9
674,cellular targeting,Targeting,1
675,cellular_component,cellular components,2
676,CELSR3 gene,epidermal growth factor-like,1
677,Central Nervous System,central nervous system,8
678,Central Nervous System,CNS,10
679,Centric heterochromatin,condensed centromeric heterochromatin,1
680,centriole replication,centriole duplication,1
681,Centromere,centromeres,1
682,centromere protein F,CENP-F,1
683,Centrosome,centrosome,8
684,Centrosome,centrosomes,3
685,centrosome duplication,centrosome duplication,1
686,centrosome localization,centrosome localization,1
687,"Ceramide Kinase, Human",lipid kinase,1
688,Cerebellum,cerebellum,11
689,Cerebral cortex,cerebral cortex,6
690,Cerebral cortex,cerebral cortices,1
691,Certain (qualifier value),confident,2
692,Cervical atypism,cellular abnormality,1
693,Cessation of life,died,7
694,Chain device,chain,1
695,chain of objects,chains,2
696,Chamber of eye,anterior chamber aqueous,1
697,Changing,changes,15
698,Changing,modified,3
699,Changing,modifies,2
700,Changing,altered,4
701,Channel,channel,2
702,channel activity,channel activity,1
703,Characteristics,characteristics,2
704,Characteristics,characteristic,2
705,Characterization,Characterization,2
706,Characterization,characterization,9
707,Characterization,characterized,5
708,Characterization,uncharacterized,2
709,CHD1 gene,CHD1,19
710,CHD1 gene,CHD,3
711,CHD1 gene,chromodomain helicase DNA-binding,1
712,CHD1 gene,Chd1,5
713,"CHD1 protein, human",chromodomain-helicase-DNA-binding protein,1
714,CHD1 wt Allele,CHD-1,2
715,CHD8 gene,axis duplication inhibitor,1
716,CHD8 gene,CHD8,9
717,"CHD8 protein, human",Duplin,4
718,Checkpoint kinase 1,CHK1 kinase,1
719,Chemical Cleavage,cleavage,3
720,chemical cofactor,cofactors,1
721,Chemical extraction,extraction,1
722,chemosensitization/potentiation,potentiation,6
723,Chemotactic Factors,chemoattractant,1
724,Chicken Meat,chicken,2
725,Chimera organism,chimera,1
726,Chimeric antigen receptor,chimeric receptor,2
727,Chinese Hamster Ovary Cell,CHO cells,1
728,Chloride Ion,chloride,1
729,Cholinergic Receptors,acetylcholine receptor,1
730,Cholinergic Receptors,AChR,2
731,Chondrosarcoma,chondrosarcomas,1
732,Choose (action),select,1
733,Chromaffin Cells,chromaffin cells,1
734,chromatin immunoprecipitation,Chromatin immunoprecipitation,1
735,chromatin immunoprecipitation,Chromatin immunoprecipitation analysis,2
736,chromatin immunoprecipitation,chromatin immunoprecipitation,1
737,chromatin immunoprecipitation,ChIP,1
738,chromatin location,chromatin,24
739,chromatin remodeling,chromatin remodeling,3
740,Chromatin Remodeling Factor,chromatin remodelling factor,1
741,chromatin silencing,transcriptional silencing,1
742,Chromatin Structure,chromatin structure,3
743,Chromatin Structure,chromatin structures,1
744,Chromatin Structure,Chromatin structure,1
745,Chromatography,chromatography,1
746,"Chromatography, Affinity",affinity chromatography,3
747,"Chromatography, Affinity",tandem affinity purification,1
748,"Chromatography, Reverse-Phase",reverse phase chromatography,1
749,Chromosomal translocation,chromosomal translocations,1
750,chromosome 11q23,chromosome 11q23,1
751,Chromosome Condensation,condensed,1
752,Chromosome Condensation,chromosomal condensation,1
753,Chromosome Deletion,chromosomal deletion,1
754,chromosome localization,Chromosomal localization,1
755,chromosome localization,chromosomal localization,2
756,chromosome localization,mitotic chromosome localization,1
757,Chromosome Pairing,synapsis,1
758,Chromosomes,chromosomes,7
759,Chromosomes,mouse chromosomes,1
760,Chromosomes,chromosome,3
761,Chromosomes,chromosome ten,1
762,"Chromosomes, Artificial, Yeast",YAC,1
763,"Chromosomes, Human, Pair 10",chromosome 10,1
764,"Chromosomes, Human, Pair 11",mouse chromosome 11,1
765,"Chromosomes, Human, Pair 11",chromosome 11,1
766,"Chromosomes, Human, Pair 17",chromosome 17,1
767,"Chromosomes, Human, Pair 4",mouse chromosome 4,1
768,"Chromosomes, Human, Pair 5",mouse chromosome 5,1
769,"Chromosomes, Human, Pair 9",mouse chromosome 9,1
770,Chronic infectious disease,chronic infection,1
771,Chronic infectious disease,chronic infections,1
772,Chronic inflammation,chronic inflammation,1
773,Chronic Kidney Diseases,loss of function,2
774,Chronic Kidney Diseases,Loss of function,1
775,Chylomicron retention disease,chylomicron retention disease,1
776,Chylomicrons measurement,chylomicrons,1
777,Cilia,cilia,1
778,Cilia,cilium,1
779,Ciliopathies,ciliopathies,1
780,cilium assembly,ciliogenesis,2
781,Circadian Rhythms,cellular circadian rhythm,1
782,Circulating,circulating,1
783,cisplatin/ifosfamide/mesna/mitomycin protocol,mimics,2
784,Citric Acid Cycle,tricarboxylic acid cycle,1
785,Citric Acid Cycle,TCA,1
786,CKAP5 gene,cytoskeleton association,1
787,Clarify,clarification,1
788,Class,class,2
789,Class 1,class I,1
790,Class 2,class II,1
791,Class 5 (qualifier value),class 5,1
792,Class III Phosphatidylinositol 3-Kinases,class III phosphatidylinositol 3-kinase,1
793,Classes - encounter,classes,3
794,Classical Lissencephaly,LIS1,78
795,Classical Lissencephaly,lissencephaly sequence,2
796,Classical Lissencephaly,type I lissencephaly,4
797,Classical Lissencephaly,isolated lissencephaly sequence,1
798,Classical Lissencephaly,ILS,3
799,Classical Lissencephaly,classical lissencephaly,1
800,Classical Lissencephaly,lissencephaly 1,1
801,Classification of information,classification,1
802,Clathrin,clathrin,2
803,Clathrin,Clathrin,1
804,Clathrin Adaptors,clathrin adaptors,2
805,Clathrin-Coated Vesicles,clathrin-coated vesicles,2
806,Clathrin-Coated Vesicles,CCVs,2
807,Clathrin-Coated Vesicles,Clathrin-coated vesicles,1
808,clathrin-mediated endocytosis,clathrin-mediated endocytosis,1
809,Clearance,clearance,4
810,Clinical act of insertion,inserted,1
811,Clinical action,actions,1
812,Clinical presentation,clinical presentation,1
813,Clinical Trial Recruitment Plan,recruit,5
814,CLIP1 gene,CLIP170,1
815,CLIP2 gene,Cyln2,1
816,CLK3 gene,CLK3,1
817,Clock Device Component,clock,4
818,CLOCK gene,locomotor output cycles kaput,1
819,CLOCK gene,CLOCK,2
820,Clone Cells,clone,7
821,Clone Cells,cloning,9
822,Clone Cells,clones,12
823,Clone Cells,cloned,16
824,Clone Cells,Cloning,1
825,"Cloning, Molecular",molecular cloning,1
826,clustering of voltage-gated calcium channels,voltage-gated calcium channels,1
827,c-myc Genes,c-myc genes,2
828,c-myc Genes,c-myc,1
829,c-myc Genes,C-MYC,1
830,c-myc Genes,c-Myc,2
831,c-myc Proto-Oncogenes,proto-oncogene c-Myc,1
832,CNS - Brain - Cerebellum (MMHCC),mouse cerebellum,1
833,CNS - Brain - Hypothalamus (MMHCC),mouse hypothalamus,1
834,CNS - Brain (MMHCC),mouse brain,8
835,CNTRL gene,centrosomal proteins,1
836,Coactivated T Cell,activated T cells,2
837,Coat (physical object),coats,2
838,Coating (film),layer,3
839,Coating (film),coated,1
840,Cocoa extract,CoCoA,1
841,Coding,coding,4
842,Codon (nucleotide sequence),codons,1
843,"CoFactor brand of 5,10-methylenetetrahydrofolate",cofactor,3
844,Cognition,cognition,2
845,Cognitive,cognitive,1
846,Cognitive function: initiation,initiation,7
847,cohesion,cohesion,1
848,Coiled-Coil Domain,coiled-coil domain,1
849,Coiled-Coil Domain,coiled-coil domains,1
850,Coiled-Coil Domain,coiled-coil,1
851,Co-Immunoprecipitation,co-immunoprecipitated,2
852,Co-Immunoprecipitation,co-immunoprecipitation,3
853,Co-Immunoprecipitation,co-immunoprecipitates,3
854,Colforsin,forskolin,1
855,Colicin Plasmids,factors,6
856,Collagen fiber,procollagen fibres,1
857,Collection Object - UML Entity,collection,1
858,Collections (publication),collections,1
859,Collision-Induced Dissociation,collision-induced dissociation,1
860,Collision-Induced Dissociation,CID,5
861,Colon Carcinoma,colon carcinoma,1
862,colonies (qualifier value),colonies,2
863,Colorectal Cancer,colorectal cancer,2
864,Column (arrangement),column,1
865,combination of objects,combination,8
866,Combinations (Undergarment),combinations,1
867,Communication,communication,1
868,COMP gene,cartilage oligomeric matrix protein,1
869,COMP gene,COMP,1
870,Compact Pattern,compact,1
871,compactin,compaction,1
872,comparative analysis,comparative analysis,1
873,comparative study publication,Comparative studies,1
874,Comparison,Comparison,3
875,Comparison,comparisons,1
876,Comparison,comparison,6
877,Comparison,Compared,1
878,Comparison,compared,4
879,Compartments [PK],compartments,4
880,Compensated,compensating,1
881,Compensation as a Defense Mechanism,compensation,2
882,competition,competition,1
883,competition,Competitive,1
884,COMPLEMENT COMPONENT C1r/C1s DEFICIENCY,C1r/C1s,1
885,Complement System Proteins,complement,1
886,Complete,completely,1
887,Complete congenital stationary night blindness,cCSNB,1
888,Complete Pharyngeal Contraction,complete,3
889,Complete Pharyngeal Contraction,Complete,1
890,Complex,complex,44
891,Complex,t complex,2
892,Complex,Complex,1
893,complex (molecular entity),protein complexes,2
894,complex (molecular entity),complexes,17
895,complex (molecular entity),AP complexes,2
896,complex (molecular entity),Complexes,1
897,Component object,components,11
898,"Component, LOINC Axis 1",component,5
899,Composition,composition,3
900,Composition,compositions,1
901,Compound heterozygous,compound heterozygous,1
902,Comprehensive,comprehensive,4
903,compromise,compromises,1
904,Concept Status - Active,active,10
905,Conditional,dependent,4
906,Conditional,actin dependent,1
907,Conditioning (Psychology),conditioning,1
908,Cone pedicle,cone pedicles,1
909,Confirmation,confirmation,1
910,Confusion,confusion,1
911,Congenital Abnormality,abnormalities,4
912,Congenital Abnormality,brain abnormalities,1
913,Congenital Abnormality,head malformations,1
914,Congenital Abnormality,malformation,1
915,Congenital Abnormality,developmental defect,1
916,Congenital Abnormality,congenital anomalies,1
917,Congenital Abnormality,developmental defects,1
918,Congenital Abnormality,developmental abnormalities,1
919,Congenital anomaly of brain,brain malformation,2
920,Congenital Disorders,congenital disorder,1
921,Congenital Heart Defects,heart defects,2
922,Congenital malformation syndrome,multiple congenital anomalies,1
923,Congenital omphalocele,omphalocele,1
924,conjugation,conjugation,1
925,Conjunction,conjunction,3
926,Consequence of,consequence,7
927,Consequence of,consequences,7
928,Consequent,consequent,1
929,Conservation,conservation,2
930,Consistent with,consistent with,19
931,Consistent with,Consistent with,10
932,constitutive androstane receptor,constitutive active,1
933,Constrain,constrains,1
934,Contact with,contacting,1
935,contextual factors,contexts,2
936,contextual factors,context,1
937,Continuance of life,survival,9
938,Contraction (finding),contraction,3
939,Contribution,contribution,4
940,Contribution,contributions,1
941,control act - action,action,8
942,control aspects,control,15
943,control aspects,Control,1
944,Control function,controlled,2
945,Control function,controlling,7
946,Conversions,conversion,1
947,cooperation,cooperation,1
948,Coordinate on an axis or a grid,coordinates,1
949,Core,core,6
950,Core,Core,1
951,Co-Repressor Proteins,corepressor,1
952,Co-Repressor Proteins,co-repressors,1
953,Corneal Neovascularization,corneal angiogenesis,1
954,Correlation,correlation,1
955,Correlation,correlate,2
956,Correlation,correlated,1
957,Cortex of bone,cortical bone,1
958,Cortex of Organ,cortex,2
959,Cortical actin cytoskeleton,cortical actin cytoskeleton,1
960,cortical plate,cortical plate,1
961,COS Cells,COS cells,4
962,COS Cells,Cos cells,1
963,COS-7 Cells,COS-7 cells,1
964,Cost Control,controls,8
965,Count Dosing Unit,count,1
966,Couple (action),coupling,4
967,Couples (persons),couples,1
968,Covalent Interaction,covalent,1
969,CPOX gene,coproporphyrinogen oxidase,1
970,Cranial,cranial,1
971,Cranial sensory ganglion,cranial sensory ganglion,1
972,craniofacial,craniofacial,2
973,Craniofacial Abnormalities,craniofacial abnormalities,2
974,Craniofacial Abnormalities,craniofacial anomalies,1
975,craniofacial development,Craniofacial development,1
976,craniofacial development,craniofacial development,1
977,craniofacial suture morphogenesis,craniofacial morphogenesis,1
978,Crawling,crawling,1
979,"Creatine Kinase, MM Form",muscle creatine kinase promoter,1
980,"Creatine Kinase, MM Form",muscle creatine kinase,1
981,"Creatine Kinase, MM Form",MCK,1
982,"CREBBP protein, human",CBP,5
983,"CRK protein, human",p38,1
984,Cross Reactions,crosstalk,1
985,Crossbreeding,hybridization,8
986,Cross-linking,cross-linking,1
987,Cross-Talk,cross-talk,4
988,CRY1 gene,CRY1,5
989,Crying,CRY,1
990,Cryptochrome-2,CRY2,11
991,Cryptochrome-2,CRY2 protein,1
992,Cryptochromes,Cryptochromes,1
993,Crystal Structure,crystal structure,2
994,Crystal Structure,crystal structures,2
995,Crystal Structure,cocrystallized,1
996,Crystals,crystal,1
997,CSPG4 wt Allele,NG2,7
998,CTCF gene,CTCF,3
999,CTNND1 wt Allele,p120,1
1000,CTSK gene,cathepsin K,1
1001,CUL3 gene,Cullin 3,1
1002,CUL3 gene,Cul3,9
1003,Cullin Family Gene,cullin family,1
1004,cullin-3,Cul-3,3
1005,cullin-3,CUL3 protein,1
1006,cullin-3,cullin-3,1
1007,Culture Dose Form,culture,5
1008,Culture Dose Form,cultured,9
1009,Cultured Cell Line,ES cell lines,1
1010,Cultured Cell Line,cell lines,6
1011,Cultured Cell Line,cultured cell lines,1
1012,Cultured Cell Line,cell line,1
1013,Cultured Cells,cultured cells,1
1014,Current (present time),currents,12
1015,Customize,custom,1
1016,Cutis Laxa,loose skin,1
1017,Cutis Laxa,cutis laxa,1
1018,CX546,CX546,1
1019,Cyclic AMP-Dependent Protein Kinases,cAMP-dependent protein kinase,1
1020,Cyclic AMP-Dependent Protein Kinases,protein kinase A,1
1021,Cyclin D,cyclin D,6
1022,Cyclin E,Cyclin E,1
1023,Cyclin E,cyclin E,4
1024,Cyclin T1,cyclin T1,1
1025,Cyclin-Dependent Kinase 4,CDK4,1
1026,Cyclin-Dependent Kinases,G1 cyclin-dependent kinases,1
1027,Cyclin-Dependent Kinases,cyclin-dependent kinases 4,1
1028,cyclin-dependent protein kinase activity,CDK,1
1029,Cyclins,cyclins,1
1030,CYFIP1 gene,Cytoplasmic FMRP Interacting Proteins,1
1031,CYFIP1 gene,CYFIP1,5
1032,CYFIP1 gene,Cyfip1,3
1033,CYFIP2 gene,CYFIP2,1
1034,Cysteine,cysteine,4
1035,Cysteine,Cys,1
1036,Cysteine-Rich Domain,cysteine-rich domains,1
1037,Cystic Fibrosis,cystic fibrosis,1
1038,cystinylglycylglycine,cystinyl-bis-glycine,3
1039,cytidylyl-3'-5'-guanosine,CpG,7
1040,Cytochalasin D,cytochalasin D,1
1041,cytokine,cytokine,1
1042,cytokine,cytokines,2
1043,Cytoplasm,cytoplasm,11
1044,Cytoplasmic,cytoplasmic,5
1045,Cytoplasmic Domain,cytoplasmic domain,4
1046,Cytoplasmic Domain,cytoplasmic tails,1
1047,Cytoplasmic Domain,cytoplasmic domains,1
1048,Cytoplasmic Domain,cytoplasmic tail,2
1049,cytoplasmic dynein heavy chain,CDHC,3
1050,Cytoplasmic Dyneins,motor cytoplasmic dynein,2
1051,Cytoplasmic Dyneins,cytoplasmic dynein,6
1052,Cytoplasmic Dyneins,cytoplasmic dynein function,3
1053,Cytoplasmic Dyneins,Cytoplasmic dynein,1
1054,Cytoplasmic Dyneins,cytoplasmic dynein regulator,1
1055,Cytoplasmic matrix,cytosolic face,2
1056,Cytoplasmic matrix,cytosol,2
1057,Cytoplasmic matrix,cytosolic,4
1058,Cytoplasmic Protein,cytoplasmic proteins,2
1059,cytoplasmic SCF ubiquitin ligase complex,cytoplasmic complex,1
1060,cytoplasmic sequestering of protein,cytoplasmic retention,1
1061,cytoskeletal part,cytoskeletal components,1
1062,Cytoskeletal Proteins,cytoskeletal protein,1
1063,Cytoskeletal Proteins,cytoskeletal proteins,2
1064,Cytoskeleton,cytoskeletal,2
1065,Cytoskeleton,actin cytoskeletal,3
1066,Cytoskeleton,cytoskeleton,1
1067,Cytoskeleton,cell cytoskeleton,1
1068,cytotoxic,cytotoxic,1
1069,cytotoxicity,cytotoxicity,1
1070,Dab fish,Dab,1
1071,Daily,Daily,1
1072,Dancing,DANCE,1
1073,Data call receiving device,data,54
1074,Data call receiving device,Data,3
1075,Data Set,dataset,1
1076,Databases,database,2
1077,day,days,7
1078,Daytime,diurnal,1
1079,"DCN protein, human",proteoglycan core protein,1
1080,DCX gene,DCX,11
1081,DCX gene,Dcx,1
1082,DDX41 gene,Abs,1
1083,DDX53 gene,cage,1
1084,de novo,de novo,2
1085,deacetylase activity,deacetylase activity,1
1086,Deacetylation,deacetylation,2
1087,debate,debate,1
1088,Decidual,decidual,1
1089,Decipher Prostate Cancer Test,deciphering,1
1090,Declining,declining,1
1091,Decrease,decrease,6
1092,Decrease,decreases,8
1093,Decreased,diminish,1
1094,Decreasing,decreasing,1
1095,Deeply,deeply,1
1096,DEFB1 wt Allele,BD1,4
1097,defects aspect,defects,36
1098,defects aspect,Defects,1
1099,Deficiency,deficient,12
1100,Deficiency,Deficiens,1
1101,Deficiency,deficiens,1
1102,Deficiency,deficiency,8
1103,Deficiency,Deficiency,2
1104,Deficit,deficits,4
1105,Deficit,deficit,3
1106,Definitive,definitive,1
1107,Definitive endoderm,primitive endoderm,1
1108,Deformity,anatomical abnormalities,1
1109,Degree Unit of Plane Angle,degree,1
1110,Delete - Document Availability Status,deleted,1
1111,Delta (difference),differences,2
1112,demethylation,demethylation,1
1113,Dendrites,dendrites,5
1114,density,density,2
1115,density,densities,1
1116,Departure - action,cleaving,1
1117,Dephosphorylation,dephosphorylates,1
1118,Dephosphorylation,dephosphorylation,1
1119,Depletion,depletion,3
1120,Depletion,Depletion,4
1121,Depletion,depleted,3
1122,Deposition,deposits,1
1123,Depressed Level of Consciousness,depressed,2
1124,Deprivation,deprivation,1
1125,Deregulation,deregulation,1
1126,Deregulation,deregulated,1
1127,derivatives,derivatives,1
1128,Dermomyotome,dermomyotome,1
1129,Desert environment,deserts,1
1130,Designated,designated,5
1131,Designated,designate,1
1132,Destination,destination,2
1133,Destruction of tissue,tissue destruction,1
1134,Detached,detached,1
1135,Detachment psychological,detachment,1
1136,Detectable,detectable,1
1137,Detected (finding),detected,23
1138,Detection,detection,3
1139,Determination Aspects,determination,3
1140,Determination of bacterial growth,bacterial growth,1
1141,Deubiquitination,deubiquitination,1
1142,Development,mouse development,4
1143,Development,developments,1
1144,Development,cancer development,2
1145,Development Lot,development,66
1146,Development of the breasts,breast development,1
1147,Developmental (qualifier value),developmental,1
1148,Developmental process,developmental processes,1
1149,Developmental stages,developmental stage,1
1150,Developmental stagnation,developmental arrest,2
1151,DHX30 gene,DHX30,1
1152,Diabetes Mellitus,diabetes,7
1153,"Diabetes Mellitus, Insulin-Dependent",type 1 diabetes,3
1154,diabetic,diabetic,1
1155,Diameter (qualifier value),diameter,1
1156,Diaphragm Dosage Form,diaphragm,3
1157,Diastasis,separation,1
1158,dictated - DocumentCompletion,dictated,1
1159,"Diet, High-Fat",high-fat diet,2
1160,Different,differentially,1
1161,Digestion,digestion,1
1162,Dihydropyridines,dihydropyridine,1
1163,Dimensions,dimensions,1
1164,dimer,dimer,1
1165,dimer,dimers,2
1166,Dimerization,dimerization,8
1167,Dimerization,dimerize,1
1168,Diploid Cell,somatic cell,1
1169,Diploid Cell,somatic cells,1
1170,Diptera,flies,1
1171,Direction,direction,2
1172,Discharge (release),release,6
1173,discoidin domain receptor 2,type 1 receptor tyrosine kinases,1
1174,Discriminate,discriminate,1
1175,Disease,disease,5
1176,Disease,diseases,3
1177,Disease,disorder,2
1178,Disease Response,response,30
1179,Disease susceptibility,vulnerability,1
1180,disease transmission qualifier,transmission,1
1181,Disintegration (morphologic abnormality),disintegration,1
1182,Disintegration (morphologic abnormality),decay,1
1183,Disintegrins,disintegrin,1
1184,Disorder of eye,eye disease,1
1185,Dispersion,dispersion,1
1186,disrupted,disrupted,8
1187,disrupted,disrupt,5
1188,disrupted,disrupts,4
1189,Disruption,disruption,8
1190,Disruption,Disruption,6
1191,Disruption,disruptions,1
1192,Disruption,gene disruption,1
1193,Dissecting,dissect,1
1194,Dissociation,Dissociation,1
1195,Distal,distal,2
1196,Distribution,distributed,1
1197,Disturbance,disturbances,1
1198,Diversity,diversity,3
1199,Diversity,diverse,3
1200,Divide,divide,2
1201,DLG2 gene,chapsyn-110,1
1202,DLG2 gene,PSD-93,3
1203,DLG3 gene,SAP102,1
1204,DLG4 wt Allele,PSD95,4
1205,DNA,DNA,11
1206,dna binding,DNA binding,8
1207,DNA Binding Domain,DNA binding domain,3
1208,DNA Breaks,breaks,1
1209,DNA Damage,DNA damage,3
1210,DNA Fragmentation,DNA fragment,1
1211,DNA glycosylase,urea DNA glycosylase,1
1212,DNA Methylation [PE],DNA methylation,2
1213,DNA Mutational Analysis,mutational analyses,1
1214,DNA polymerase activity,DNA polymerase activity,1
1215,DNA polymerase alpha-primase,DNA polymerase alpha-primase,1
1216,DNA Primase,DNA primase,1
1217,DNA primase activity,DNA primase activity,1
1218,DNA Repair,DNA repair,1
1219,DNA Repair,DNA damage repair,1
1220,DNA Replication,DNA synthesis,2
1221,DNA Replication,DNA replication,7
1222,DNA Sequence,sequences,17
1223,DNA Sequence,DNA sequence,2
1224,DNA Sequence Rearrangement,rearrangement,1
1225,"DNA, Complementary",cDNA,44
1226,"DNA, Complementary",cDNAs,24
1227,"DNA, Double-Stranded",double-stranded DNA,1
1228,DNA-Binding Proteins,DNA binding proteins,1
1229,DNA-Binding Proteins,TDP-43,1
1230,DNA-Directed RNA Polymerase,RNA polymerase,1
1231,DNAH7 gene,DNAH7,2
1232,DNMT1 gene,Dnmt1,6
1233,DNMT1 gene,DNA methyltransferase,1
1234,Dock - Manufactured Object,docks,1
1235,Document Completion - incomplete,incomplete,1
1236,Document type,document,1
1237,Does carry,carries,1
1238,Does steer,steering,1
1239,Does turn (finding),turns,1
1240,Dominant,dominant,5
1241,dominant inheritance,dominant inheritance,1
1242,Dominant-Negative Mutation,dominant-negative,3
1243,Dosage,doses,1
1244,Dosage,dosage,1
1245,Dosing Days to Detection,detect,2
1246,Down Syndrome,Down syndrome,10
1247,Down Syndrome,DS,2
1248,Down-Regulation,down-regulation,7
1249,Down-Regulation,down-regulated,1
1250,Down-Regulation,down-regulating,1
1251,Down-Regulation,downregulation,4
1252,Down-Regulation,Down-regulation,1
1253,Downstream,downstream,8
1254,DPEP1 gene,MBD1,7
1255,DPEP1 gene,Mbd1,1
1256,DPEP3 gene,DPEP3,4
1257,DPEP3 gene,dipeptidase 3,1
1258,DPEP3 gene,Dpep3,3
1259,DPF3 gene,BAF45c,1
1260,"Drosophila <fruit fly, genus>",Drosophila,3
1261,Drosophila melanogaster,Drosophila melanogaster,1
1262,Drug Delivery Systems,drug targeting,1
1263,Drug Design,rational drug design,1
1264,Drug-induced,drug-induced,1
1265,DRUGS,drugs,1
1266,Dual,dual,3
1267,Dual diagnosis (psychiatry),psychiatric diagnoses,1
1268,Duplicate,double,1
1269,Duplicate,duplicates,2
1270,Duplication (finding),duplicated,1
1271,Duplication (finding),duplications,3
1272,Duplication (finding),duplication,1
1273,Duration of menstrual flow,period length,1
1274,dynactin subunit 1,dynactin,8
1275,dynactin subunit 1,Dynactin,1
1276,Dynamic,dynamic,1
1277,Dynamics,dynamics,10
1278,dynein activity,dynein activity,2
1279,Dynein ATPase,dynein,18
1280,Dynein complex,dynein motor complex,1
1281,dynein heavy chain binding,Dynein Heavy chain 7,1
1282,DYRK1A gene,DYRK,6
1283,DYRK1A gene,Dyrk gene,2
1284,DYRK1A gene,DYRK gene,1
1285,DYRK1A gene,Dyrk protein,2
1286,DYRK1A gene,Dyrk1A,9
1287,DYRK1A gene,DYRK1A,17
1288,DYRK1A gene,dual-specificity tyrosine phosphorylation-regulated kinase 1A,1
1289,DYRK1A gene,MNB,1
1290,DYRK1A gene,DYRK1A kinase,1
1291,DYRK1A gene,Dyrk1a,2
1292,DYRK2 gene,DYRK2,1
1293,DYRK3 gene,DYRK3,3
1294,DYSFUNCTION - SKIN DISORDERS,dysfunction,1
1295,e protein,E protein,1
1296,E3 SUMO-Protein Ligase PIAS1,protein interacting,1
1297,Early,early,27
1298,Early lethal,early lethal,1
1299,Early stage,early stages,1
1300,E-Box Elements,E-box,3
1301,E-Cadherin,E-cadherin,1
1302,Ectoderm,ectoderm,1
1303,Ectopic,ectopic,2
1304,Ectopic,Ectopic,1
1305,Edema,oedema,2
1306,Edetic Acid,EDTA,1
1307,Effect,effects of,4
1308,Effect,effects,7
1309,Effect,effect,12
1310,Effect,Cis effects,1
1311,Effect,cis effects,1
1312,Effective,effective,1
1313,Efficacy Study,efficacy,2
1314,Efficiency,efficiency,3
1315,Efficient,efficient,5
1316,EGF Family of Proteins,epidermal growth factor-like domains,1
1317,EGF gene,epidermal growth,1
1318,EGF gene,epidermal growth factor,4
1319,EGF gene,EGF,3
1320,EGF gene,Epidermal growth factor,1
1321,EGFL6 gene,EGF-like,2
1322,"EGFR protein, human",ErbB1,1
1323,EGFR wt Allele,ERBB,2
1324,EIF2B5 wt Allele,CaCh 1,2
1325,EIF2B5 wt Allele,CaCh 2,4
1326,EIF2B5 wt Allele,CaCh 3,2
1327,elastase activity,elastase activity,1
1328,Elastic Fibers,elastic fibres,5
1329,Elastic Fibers,elastic fibre,1
1330,elasticity,elasticity,1
1331,Electroconvulsive Therapy,EST,1
1332,Electron Microscopy,electron microscopy,6
1333,Electrophoretic Mobility Shift Assay,electrophoretic mobility shift assay,1
1334,Electrophysiology (science),electrophysiology,2
1335,Elements,elements,1
1336,Elevated,elevated,5
1337,Elevation,elevation,1
1338,Elicited by,elicit,1
1339,ELN gene,2-Mb Williams-Beuren syndrome,1
1340,ELN gene,WBS,2
1341,ELN gene,elastin,2
1342,ELSPBP1 gene,E12,2
1343,Embryo,embryos,24
1344,Embryo,embryonic day,7
1345,Embryo,embryonic,16
1346,Embryo,mouse embryos,11
1347,Embryo,Embryos,2
1348,Embryo,embryo,6
1349,Embryo,mouse embryo,4
1350,Embryo,E,3
1351,Embryo,mouse embryonic,1
1352,Embryo,Mouse embryos,1
1353,EMBRYONAL CELL CARCINOMA,embryonal carcinoma cell line,1
1354,Embryonic brain,embryonic brain,1
1355,Embryonic Cell,embryonic cell,1
1356,Embryonic Development,embryogenesis,10
1357,Embryonic Development,embryonic development,10
1358,Embryonic Development,murine embryogenesis,1
1359,Embryonic Development,mouse embryogenesis,2
1360,Embryonic heart,Embryonic mouse heart,1
1361,Embryonic heart,embryonic heart,3
1362,Embryonic heart,embryonic hearts,1
1363,Embryonic Lethal Mutation,embryonic lethal,3
1364,Embryonic Nervous System,embryonic nervous system,1
1365,Embryonic Stem Cells,ES,3
1366,Embryonic Stem Cells,embryonic stem,2
1367,Embryonic Stem Cells,embryonic stem cells,5
1368,Embryonic Stem Cells,ESCs,2
1369,Embryonic tissue,embryonic tissues,1
1370,Emericella nidulans allergenic extract,Aspergillus nidulans,2
1371,emotional dependency,dependency,1
1372,Encephalomyocarditis virus,encephalomyocarditis,1
1373,Encode (action),encode,5
1374,Encode (action),encoded,1
1375,Encode (action),encoding,2
1376,Encode (action),gene encoding,1
1377,Encounter due to puberty,puberty,1
1378,Encounter due to vagabond status,transients,1
1379,End,ends,2
1380,Endocardium Specimen Code,endocardium,1
1381,Endocervical Route of Drug Administration,EC,1
1382,Endocrine Cells,endocrine cells,1
1383,Endocytosis,endocytosis,5
1384,endodeoxyribonuclease III activity,Endonuclease III,1
1385,Endoderm,endoderm,4
1386,Endogenous,endogenous,23
1387,Endogenous,Endogenous,2
1388,Endopeptidase K,proteinase K,1
1389,Endoplasmic Reticulum,endoplasmic reticulum,1
1390,Endosomes,endosomes,1
1391,endothelial cell migration,endothelial cell migration,2
1392,endothelial cell proliferation,endothelial cell proliferation,2
1393,Endothelial Cells,endothelial cells,24
1394,Endothelial Cells,Endothelial cells,1
1395,Endothelial Cells,ECs,2
1396,Endothelial Cells,endothelial cell,3
1397,Endothelial Cells,endothelial cell lines,1
1398,Endothelium,endothelium,1
1399,Endothelium,endothelial,1
1400,energy homeostasis,energy homeostasis,1
1401,Energy Metabolism,energy expenditure,1
1402,Energy Metabolism,energy metabolism,2
1403,Enhance (action),enhanced,11
1404,Enhance (action),enhance,2
1405,Enhance (action),enhances,7
1406,Enhance (action),Enhanced,1
1407,Enhancer brand,enhancer,1
1408,Enhancer of transcription,enhancers,1
1409,enrich,enrich,1
1410,Entity,entity,1
1411,Entity Determiner - specific,specific,2
1412,Entity Name Part Type - family,family,23
1413,Entry (data),entry,2
1414,"env Gene Products, Human Immunodeficiency Virus",human immunodeficiency virus envelope protein,1
1415,Environment,environment,2
1416,Environment,native environment,1
1417,Enzymatic Activity [MoA],enzymatic activity,4
1418,enzyme activity,enzyme activity,1
1419,Enzyme Assays,enzyme assays,1
1420,Enzyme-Linked Immunosorbent Assay,Enzyme-linked immunosorbent,1
1421,Enzymes,enzyme,13
1422,Enzymes,enzyme heme,1
1423,"Enzymes, hematological",enzymes,7
1424,EP300 gene,p300,7
1425,EPHB2 wt Allele,ERK,2
1426,Epiblast,epiblast,1
1427,Epidermal Growth Factor Receptor,epidermal growth factor receptor 4,1
1428,Epidermal Growth Factor Receptor Pathway Substrate 15,Eps15,2
1429,Epidermal Growth Factor Receptor Pathway Substrate 8,EPS8,1
1430,Epidermis,epidermis,1
1431,Epiphysial cartilage,epiphyseal growth plate,1
1432,epithelial,epithelial,1
1433,epithelial,epithelia,1
1434,epithelial cell morphogenesis,epithelial morphogenesis,1
1435,Epithelial cell of renal tubule,renal cell line,1
1436,Epithelial Cells,epithelial cells,10
1437,Epithelial hyperplasia,epithelial hyperplasia,1
1438,Epithelial proliferation,epithelial proliferation,1
1439,epithelial to mesenchymal transition,epithelial-mesenchymal,1
1440,Epithelioma,epithelial tumors,1
1441,Epithelium,epithelium,5
1442,Epitopes,epitope,1
1443,Equal,equivalent,2
1444,Equilibrium,balance,2
1445,Equilibrium,balancing,1
1446,Equilibrium,equilibrium,1
1447,Equivalent Weight,equivalents,1
1448,ErbB Receptors,erbB family,1
1449,ErbB Receptors,epidermal growth factor receptor family,1
1450,ErbB Receptors,epidermal growth factor receptor family member,2
1451,ErbB Receptors,ErbB family,1
1452,erbB-2 Receptor,erbB2,2
1453,erbB-2 Receptor,ErbB2,1
1454,ERBB3 gene,erbB3,3
1455,ERBB3 gene,ErbB3,2
1456,ERBB4 gene,ErbB4 gene,1
1457,ERBB4 gene,erbB4 gene,2
1458,ERBB4 Signaling Pathway,ErbB4 signaling,3
1459,EREG gene,epiregulin,1
1460,Erg - unit of measure,ERG,1
1461,Erythroid,erythroid,1
1462,Erythroid Cells,erythroid cells,1
1463,Erythropoiesis,erythrocyte differentiation,1
1464,Escherichia coli,Escherichia coli,3
1465,Escherichia coli,E. coli,2
1466,Escherichia coli,E.coli,1
1467,Essential,essential,24
1468,establishment and maintenance of localization,localization,28
1469,establishment and maintenance of localization,Localization,1
1470,establishment and maintenance of localization,colocalization,6
1471,establishment and maintenance of localization,site localization,1
1472,ESTERASE C,ESC,3
1473,Estrogen Receptors,estrogen receptor,1
1474,Estrogens,estrogen,1
1475,Estrogens,oestrogen,1
1476,Etiology,etiology,4
1477,Euchromatin,euchromatin,1
1478,Euchromatin,euchromatin protein,1
1479,Eukaryota,eukaryotes,2
1480,"Eukaryotic Translation Initiation Factor 4E, human",eIF4E,1
1481,Evaluation,evaluated,1
1482,Evaluation,evaluate,1
1483,Event Consequence - Death,death,2
1484,Evidence,evidence,19
1485,Evidence,Evidence,1
1486,Examined,examined,1
1487,Exception - Property or Attribute,exception,1
1488,Excessive,excessive,4
1489,Excitation Contraction Coupling,excitation-contraction coupling,1
1490,Excitatory Postsynaptic Currents,mEPSCs,1
1491,Excitatory Synapse,excitatory synapses,3
1492,Excretory function,elimination,3
1493,Exercise Pain Management,exercise,1
1494,Exist,exist,1
1495,EXOC6 gene,Sec15l1,1
1496,Exocytosis,exocytosis,1
1497,Exodeoxyribonuclease V,ATP-dependent,1
1498,Exogenous,exogenous,3
1499,Exogenous,Exogenous,1
1500,Exons,exons,10
1501,Exons,exon 1,1
1502,Exons,exon 2,1
1503,Exons,exon,2
1504,Expectation,expectation,1
1505,expense,expense,1
1506,expense,expense of,1
1507,Experience,experience,1
1508,Experimental Organism Aborted,aborted,1
1509,Experimental Result,result,1
1510,explanation,explanation,1
1511,export,export,1
1512,Exposure to,exposed to,1
1513,Exposure to,exposure to,1
1514,Expressed Sequence Tags,ESTs,1
1515,Expression procedure,expression,164
1516,Expression procedure,Expression,18
1517,Expression procedure,D expression,1
1518,expression vector,expression vector,5
1519,Extent,extends,1
1520,Extracellular,extracellular region,2
1521,Extracellular,extracellular part,2
1522,Extracellular,extracellular side,1
1523,Extracellular Domain,extracellular domain,7
1524,Extracellular Domain,extracellular domains,1
1525,Extracellular Domain,intracellular domain,1
1526,Extracellular Matrix,extracellular matrix,2
1527,Extracellular Matrix Degradation,extracellular matrix degradation,1
1528,Extracellular Matrix Proteins,extracellular matrix proteins,1
1529,Extracellular Protein,extracellular protein,2
1530,Extraction,removal,3
1531,Extraembryonic membranes,extraembryonic,1
1532,Extrinsic,outer,3
1533,Extrinsic,outside,1
1534,Eye - Retina (MMHCC),mouse retina,1
1535,FABP4 wt Allele,AP2,4
1536,Face,faces,1
1537,Face (spatial concept),face,2
1538,Facilitation,facilitation,1
1539,F-Actin,F-actin,1
1540,Factor,Determinants,1
1541,Factor,determinant,1
1542,Factor,determinants,2
1543,failed,fails,3
1544,Failure (biologic function),failure,2
1545,FAK Family Tyrosine Kinase,tyrosine kinase family,1
1546,Family,gene families,1
1547,Family,families,3
1548,Family Dasypodidae,Armadillo,1
1549,Family history of hereditary disease,genetic diseases,2
1550,Family member,family members,4
1551,Family member,family member,1
1552,Fanconi anaemia nuclear complex,nuclear complex,1
1553,FAS-AS1 gene,SAF,1
1554,Fasting,fasting,1
1555,Fat-Restricted Diet,low-fat diet,1
1556,fatty acid metabolism,fatty acid metabolism,1
1557,Fatty Acids,fatty acids,1
1558,FBXL21 gene,FBXL21,1
1559,FBXL21 gene,Fbxl21 gene,1
1560,FBXL3 gene,FBXL3,2
1561,FBXL3 gene,Fbxl3,1
1562,FBXO2 gene,F-box protein,1
1563,Feature,features,3
1564,feeding of newborn,feeding,1
1565,Feeling upset,UpSET,1
1566,Femto,F,1
1567,"Fermitin Family Homolog 2, human",Kindlin-2,4
1568,FERROCHELATASE,ferrochelatase,1
1569,"Ferrum metallicum, Homeopathic preparation",iron,3
1570,Fertility,fertile,4
1571,Fertility Domain,fertility,7
1572,Fetal development of the mammalian embryo or fetus,fetal development,1
1573,FGF1 gene,endothelial cell growth,1
1574,FGF1 gene,endothelial cell growth factor,1
1575,"FGF10 protein, human",FGF-10,1
1576,FGF23 gene,FGF23,7
1577,"FGF7 protein, human",FGF-7,1
1578,FGFR1 gene,fibroblast growth factor receptor 1,2
1579,FGFR1 gene,fgfr-1,2
1580,FGFR1 gene,H3,7
1581,"FGFR1 protein, human",FGFR1,30
1582,"FGFR1 protein, human",FgfR1,1
1583,FGFR1 wt Allele,FLG,1
1584,"FGFR2 protein, human",FGFR2,1
1585,"FGFR3 protein, human",FGFR3,1
1586,FGG gene,fibrinogen gamma chain,1
1587,Fibrillins,fibrillins,1
1588,Fibrinogen,fibrinogen,2
1589,Fibroblast Growth Factor,fibroblast growth factor,6
1590,Fibroblast Growth Factor,FGF,29
1591,Fibroblast Growth Factor,FGFs,4
1592,Fibroblast Growth Factor,murine fibroblast growth factor,1
1593,Fibroblast Growth Factor,fibroblast growth factors,1
1594,Fibroblast Growth Factor,Fibroblast growth factors,1
1595,Fibroblast Growth Factor,Fibroblast growth factor,1
1596,Fibroblast Growth Factor 2,bFGF,4
1597,Fibroblast Growth Factor 2,FGF-2,15
1598,Fibroblast Growth Factor 2,fibroblast growth factor-2,1
1599,Fibroblast Growth Factor 2,Basic fibroblast growth factor,1
1600,Fibroblast Growth Factor 21 Measurement,Fibroblast growth factor 21,1
1601,Fibroblast Growth Factor 21 Measurement,FGF21,4
1602,Fibroblast Growth Factor 21 Measurement,FGF21 activity,2
1603,Fibroblast Growth Factor Receptors,fibroblast growth factor receptor,1
1604,Fibroblast Growth Factor Receptors,bFGF-R,3
1605,Fibroblast Growth Factor Receptors,chick FGF receptor,1
1606,Fibroblast Growth Factor Receptors,FGF receptor,2
1607,Fibroblast Growth Factor Receptors,FGF receptors,4
1608,Fibroblast Growth Factor Receptors,fibroblast growth factor receptor-1,1
1609,Fibroblast Growth Factor Receptors,FGFR,2
1610,fibroblast growth factor-1,FGF-1,1
1611,Fibronectin Type III Domain,fibronectin type III domains,2
1612,Fibronectin Type III Domain,fibronectin type III,1
1613,Fibronectin Type III Domain,fibronectin type 3 domain,1
1614,Fibronectins,fibronectin,2
1615,Fibrosis,fibrosis,1
1616,Fibula,fibula,1
1617,Figs - dietary,FIG,1
1618,filamentous actin location,filamentous actin,1
1619,Filamin C,filamin C,5
1620,Filamin C,FLNC,2
1621,Filamins,filamin,5
1622,Filamins,filamins,1
1623,Firm,firm,1
1624,Flank (surface region),gene flanking,1
1625,Flank (surface region),flanking,2
1626,Flexible,flexible,1
1627,"FLNA protein, human",filamin-A,1
1628,FLNC gene,Flnc,1
1629,"FLNC protein, human",filamin-C,1
1630,Flow Cytometry,flow cytometry,1
1631,Flow Cytometry,Flow cytometry,1
1632,Flow Rate,FLRT,5
1633,FLRT1 gene,FLRT1,1
1634,FLRT2 gene,FLRT2,1
1635,FLRT3 gene,FLRT3,3
1636,Fluorescence,Fluorescence,1
1637,Fluorescent in Situ Hybridization,FISH,1
1638,Fluorescent stain,Fluorescent,1
1639,FMR1 gene,FMR1 gene,1
1640,"FMR1 protein, human",fragile X mental retardation protein,2
1641,"FMR1 protein, human",FMRP,11
1642,Focal,foci,1
1643,Focal Adhesion Kinase 1,FAK,7
1644,Focal Adhesion Kinase 1,focal adhesion kinase,1
1645,Focal Adhesions,focal contacts,1
1646,Focal Adhesions,focal adhesion,1
1647,Focal Adhesions,focal adhesion protein,1
1648,Focal Adhesions,focal adhesions,3
1649,Folded structure,folds,1
1650,FOLH1 gene,Prostate Specific Membrane Antigen,1
1651,FOLH1 gene,PSMA,3
1652,FOLH1 gene,FOLH1,1
1653,FOLH1 gene,Folh1,6
1654,FOLH1 gene,NAALADase,2
1655,FOLH1 gene,folate hydrolase,1
1656,Force,Forced,1
1657,Forced,forcing,1
1658,forebrain development,forebrain development,1
1659,Forkhead Box Protein O4,Foxo4,3
1660,Formation,formation,30
1661,FOS gene,c-Fos,1
1662,Fourier Analysis,Fourier analysis,1
1663,FOXD3 wt Allele,genesis,1
1664,FOXK1 gene,Foxk1,5
1665,FOXO Family,Foxo,1
1666,FOXP3 gene,Foxp3,5
1667,FOXP3 gene,FOXP3,1
1668,FOXP3 protein,Foxp3 protein,1
1669,f-protein,protein F,1
1670,Fraction of,fractions,2
1671,Fraction of,fraction,1
1672,Fragile X Syndrome,Fragile X Syndrome,1
1673,Fragment of (qualifier value),PS fragments,1
1674,Fragments,fragments,1
1675,Fragments,fragment,1
1676,Frequencies (time pattern),frequencies,1
1677,Frequently,frequent,1
1678,Friedreich Ataxia,Friedreich\'s ataxia,3
1679,Friedreich Ataxia,FRDA,10
1680,Friedreich Ataxia,Friedreich ataxia,4
1681,Frizzled Receptors,frizzled2 receptor,1
1682,frontal lobe,frontal cortex,1
1683,"FRS2 protein, human",FRS2,3
1684,Fuhrman Grade 1,G1,2
1685,fully spanning the plasma membrane,transmembrane,2
1686,fumarate,fumarate,2
1687,Function,functions,30
1688,Functional,functional,38
1689,Functional,functioning,1
1690,Functional behavioral assessment,Functional analysis,1
1691,Functional Laterality,functionality,1
1692,Functional Map,map,1
1693,Fungal,fungi,1
1694,Fungal,fungal,1
1695,Fused,fused,4
1696,Fusion procedure,fusion,1
1697,Fusion procedure,fusions,2
1698,Fusion protein,fusion protein,1
1699,Fusion protein,fusion proteins,1
1700,FXN gene,Frataxin,3
1701,FXN gene,frataxin,20
1702,FXN gene,Fxn,4
1703,FXN gene,FXN,1
1704,FYN gene,Fyn,1
1705,FYN wt Allele,SLK,1
1706,"FZD2 protein, human",Fzd2,1
1707,G1 to S Transition Process,G1/S transition,1
1708,GABA-A Receptor,GABA(A) receptor,1
1709,Gamma - unit of measure,gamma,5
1710,Gamma - unit of measure,IFNgamma,4
1711,gamma-Secretase,gamma-secretases,1
1712,gamma-Secretase,gamma-secretase binding,1
1713,gamma-secretase complex,gamma-secretase complex,1
1714,Gamma-Secretase Subunit PEN-2,presenilin enhancer,1
1715,gamma-Tubulin,gamma-tubulin,4
1716,Ganciclovir,DHPG,1
1717,Gastrointestinal tract structure,gastrointestinal tract,3
1718,Gastrulation,gastrulating,1
1719,Gastrulation,gastrulation,4
1720,"GDF15 protein, human",NRG-1,2
1721,Gel,gels,1
1722,Gel Chromatography,gel filtration,2
1723,Gel Chromatography,exclusion chromatography,1
1724,GenBank,GenBank,1
1725,Gene Activation,gene activation,2
1726,Gene Deletion,Deletions,1
1727,Gene Deletion,deletions,5
1728,Gene Deletion,gene deletion,1
1729,Gene Deletion Abnormality,deletion,20
1730,Gene Duplication,gene duplication,1
1731,Gene Enrichment Probability,enrichment of,1
1732,Gene Expression,gene expression,19
1733,Gene Expression,Gene expression,1
1734,Gene Expression Regulation,gene regulation,1
1735,Gene Expression Regulation,genetic control,1
1736,Gene Feature,gene organization,1
1737,gene induction,gene induction,1
1738,Gene Knockdown Techniques,knockdown,12
1739,Gene Knockdown Techniques,Knockdown,2
1740,Gene Mutation,gene mutations,1
1741,"Gene Products, vif",gene products,3
1742,Gene Rearrangement,genomic rearrangements,1
1743,Gene Regulatory Networks,transcriptional networks,2
1744,Gene Regulatory Networks,Gene regulatory networks,1
1745,Gene Regulatory Networks,transcriptional network,1
1746,Gene Regulatory Networks,genetic network,1
1747,Gene Silencing,silencing,1
1748,Gene Silencing,Silencing,3
1749,Gene Silencing,genetic inactivation,1
1750,Gene Targeting,gene targeting,4
1751,Generation (action),generation,6
1752,Genes,gene,34
1753,Genes,genes,77
1754,Genes,Gene 1,1
1755,"Genes, Developmental",developmental genes,4
1756,"Genes, Immunoglobulin",immunoglobulin reporter gene,1
1757,"Genes, Reporter",reporter gene,8
1758,"Genes, Switch",switching,1
1759,Genetic,genetic,2
1760,Genetic Analysis,genetic analysis,1
1761,Genetic Hotspot,hotspot,1
1762,genetic linkage,linkages,1
1763,genetic linkage,linkage,1
1764,genetic manipulation,genetic manipulations,1
1765,Genetic Polymorphism,polymorphisms,2
1766,Genetic Translation Process,translational,1
1767,Genome,genome,6
1768,Genome Assembly Sequence,genome assembly,1
1769,Genomic DNA,genomic DNA,2
1770,Genomic Instability,genome instability,1
1771,Genomic Instability,genomic instability,1
1772,Genomic Library,mouse genomic library,1
1773,Genomic Stability,genomic stability,2
1774,Genomics,genomic,1
1775,genotoxicity,genotoxicity,1
1776,Genotype,genotypes,1
1777,Genus Aria,ARIA,8
1778,Genus Danio,Danio,1
1779,geographic population,populations,2
1780,geographic population,population,2
1781,Geographic state,states,2
1782,germ cell development,germ-cell development,1
1783,Germ Cells,germ-line,1
1784,Germ Cells,germ cells,1
1785,germinal center formation,germinal center formation,1
1786,Germline,germline,2
1787,Germ-Line Mutation,germ-line mutation,1
1788,GIT1 gene,GIT1,1
1789,GLI3 gene,DNA-binding protein,2
1790,GLI3 gene,DNA-binding,1
1791,Glioblastoma Multiforme,glioblastoma multiformes,1
1792,Glioma,glioma,1
1793,Global,Global,1
1794,Global,global,1
1795,Glucocorticoid Receptor,glucocorticoid receptor,6
1796,Glucocorticoid Receptor,GR,5
1797,glucocorticoid receptor-interacting protein 1,glucocorticoid receptor interacting protein 1,1
1798,glucocorticoid receptor-interacting protein 1,protein transcription intermediary factor 2,1
1799,glucocorticoid receptor-interacting protein 1,TIF2,3
1800,glucocorticoid receptor-interacting protein 1,SRC-2,11
1801,glucocorticoid receptor-interacting protein 1,hepatic steroid receptor coactivator 2,1
1802,Glucocorticoids,glucocorticoid,1
1803,Glucocorticoids,glucocorticoid action,1
1804,Glucocorticoids,glucocorticoids,1
1805,Glucocorticoids,glucocorticoid signal,1
1806,Glucose,glucose production,1
1807,Glucose measurement,glucose,3
1808,glucose uptake,glucose uptake,2
1809,GLUCOSE-6-PHOSPHATASE,Glucose-6-phosphatase,1
1810,GLUCOSE-6-PHOSPHATASE,G6Pase,2
1811,Glutamate,glutamate,1
1812,Glutamate Carboxypeptidase II,folate hydrolase I,1
1813,"glutamate carboxypeptidase II, human",gamma-glutamyl carboxypeptidase,1
1814,Glutathione S-Transferase,Glutathione S-transferase,1
1815,Glutathione S-transferase measurement,GST,1
1816,Glycogen Storage Disease Type I,Von Gierke\'s disease,2
1817,Glycogen storage disease type II,GAA,1
1818,glycogen synthase kinase 3 beta,GSK-3beta,2
1819,glycogen synthase kinase 3 beta,GSK-3beta (,1
1820,glycogen synthase kinase 3 beta,GSK3beta,2
1821,Glycogen Synthase Kinases,glycogen synthase kinase,1
1822,Glycoproteins,glycoprotein,1
1823,Golgi Apparatus,Golgi,1
1824,Golgi Apparatus,Golgi complex,1
1825,Golgi Apparatus,Golgi apparatus,2
1826,GOLPH3 gene,Golgi-associated protein,1
1827,GOPC gene,GOPC,1
1828,GOPC wt Allele,PIST,1
1829,G-Protein-Coupled Receptors,G-protein-coupled receptors,2
1830,G-Protein-Coupled Receptors,G protein-coupled receptors,1
1831,"GPS2 protein, human",G-Protein Pathway Suppressor 2,1
1832,"GPS2 protein, human",GPS2,3
1833,gram,G,6
1834,Granulocyte component of blood,granulocytes,1
1835,GRB14 gene,Grb14,7
1836,GRB2 gene,Grb2,3
1837,GRB2 gene,Grb,1
1838,Greek letter alpha (qualifier value),alpha,6
1839,Greek letter rho,Rho,1
1840,Green Fluorescent Proteins,green fluorescent protein,1
1841,Green Fluorescent Proteins,green fluorescence protein,1
1842,GRIA1 gene,GluR1,2
1843,GRIA2 gene,GluRB,2
1844,GRIK1 gene,GluR5,1
1845,GRIP1 gene,Glutamate receptor interacting protein,1
1846,GRIP1 gene,GRIP,3
1847,GRM6 wt Allele,mGluR6,1
1848,Gross (qualifier value),gross,1
1849,Groups,group,2
1850,Growth,mouse embryonic growth,1
1851,Growth action,growth,8
1852,Growth Cones,growth cone,1
1853,Growth Factor,growth factors,3
1854,Growth Factor,growth factor,3
1855,Growth Factor,GF,1
1856,growth factor receptor-bound protein 10,Grb10,1
1857,Growth Factor Receptor-Bound Protein 7,Grb7,7
1858,Growth Factor Receptors,growth factor receptors,2
1859,Growth Factor Receptors,growth factor receptor,1
1860,Growth Factor Receptors,Growth factor receptor,1
1861,growth hormone activity,growth hormone,2
1862,Growth rate,growth rate,1
1863,Growth retardation,growth retardation,1
1864,Growth retardation,growth retarded,1
1865,GSK1210151A,GSK1210151A,1
1866,GTF2I gene,Gtf2i,10
1867,GTF2I gene,GTF2I,6
1868,GTF2I gene,general transcription factor II-I,1
1869,GTF2I gene,BAP-135,1
1870,GTF2I gene,TFII-I,7
1871,GTF2IP1 gene,GTF2IP1,1
1872,GTF2IRD1 gene,GTF2IRD1,2
1873,GTF2IRD1 gene,Gtf2ird1,4
1874,GTPase-Activating Proteins,GTPase activating protein,1
1875,Guanine Nucleotide Exchange Factors,exchange factor,1
1876,Guanine Nucleotide Exchange Factors,guanine nucleotide exchange region,1
1877,Guanosine Triphosphate,guanosine triphosphate,1
1878,Guanosine Triphosphate Phosphohydrolases,GTPase,2
1879,Guanosine Triphosphate Phosphohydrolases,GTPases,2
1880,Guanosine Triphosphate Phosphohydrolases,guanosine triphosphate hydrolases,1
1881,guidance - Measure Attribute,guidance,2
1882,Gut,gut,2
1883,H19 gene,H19,2
1884,Hair follicle structure,hair follicle,1
1885,Half-Life,half-life,2
1886,Half-Life,protein half-life,2
1887,Hamartoma,hamartomas,1
1888,Haploinsufficiency,haploinsufficiency,9
1889,Haploinsufficiency,Haploinsufficiency,1
1890,Haploinsufficiency,haploinsufficient,1
1891,Haplotypes,haplotypes,2
1892,Haplotypes,haplotype mice,1
1893,Haplotypes,haplotype,2
1894,Harmine,harmine,1
1895,Has property,properties,6
1896,Having administered,administered,1
1897,"HBEGF protein, human",heparin-binding EGF-like growth factor,2
1898,"HBEGF protein, human",heparin-binding EGF,1
1899,HBEGF wt Allele,HB-EGF,2
1900,HCT116 Cells,HCT116,1
1901,"HDAC1 protein, human",HDAC1,1
1902,HDAC2 gene,HDAC2,1
1903,HDAC9 wt Allele,HDAC7,10
1904,Health,health,1
1905,Health problem 1,health problem,1
1906,Heart,heart,19
1907,Heart,Heart,1
1908,Heart,hearts,1
1909,Heart,Hearts,1
1910,Heart- and Neural Crest Derivatives-Expressed Protein 2,dHAND gene,1
1911,Heart cell,heart cells,1
1912,heart development,heart development,1
1913,Heart failure,heart failure,2
1914,heart growth,heart growth,1
1915,heart morphogenesis,cardiac morphogenesis,1
1916,Heart tissue,heart tissue,1
1917,Heart Ventricle,heart ventricle,1
1918,Heat shock proteins,heat-shock protein,1
1919,HEK293 Cells,HEK293 cells,5
1920,HeLa Cells,HeLa cell,1
1921,HeLa Cells,HeLa cells,2
1922,helicase activity,helicase activity,1
1923,Helice,helices,1
1924,Helix-Loop-Helix Motifs,helix-loop-helix,4
1925,Helix-Loop-Helix Motifs,bHLH,3
1926,Helix-Loop-Helix Motifs,helix-loop-helix domains,1
1927,Helix-Loop-Helix Motifs,helix-loop-helix repeats,1
1928,Helix-Loop-Helix Motifs,helix-loop-helix motif,1
1929,Helper-Inducer T-Lymphocyte,T-helper cells,1
1930,Hemangioblasts,angioblasts,2
1931,Hemangioma of liver,hepatic hemangiomas,1
1932,Hematopoiesis,hematopoiesis,2
1933,Hematopoietic Cell Lineage Pathway,hematopoietic lineages,1
1934,Hematopoietic Neoplasms,haematopoietic malignancy,1
1935,Hematopoietic stem cells,neural precursor cells,1
1936,Hematopoietic stem cells,HSCs,11
1937,Hematopoietic stem cells,heart precursor cells,1
1938,Hematopoietic stem cells,haematopoietic stem cells,1
1939,Hematopoietic stem cells,hematopoietic stem cells,1
1940,Hematopoietic System,haematopoietic system,1
1941,Heme,heme,2
1942,heme biosynthetic process,heme biosynthesis,1
1943,heme biosynthetic process,heme synthesis,1
1944,Hemizygosity,Hemizygous deletion,1
1945,Hemizygosity,hemizygous deletion,1
1946,Hemizygosity,hemizygosity,1
1947,Hemoglobin Subunit Beta,beta-globin,1
1948,Hemorrhage,haemorrhage,1
1949,Hemostatic function,hemostasis,2
1950,Hep G2 Cells,HepG2,2
1951,Hep G2 Cells,HepG2 cells,1
1952,Heparan Sulfate Proteoglycans,cell surface heparan sulfate proteoglycan,1
1953,Heparan Sulfate Proteoglycans,heparan sulfate proteoglycans,3
1954,heparin,Heparin,1
1955,heparin,heparin,6
1956,Hepatic methionine adenosyltransferase deficiency,met,1
1957,Hepatic methionine adenosyltransferase deficiency,Met,1
1958,Hepatic methionine adenosyltransferase deficiency,MET,4
1959,Hepatocyte,liver cells,1
1960,Hepatocyte,live cells,1
1961,Hepatocyte Growth Factor,Hepatocyte Growth Factor,1
1962,Hepatocyte Growth Factor,HGF,6
1963,Hepatocyte Growth Factor,Hepatocyte growth factor,1
1964,Hepatocyte Growth Factor,hepatocyte growth factor,1
1965,Hereditary,inherited,3
1966,Hereditary Diseases,genetic disease,1
1967,Hereditary Diseases,genetic condition,1
1968,Hereditary Diseases,genetic disorder,1
1969,Heterochromatin,heterochromatin,6
1970,heterochromatin-specific nonhistone chromosomal protein HP-1,HP1,1
1971,Heterodimerization,heterodimerization,1
1972,Heterogeneity,heterogeneity,2
1973,Heterogeneous-Nuclear Ribonucleoproteins,heterogeneous nuclear ribonucleoprotein,1
1974,Heterotrimeric GTP-Binding Proteins,heterotrimeric,1
1975,Heterozygote,heterozygous,7
1976,Heterozygote,heterozygotes,3
1977,Heterozygote,heterozygous cells,1
1978,Heterozygote,Heterozygous,1
1979,Heterozygote,heterozygous deletion,1
1980,Heterozygote,heterozygote,1
1981,HGFAC wt Allele,hGFAP,1
1982,HIF1A gene,superfamily member,1
1983,High,higher,4
1984,High Mobility Group Proteins,High Mobility Group,1
1985,Highest,highest,1
1986,High-Throughput RNA Sequencing,high-throughput sequencing,1
1987,hindbrain,hindbrain,4
1988,Hinge (physical object),hinge,1
1989,Hippocampus (Brain),hippocampal,5
1990,Hippocampus (Brain),Mouse hippocampal,1
1991,Hippocampus hippocampus,hippocampus,10
1992,HIST1H1C gene,formerly,4
1993,HIST1H4F gene,H4,4
1994,Histidine,histidines,2
1995,Histocompatibility,histocompatibility,2
1996,Histologic,histological,1
1997,Histological Techniques,Histological examination,1
1998,Histology aspects,Histology,1
1999,Histone antigen,histone,22
2000,Histone antigen,Histone,1
2001,Histone Code,histone code,1
2002,Histone Code,histone codes,1
2003,Histone Deacetylase,HDAC,3
2004,Histone Deacetylase,histone deacetylase,1
2005,Histone Deacetylase,histone deacetylases,1
2006,histone deacetylase 3,Hdac3,1
2007,Histone Deacetylase Complexes,deacetylase complex,1
2008,Histone deacetylase inhibitor,histone deacetylase inhibitor,1
2009,Histone H1,histone H1,1
2010,Histone H3,histone H3,2
2011,Histone H3 Lysine 27,H3K27,2
2012,Histone H3 Lysine 4,H3K4,4
2013,Histone H3 Lysine 9,H3K9,1
2014,histone methyltransferase,histone methyltransferase,1
2015,histone methyltransferase,HMT,1
2016,"Histone-Arginine Methyltransferase CARM1, human",Coactivator-associated arginine methyltransferase 1,1
2017,"Histone-Arginine Methyltransferase CARM1, human",CARM1,18
2018,"Histone-Arginine Methyltransferase CARM1, human",coactivator-associated arginine methyltransferase-1,1
2019,Histones,histones,2
2020,Histopathologic Grade differentiation,differentiation,46
2021,Histopathologic Grade differentiation,Differentiation,1
2022,Histopathologic Grade differentiation,Treg differentiation,1
2023,Histopathology,histopathological,1
2024,Histopathology,histopathologic,1
2025,HIVEP2 gene,MIBP1,4
2026,hiv-infection/aids,HIV/AIDS,1
2027,HMBS gene,hydroxymethylbilane synthase,1
2028,HMG Domain,HMG box,1
2029,Homeostasis,homeostasis,5
2030,Homo sapiens,human,122
2031,Homo sapiens,humans,9
2032,Homo sapiens,Human,2
2033,Homo sapiens,Humans,1
2034,homoaconitate hydratase activity,Lys4,4
2035,Homodimerization,homodimerization,1
2036,Homogenate,renal homogenate,1
2037,Homogeneity,homogeneity,1
2038,Homologous Gene,homologous,8
2039,Homologous Gene,homolog,4
2040,Homologous Gene,homologue,2
2041,Homologous Gene,mouse homologue,1
2042,Homologous Gene,homologues,2
2043,Homologous Gene,SCAR homologue,1
2044,Homologous Recombination Pathway,homologous recombination,4
2045,Homology (attribute),homology,18
2046,Homology Modeling,Homology modeling,1
2047,homopolymer,homopolymer,2
2048,Homozygote,homozygous mutant,2
2049,Homozygote,homozygous,12
2050,Homozygote,homozygous lethal,1
2051,Homozygote,Homozygotes,1
2052,Homozygote,Homozygous,1
2053,Homozygote,homozygote,1
2054,Homozygote,Homozygous deletion,1
2055,Homozygote,homozygous mice,1
2056,Hope (emotion),hopes,1
2057,hormonal regulation,hormonal regulation,1
2058,Hormones,hormone,2
2059,Host (organism),host,2
2060,House mice,Mus musculus,1
2061,HP gene,bp,1
2062,HSP90 Heat-Shock Proteins,Hsp90,5
2063,hSWI/SNF,SWI/SNF,2
2064,human cell line,human cell line,1
2065,Human cells,human cells,3
2066,Human Herpesvirus 5,human cytomegalovirus,1
2067,Hybrids,hybrid,1
2068,Hydrocephalus,hydrocephalus,1
2069,Hydrophilicity,hydrophilic,1
2070,Hydrophobicity,hydrophobic,3
2071,Hyperactive behavior,hyperactivity,2
2072,Hyperglycemia,hyperglycemia,1
2073,hypersensitivity desensitization,desensitization,3
2074,Hypertensive disease,hypertension,2
2075,Hypertrophy,hypertrophy,2
2076,hyphal growth,hyphal growth,1
2077,Hypofibrinogenemia,hypofibrinogenemic,1
2078,Hypomethylation,hypomethylation,1
2079,Hypothesis,hypothesis,2
2080,Hypoxia,hypoxia,1
2081,Ideal,ideal,1
2082,Identical,identical,6
2083,Identified,identified,24
2084,Identified,identification,21
2085,Identified,Identification,1
2086,IFITM3 gene,IFITM3,1
2087,IFNGR2 wt Allele,AF-1,2
2088,IGA Glomerulonephritis,immunoglobulin A nephropathy,1
2089,IgE B cell receptor complex,membrane-bound,1
2090,IGF2 gene,IGF2,1
2091,IGFN1 gene,Igfn1,2
2092,IGFN1 gene,IGFN1,3
2093,IGK gene,kappa immunoglobulin gene,1
2094,IL23A wt Allele,P19,1
2095,IL4I1 gene,Fig1,1
2096,Illness (finding),mental illnesses,1
2097,Imbrication (procedure),overlapped,1
2098,imidazole-4-acetic acid,IMAC,3
2099,Immature,immature,6
2100,Immortalization,immortalized,4
2101,Immune response,immune response,1
2102,Immune System Finding,immune system,1
2103,Immune Tolerance,immunological tolerance,1
2104,"Immunity, Innate",innate immune response,2
2105,Immunoblotting,Immunoblotting,1
2106,Immunofluorescence assay,Immunofluorescence,1
2107,Immunofluorescence assay,immunofluorescence,3
2108,Immunofluorescence Microscopy,Immunofluorescence microscopy,1
2109,Immunoglobulin C2-set Domain,C2-type immunoglobulin-like domains,1
2110,"Immunoglobulin complex location, circulating",antibody,4
2111,Immunoglobulin Domains,immunoglobulin-like loop domains,1
2112,Immunoglobulin Domains,Immunoglobulin-like,1
2113,Immunoglobulin E measurement,IgE,3
2114,Immunoglobulin G Subclass 1 Measurement,IgG1,2
2115,Immunoglobulin Isotypes,Immunoglobulin isotype analysis,1
2116,Immunoglobulin-like Domain,immunoglobulin-like domains,2
2117,Immunoglobulin-like Domain,Ig-like domains,1
2118,Immunoglobulin-like Domain,immunoglobulin-like domain,1
2119,Immunoglobulin-like Domain,Ig-like domain,3
2120,Immunoglobulins,immunoglobulin,1
2121,Immunoglobulins,immunoglobulin locus,1
2122,Immunoglobulins,Dual immunoglobulin,1
2123,Immunohistochemistry,Immunohistochemistry,3
2124,Immunohistochemistry,immunohistochemistry,3
2125,immunologic,immunological,1
2126,Immunoprecipitation,immunoprecipitated,4
2127,Immunoprecipitation,immunoprecipitation,3
2128,Immunoprecipitation,immunoprecipitants,3
2129,Immunoprecipitation,coimmunoprecipitation,2
2130,Immunoprecipitation,immunoprecipitations,1
2131,Immunoprecipitation,immunoprecipitation method,1
2132,Immunoprecipitation,Coimmunoprecipitation,1
2133,immunoreactivity,immunoreactivity,4
2134,Impact food supplement,impact,1
2135,Impacted tooth,impacted,1
2136,Impaired,impaired,18
2137,Impaired,Impaired,2
2138,Impaired cognition,cognitive deficit,1
2139,Impaired health,impairment,5
2140,Impaired health,impairments,1
2141,Impaired thrombin-induced platelet aggregation,thrombin-induced platelet aggregation,1
2142,Implantation procedure,implantation,1
2143,Import into cell,uptake,5
2144,Imprinting (Psychology),imprinted,1
2145,In situ,In situ,8
2146,In situ,in situ,4
2147,In Situ Hybridization,in situ hybridization,9
2148,in vitro,in vitro,59
2149,in vitro,In vitro,6
2150,in vivo,in vivo,73
2151,in vivo,In vivo,7
2152,inactivation,Inactivation,1
2153,inactivation,inactivation,5
2154,Inactive Healthcare Coverage,inactive,1
2155,Inappropriate Specimen,inappropriate,1
2156,Incidence,incidence,2
2157,Inclusion,inclusion,1
2158,Incompetence,incompetence,1
2159,incorporation,incorporation,1
2160,Increase,increase,19
2161,Increased,increased,71
2162,Increased,increases,13
2163,Increased,augmented,2
2164,Increased,Increased,1
2165,Increasing,increasing,3
2166,Increment,incremental,1
2167,Independently able,independent,1
2168,Indication,indication,1
2169,Indication of (contextual qualifier),reasons,1
2170,Individual - insurance coverage level,individual,6
2171,Individual - insurance coverage level,individuals,3
2172,Induce (action),induce,8
2173,Induce (action),induction,12
2174,Induce (action),Induced,1
2175,Induce (action),induced,32
2176,Induce (action),Induction,1
2177,Induce (action),inducible,1
2178,Inducer,inducer,1
2179,Industrial machine,machinery,1
2180,Inefficient,inefficient,1
2181,"Infant, Newborn",newborn mice,1
2182,Infection,infection,5
2183,Infertility,sterile,1
2184,Infertility,infertility,4
2185,Infertility,infertility genes,1
2186,Infertility,infertile men,1
2187,Inflammation,inflammation,4
2188,Inflammatory cell,inflammatory cells,1
2189,Influence,influences,4
2190,Influence,influence,5
2191,Influence,influenced,1
2192,Information,information,8
2193,inhibited,inhibited,19
2194,Inhibition,inhibiting,3
2195,Inhibition,inhibitory,1
2196,inhibition of growth,growth inhibition,1
2197,Inhibitor,inhibitor,10
2198,inhibitors,inhibitors,4
2199,Initiate (source type),initiate,1
2200,Injection,injection,1
2201,Injection Route of Drug Administration,injections,1
2202,Inner cell mass,inner cell mass,3
2203,Inner cell mass,ICM,4
2204,Inner Plexiform Layer,inner plexiform layer,1
2205,Inner Plexiform Layer,IPL,2
2206,Insert (object),insertion,7
2207,Insulation Device Component,insulation,1
2208,Insulitis,insulitis,4
2209,Intact,integrity,2
2210,Intact,intact,7
2211,Intact,gene integrity,1
2212,Integral,integral,1
2213,Integral Membrane Proteins,transmembrane proteins,3
2214,Integral Membrane Proteins,integral membrane proteins,2
2215,Integral Membrane Proteins,single transmembrane protein,1
2216,Integration (data processing),integration,1
2217,Integrin alphaVbeta3,alphavbeta3,4
2218,Integrin alphaVbeta3,alphaVbeta3,1
2219,Integrin alphaVbeta3,integrin alphaVbeta3 pathway,1
2220,integrin alphaVbeta5,alphavbeta5,1
2221,Integrin beta Chains,integrin beta subunits,1
2222,Integrin beta3,beta3 integrins,4
2223,Integrin beta3,beta3 integrin,1
2224,Integrin beta3,integrin beta3,1
2225,integrin ligand,integrin ligand,1
2226,Integrins,integrin,15
2227,Integrins,integrins,7
2228,Integrins,Integrins,1
2229,Integrins,integrin action,1
2230,Intellectual Disability,intellectual disability,4
2231,Intellectual Disability,ID,1
2232,Intercellular Junctions,cell junction,1
2233,Intercellular Junctions,cell-cell junctions,1
2234,intercellular transport,intercellular transport,1
2235,Interested,interested,1
2236,Interested,interesting,1
2237,Interferes with,interfering,1
2238,Interferes with,RNAi,6
2239,Interferon Gamma Receptor Complex,IFN-gamma receptor,1
2240,Interferon Type II,IFN-gamma,15
2241,Interferon Type II,Interferon-gamma,2
2242,Interferon Type II,interferon-gamma,2
2243,Interferon Type II,Interferon gamma,1
2244,Interferon-alpha,interferon-alpha,1
2245,Interleukin-17,interleukin-17,1
2246,Interleukin-17A,interleukin-17A,1
2247,Intermediate Mitosis-Karyorrhexis Index,intermediate,2
2248,Internal,intrinsic,1
2249,Internal,inner,1
2250,Internal Ribosome Entry Sites,internal ribosome entry site,1
2251,Internal Ribosome Entry Sites,IRES,1
2252,internalization,internalization,4
2253,Interneurons,interneurons,1
2254,Interphase Cell,resting,1
2255,Interprets,interpreting,2
2256,Interventional procedure,intervention,3
2257,Intervertebral disc structure,intervertebral discs,1
2258,Intestine - Small Intestine (MMHCC),mouse small intestine,1
2259,Intestines,intestinal,2
2260,Intestines,intestine,1
2261,"Intestines, Small",small intestine,1
2262,intracellular protein transport,protein localizations,1
2263,intracellular protein transport,subcellular targeting,1
2264,intracellular protein transport,protein localization,1
2265,intraciliary transport,intraflagellar transport,1
2266,Intra-embryonic mesoderm,extraembryonic mesoderm,1
2267,Intraocular pressure disorder,IOP,2
2268,Intravenous Route of Drug Administration,intravenous,1
2269,Introduces,introduces,1
2270,Introns,introns,2
2271,Introns,intron,2
2272,Introns,intronic,1
2273,Invasive Carcinoma,invasive carcinomas,1
2274,Invasiveness,invasiveness,2
2275,Inversion,inversion,1
2276,Investigates,investigate,14
2277,Investigates,investigated,8
2278,Investigates,investigating,1
2279,Investigational,experimentally,1
2280,Involvement with,involvement,5
2281,inward rectifier potassium channel,Classical inwardly rectifying K+ channels,1
2282,Ion Channel,channels,3
2283,Ion Channel,ion channels,2
2284,IQGAP1 gene,IQGAP1,3
2285,IRF6 wt Allele,LPS,1
2286,Iron accumulation in brain,iron accumulation,1
2287,iron metabolism,iron metabolism,2
2288,"Iron stain method, blood or bone marrow",iron staining,1
2289,iron-sulfur cluster binding,iron-sulfur clusters,1
2290,iron-sulfur cluster binding,iron-sulfur cluster,3
2291,Irregular,irregular,1
2292,Islands,islands,1
2293,Isoenzymes,beta isozyme,1
2294,Isolate - microorganism,isolate,4
2295,Isolate - microorganism,isolates,1
2296,Isolated,isolated,35
2297,Isolated limb perfusion,Hind limb perfusion,1
2298,Isoproterenol,isoproterenol,1
2299,ITGA8 gene,Itga8,1
2300,ITGB3 gene,ITGB3 gene,1
2301,"ITGB3 protein, human",Itgb3,1
2302,ITGB7 gene,Itgb7,1
2303,JUN gene,AP1,1
2304,junctophilin,Junctophilin-2,1
2305,junctophilin,JP2,3
2306,JUND gene,AP-1,4
2307,juxtamembrane,JM,1
2308,juxtaparanode region of axon,juxtaparanodes,3
2309,juxtaparanode region of axon,juxtaparanodal,1
2310,KAT2B gene,p300/CBP-associated factor,1
2311,KCNA2 gene,Kv1.2,3
2312,KCNJ4 gene,Kir2.3,7
2313,KDR gene,Vascular Endothelial Growth Factor receptor 2,1
2314,KEAP1 gene,Keap1,29
2315,KEAP1 gene,Keap1 react,1
2316,KEAP1 gene,keap1,1
2317,KELL NULL,KO,5
2318,Ketamine,NMDA,2
2319,KIAA0319 gene,neuronal migration,33
2320,Kidney,kidney,9
2321,Kidney,renal,1
2322,Kidney Neoplasm,renal tumors,1
2323,Killer-Cell Immunoglobulin-Like Receptor,inhibitory receptors,1
2324,kinase activity,kinase activity,6
2325,kinase inhibitor,MAP kinase inhibitor,1
2326,kinase inhibitor,kinase inhibitors,1
2327,Kind of quantity - Shape,shape,1
2328,Kinesin,kinesin,1
2329,Kinetics,kinetic,1
2330,Kinetics (discipline),kinetics,4
2331,Kinetochores,kinetochores,3
2332,KITLG gene,SCF,1
2333,KL wt Allele,Klotho,6
2334,"KLB protein, human",betaKlotho,4
2335,"KLB protein, human",BetaKlotho,1
2336,KMT2A gene,MLL1,5
2337,Knock-in,knock-in,1
2338,Knock-in,KI,1
2339,Knock-out,knockout,3
2340,KNOWLEDGE (recall and interpretation ability),knowledge,1
2341,KNTC1 gene,rod,1
2342,Kringles,kringle domains,1
2343,KY gene,KY,7
2344,Labeled (qualifier),tagged,2
2345,Labeling Activity,Labeling,1
2346,Labels (device),labels,1
2347,Laboratory,laboratories,1
2348,Lacking,lacks,2
2349,Lacking,lack,1
2350,LacZ Genes,lacZ,4
2351,LacZ Genes,lacZ gene,2
2352,Landscapes,landscape,2
2353,LAT2 gene,lab,1
2354,late pregnancy,late pregnancy,1
2355,Latent,latent,1
2356,"LDLR protein, human",VLDLR,3
2357,"LDLR protein, human",low-density lipoprotein receptor,1
2358,Lead compound,lead compound,1
2359,Learning,learning,10
2360,Learning,Learning,1
2361,Length,lengths,1
2362,Length,length,3
2363,Leptomeninges,leptomeninges,1
2364,Lesion,lesions,1
2365,Lethal,lethal,5
2366,Leucine,leucine,3
2367,Leucine-Rich Repeat,Leucine-rich repeat,1
2368,Leucine-Rich Repeat,leucine-rich repeat,1
2369,leukemia,leukaemia,2
2370,"Leukemia, Myelocytic, Acute",acute myeloid leukaemia,1
2371,"Leukemia, Myelocytic, Acute",AML,4
2372,leukocyte homeostasis,immune homeostasis,1
2373,Leukotriene D4 Measurement,leukotriene D4,2
2374,Leukotriene D4 Measurement,LTD4,5
2375,Levels (qualifier value),levels,52
2376,Levels (qualifier value),level,19
2377,Levels (qualifier value),Levels,1
2378,LGALS4 gene,Gal4,1
2379,Libraries,libraries,2
2380,Libraries,library,2
2381,life span,life span,1
2382,Ligand Binding,ligand binding,5
2383,Ligand Binding,binding ligand,1
2384,Ligand Binding Domain,ligand binding domain,1
2385,Ligand Binding Domain,LBD,3
2386,Ligand Binding Domain,ligand binding domains,1
2387,Ligand Binding Domain,ligand-binding domains,1
2388,Ligand Binding Domain,ligand-binding domain,1
2389,Ligands,ligand,11
2390,Ligands,ligands,11
2391,Limb Buds,limb bud,2
2392,Limb structure,limb,2
2393,Limited (extensiveness),limiting,1
2394,LIN7C gene,VELI3,1
2395,Linear,lines,1
2396,Linked gene,gene linked,1
2397,lipid kinase activity,lipid kinase activity,1
2398,lipid mediator,lipid mediator,1
2399,Lipid R1 MRI,mobile,2
2400,Lipopolysaccharides,lipopolysaccharide,1
2401,LIS1 Pathway,LIS1 pathway,2
2402,Lissencephaly,lissencephaly,15
2403,Lissencephaly,Lissencephaly,2
2404,Lissencephaly,human lissencephaly,1
2405,Lissencephaly 3,Lis3,1
2406,LISSENCEPHALY 4,Lis4,1
2407,Listeria monocytogenes,Listeria monocytogenes,1
2408,Lithium,lithium,1
2409,Liver carcinoma,hepatocellular carcinomas,1
2410,Liver Flavor,liver,7
2411,Liver parenchyma,liver tissues,1
2412,Local,local,1
2413,local level,local level,1
2414,localization,localizations,1
2415,localization within membrane,perimembrane localization,1
2416,Localized,localized,27
2417,Localized,colocalize,4
2418,Localized,colocalized,4
2419,Localized,localizing,1
2420,Localized,localise,1
2421,location participation type,location,4
2422,Locus,locus,4
2423,Locus Control Region,locus control region,1
2424,Logical Condition,conditions,4
2425,Long,long,5
2426,Long,elongated,1
2427,Long-term,long-term,11
2428,Long-Term Depression Pathway,LTD,4
2429,Long-Term Potentiation Pathway,LTP,8
2430,Looping Medical Device Problem,looping,1
2431,Loss,loss,23
2432,Loss,Loss,4
2433,Loss,loss of,1
2434,Lost Medical Device,lost,1
2435,Lower (action),lower,3
2436,Lower case Roman letter b,B,1
2437,LRFN1 gene,Lrfn1,4
2438,LRFN2 gene,Lrfn2,3
2439,LRFN3 gene,Lrfn3,2
2440,LRFN4 gene,Lrfn4,3
2441,LRFN5 gene,Lrfn5,2
2442,LRIT3 gene,LRIT3,6
2443,LRIT3 gene,Lrit3,1
2444,LRP8 gene,ApoER2,3
2445,LRP8 gene,Lrp8,1
2446,LRP8 gene,apolipoprotein E receptor 2,1
2447,L-Type Calcium Channels,L-type calcium channels,1
2448,luciferin monooxygenase activity,luciferase activity,3
2449,Lung,lung,6
2450,LY 294002,LY294002,1
2451,Lyase Gene,lyase gene,1
2452,lymph node development,hematopoietic development,1
2453,Lymphocyte Activation,lymphocyte activation,1
2454,Lymphocytic (qualifier value),lymphocytic,1
2455,"Lymphohistiocytosis, Hemophagocytic",HLH protein,1
2456,Lysine,lysine,4
2457,lysophosphatidic acid,lysophosphatidic acid,1
2458,Lysosomes,lysosomes,1
2459,Macromolecular alteration,conformational change,2
2460,macrophage,macrophages,5
2461,macrophage,mouse bone marrow-derived macrophages,1
2462,macrophage,BMMs,3
2463,macrophage,macrophage,1
2464,Macrophage Activation,macrophage activation,1
2465,Macrophage Colony-Stimulating Factor,macrophage colony-stimulating factor,1
2466,Macrophage Colony-Stimulating Factor,M-CSF,2
2467,"Macrophages, Peritoneal",peritoneal macrophages,1
2468,Made redundant (finding),redundant,1
2469,Madin Darby Canine Kidney Cells,MDCK,1
2470,Madin Darby Canine Kidney Cells,MDCK cell lines,1
2471,Madin Darby Canine Kidney Cells,MDCK cells,3
2472,MAGEE1 gene,damage,1
2473,Main,predominant,5
2474,main terminal branch,Mycobacterium tuberculosis,1
2475,Maintenance,maintenance,12
2476,Maintenance,maintain,1
2477,Male Phenotype,male,14
2478,"Malformations of Cortical Development, Group II",neuronal migration disorders,2
2479,"Malformations of Cortical Development, Group II",neuronal migration disorder,3
2480,Malignant neoplasm of breast,breast cancer,3
2481,Malignant Neoplasms,cancers,5
2482,Malignant Neoplasms,cancer,9
2483,Malignant Neoplasms,Cancer,1
2484,Mammalian Cell,mammalian cells,14
2485,Mammals,mammalian,38
2486,Mammals,mammals,13
2487,Mammals,mammalian genes,1
2488,Mammals,Mammalian,3
2489,Mammary Epithelium,mammary epithelia,1
2490,Mammary Epithelium,mammary epithelium,4
2491,Mammary Epithelium,mammary ductal epithelium,1
2492,Mammary gland,mammary gland,4
2493,Mammary gland,mammary glands,1
2494,mammary gland development,mammary development,1
2495,mammary gland development,mammary gland development,1
2496,MAMSTR gene,MASTR,2
2497,manchette,manchette,1
2498,Manifest,manifest,1
2499,Manifestation of,manifestations,1
2500,Manipulation procedure,manipulation,1
2501,MAP Kinase Cascade,MAP kinase cascade,1
2502,"MAPK14 protein, human",p38 MAPK,1
2503,MAPK8IP1 gene,Ib1,1
2504,mapped,mapped,7
2505,Mapping (action),mapping,4
2506,Mapping (action),Mapping,1
2507,Marginal Zone,marginal zone,1
2508,Marginal Zone,MZ,1
2509,Marines,marine,1
2510,MARK2 gene,serine/threonine kinase,1
2511,MARK2 gene,serine/threonine kinases,1
2512,Markers (device),markers,7
2513,Mass Spectrometry,mass spectrometry,5
2514,Mass Spectrometry,Mass spectrometry,1
2515,Massive,massive,1
2516,Massive,marks,1
2517,Massively-Parallel Sequencing,next-generation sequencing,1
2518,Mass-to-Charge Ratio,MZ B,1
2519,mast cell,mast cells,2
2520,mast cell,mast cell,1
2521,Mathematical Factor,factor,4
2522,Mathematical Model,Mathematical modeling,1
2523,Mathematical Operator,function,77
2524,matrigel,Matrigel,1
2525,Matrix Attachment Regions,scaffold attachment,2
2526,Matrix Metalloproteinase 9,MMP-9,1
2527,Mature,mature,21
2528,MBD2 gene,MBD2,13
2529,MBD2 gene,Mbd2,1
2530,MBD3 gene,MBD3,9
2531,MBD3 gene,methyl-CpG binding domain,2
2532,MBD3 gene,MBD,1
2533,MBD3 gene,Mbd3,2
2534,MBD3 gene,MBD3 proteins,1
2535,MBD4 gene,Mbd4 genes,1
2536,"MBD4 protein, human",MBD4,7
2537,"MBD4 protein, human",Mbd4,1
2538,MCF-7 Cells,MCF-7 cells,1
2539,"MCM4 protein, human",cdc21 homolog,1
2540,MDF Attribute Type - Indicator,indicator,1
2541,MDM2 gene,Mdm2,1
2542,Measured Tumor Identification,measured,1
2543,Measurement,measurement,2
2544,Measurement,Measurement of,1
2545,Measurement,measurements,1
2546,Mechanism (attribute),mechanism,36
2547,Mechanism (attribute),mechanisms,20
2548,MECOM gene,Prdm3,4
2549,MECP2 gene,methyl-CpG-binding proteins,1
2550,MECP2 wt Allele,MeCP2,4
2551,Mediate,mediates,1
2552,Mediator brand of benfluorex hydrochloride,mediators,1
2553,Mediator of activation protein,mediator,4
2554,Mediator of activation protein,coactivator complex,1
2555,Medical Device Misassembled by Users,misassembled,1
2556,Medical Product Stability,stability,5
2557,Medium,medium,1
2558,MEF2 Transcription Factors,MEF2 protein,2
2559,MEF2 Transcription Factors,MEF2 proteins,2
2560,MEF2 Transcription Factors,Mef2C,6
2561,MEF2 Transcription Factors,Myocyte enhancer factor 2,3
2562,MEF2 Transcription Factors,MEF2 transcription factor,1
2563,MEF2 Transcription Factors,myocyte enhancer factor 2,1
2564,MEF2A gene,MEF2A,4
2565,MEF2C gene,MEF2C gene,2
2566,MEF2C gene,Mef2c,6
2567,MEF2D gene,MEF2D RNA,1
2568,MEFV gene,pyrin,1
2569,Megakaryocytes,megakaryocyte,2
2570,Megakaryocytes,megakaryocytic cells,1
2571,Megakaryocytopoiesis,megakaryopoiesis,1
2572,meiotic cell cycle,meiosis,4
2573,Meiotic chromosome,meiotic chromosomes,2
2574,Meiotic Prophase I,Prophase I,1
2575,Meiotic Prophase I,meiotic prophase I,1
2576,Meiotic Recombination,meiotic recombination,1
2577,Melanosomes,melanosomes,1
2578,member,members,26
2579,member,member,17
2580,member,Members,4
2581,Membrane,membrane,5
2582,membrane budding,vesicle formation,1
2583,Membrane Proteins,membrane-associated proteins,1
2584,Membrane Proteins,membrane proteins,2
2585,Membrane Transport Proteins,transporters,2
2586,membrane-associated guanylate kinase,membrane-associated guanylate kinases,1
2587,membrane-associated guanylate kinase,MAGUKs,4
2588,memory b cell,memory B cells,3
2589,Memory Device Component,memory,12
2590,Memory Device Component,Memory,1
2591,Memory impairment,memory deficits,1
2592,Memory performance,memory performance,1
2593,Memory recall,memory recall,1
2594,Mental association,association,29
2595,Mental association,associations,2
2596,Mental concentration,concentration,2
2597,Mental concentration,concentrations,6
2598,Mental Depression,depression,3
2599,Mental disorders,psychiatric disorders,1
2600,Mental Orientation,orientation,3
2601,Mental Retardation,mental retardation,3
2602,mercaptopurine,6-mercaptopurine,1
2603,Mesenchyma,mesenchyme,1
2604,Mesoderm,mesoderm,7
2605,mesodermal,mesodermal,4
2606,Mesodermal cell,mesodermal cell fates,1
2607,Mesodermal cell,mesodermal cells,1
2608,messenger ribonucleoprotein,messenger ribonucleoprotein,1
2609,messenger ribonucleoprotein,mRNP,1
2610,Mesylates,mesylate,1
2611,"MET protein, human",hepatocyte growth factor receptor,1
2612,MET wt Allele,c-met,1
2613,MET wt Allele,c-Met,2
2614,Metabolic,metabolic,1
2615,Metabolic Inhibition,inhibition,30
2616,Metabolic Inhibition,Inhibition,6
2617,metabolic rates,metabolic rate,1
2618,Metabolism,metabolic processes,1
2619,Metalloproteases,metalloproteinase 22,1
2620,Metazoa,Metazoans,1
2621,Methionine,methionine,1
2622,Methodology,METHODOLOGY,1
2623,Methods,METHODS,1
2624,Methyl Methanesulfonate,methyl methanesulfonate,1
2625,methylate,methylated,5
2626,methylate,methylate,1
2627,Methylation,Methylation,1
2628,Methylation,methylation,19
2629,methyl-CpG binding,methyl-CpG,1
2630,Methyltransferase,methyltransferases,1
2631,Methyltransferase,methyltransferase,1
2632,methyltransferase activity,methyltransferase activity,1
2633,MG 132,MG132,1
2634,Mi-2 Nucleosome Remodeling and Deacetylase Complex,NuRD complex,1
2635,MICALL2 gene,junctional Rab13-binding protein,1
2636,MICALL2 gene,JRAB,3
2637,"Mice, Inbred NOD",nonobese diabetic,1
2638,"Mice, Inbred NOD",NOD,1
2639,"Mice, Knockout",knockout mouse,1
2640,"Mice, Knockout",knockout mice,5
2641,"Mice, Knockout",Dpep3-/-,1
2642,"Mice, Transgenic",transgenic mice,5
2643,"Mice, Transgenic",Transgenic mice,2
2644,Microarray,microarray,1
2645,Microarray Analysis,expression profile,1
2646,Microarray Analysis,gene expression profiling,1
2647,Microarray Analysis,microarray analysis,1
2648,Microcephaly,microcephaly,1
2649,Microcephaly,microencephaly,1
2650,Micrococcal Nuclease,micrococcal nuclease,1
2651,Microfibrils,microfibril proteins,1
2652,Microfilaments,actin cytoskeleton,8
2653,Microfilaments,actin filaments,1
2654,Microglia,microglia,1
2655,Microinjections,Microinjection,1
2656,Microinjections,microinjection,4
2657,"Microscopy, Confocal",confocal microscopy,2
2658,"Microscopy, Immunoelectron",Immunoelectron microscopy,1
2659,Microtubule cytoskeleton,microtubule cytoskeleton,1
2660,Microtubule-Associated Proteins,microtubule-associated protein,1
2661,Microtubule-Associated Proteins,microtubule-associated proteins,1
2662,Microtubule-Associated Proteins 1A/1B Light Chain 3,LC3,1
2663,Microtubule-Organizing Center,MTOC,1
2664,Microtubule-Organizing Center,microtubule-organizing center,1
2665,Microtubules,microtubules,14
2666,Microtubules,microtubule,21
2667,Microtubules,MT,5
2668,Midbrain structure,mesencephalon,1
2669,Midbrain structure,midbrain,2
2670,Midline 1 RING Finger Protein,midline-1,1
2671,migrated,migrate,5
2672,migrated,migrating,3
2673,"Migration, Cell",cell migration,6
2674,Migratory (qualifier value),migratory,2
2675,Miller Dieker syndrome,Miller-Dieker lissencephaly syndrome,1
2676,Miller Dieker syndrome,MDS,8
2677,Miller Dieker syndrome,Miller-Dieker syndrome,3
2678,Minichromosome Maintenance 1 Protein,MCM,2
2679,Minichromosome Maintenance Complex Component 5,CDC46 protein,1
2680,Missense Mutation,Missense mutations,1
2681,Missense Mutation,missense mutations,1
2682,Missing Study Animal,missing,2
2683,Mitochondria,mitochondrion,2
2684,Mitochondria,mitochondria,19
2685,Mitochondrial Biogenesis,basal mitochondrial biogenesis,1
2686,Mitochondrial Degradation,mitophagy,3
2687,mitochondrial depolarization,mitochondrial depolarization,2
2688,Mitochondrial Diseases,mitochondrial disease,1
2689,mitochondrial DNA metabolic process,mitochondrial metabolism,1
2690,Mitochondrial Inheritance,mitochondrial,9
2691,Mitochondrial Inheritance,mitochondrially,1
2692,Mitochondrial Inheritance,mitochondrial iron,2
2693,Mitochondrial Inheritance,mitochondrial mass,1
2694,Mitochondrial matrix,mitochondrial matrix,2
2695,"Mitochondrial Membrane, Outer",mitochondrial outer membrane,2
2696,Mitochondrial Membranes,mitochondrial membranes,1
2697,Mitochondrial Membranes,mitochondrial membrane,1
2698,mitochondrial processing peptidase,mitochondrial processing peptidase,1
2699,Mitochondrial Proteins,mitochondrial protein,2
2700,Mitogen-activated protein,mitogen-activated protein,1
2701,Mitogen-activated protein,MAP,7
2702,mitogen-activated protein kinase p38,p38 mitogen-activated protein kinase signaling,1
2703,mitogen-activated protein kinase p38,p38 mitogen-activated protein,1
2704,Mitogen-Activated Protein Kinases,MAP kinase,3
2705,Mitogen-Activated Protein Kinases,MAPK,1
2706,mitogenic activity,mitogenic activity,2
2707,Mitosis,mitosis,9
2708,Mitosis,mitotic cycle,1
2709,Mitotic,mitotic,1
2710,Mitotic Cell Cycle,cell cycle,5
2711,Mitotic chromosome,mitotic chromosomes,7
2712,Mitotic Spindle Apparatus,mitotic spindle,1
2713,Mixed phenotype acute leukemia,mixed lineage leukaemia,1
2714,Mixed phenotype acute leukemia,MLL,3
2715,Mixture,mixture,1
2716,"MLL protein, human",ALL-1,2
2717,"MLL protein, human",All-1,3
2718,"MLL protein, human",ALL-1 gene,1
2719,"MLL protein, human",All-1 proteins,1
2720,MLL/MLLT3 Fusion Gene,MLL-AF9,1
2721,mmHg,mmHg,1
2722,MMP9 gene,matrix metalloproteinase 9,1
2723,Model,models,2
2724,Model Number,model,7
2725,"Models, Genetic",genetic models,1
2726,"Models, Molecular",molecular model,1
2727,Moderation,moderate,1
2728,Modified By,modifier,2
2729,Modulated,modulates,8
2730,Modulated,modulate,7
2731,Modulated,modulation,7
2732,Modulated,modulated,1
2733,Modulated,modulating,4
2734,Modulated,Modulation,1
2735,Module,module,2
2736,Molecular,molecular,2
2737,MOLECULAR BASIS,molecular basis,6
2738,Molecular Conformation,conformation,1
2739,Molecular helix,helix 3,1
2740,Molecular helix,helix,1
2741,Molecular Mass,molecular masses,1
2742,Molecular Mass,molecular mass,1
2743,Molecular Target,molecular targets,1
2744,Molecular Target,molecular target,1
2745,Molecular Weight,molecular weight pool,2
2746,Molecular Weight,molecular weight,1
2747,Molecule,molecule,6
2748,Molecule,molecules,15
2749,Monkeys,monkey,1
2750,Monobasic Proteolytic Cleavage Site,proteolytic cleavage site,1
2751,Monoclonal Antibodies,mAb,1
2752,monomer,monomer,1
2753,monomer,monomers,1
2754,Monomeric GTP-Binding Proteins,monomeric small G-proteins,1
2755,Monomeric GTP-Binding Proteins,small GTPase,1
2756,Monophasic,monophasic,1
2757,Morphogenesis,morphogenesis,4
2758,morphogenesis of a branching structure,branching morphogenesis,1
2759,Morphologic Complete Response,morphologic,1
2760,morphological,morphological,2
2761,"Mortality, Premature",premature death,1
2762,Mother (person),maternal,2
2763,Mother (person),mother,2
2764,Motility result,motility,2
2765,motor movement,motor,2
2766,Motor protein,motor protein,1
2767,Mount used,mounted,1
2768,Mouse Cornea,mouse cornea,1
2769,Mouse Embryonic Stem Cells,mouse embryonic stem,1
2770,Mouse Embryonic Stem Cells,mouse embryonic stem cells,2
2771,Mouse Embryonic Stem Cells,mESCs,4
2772,Mouse Heart,mouse heart,3
2773,Mouse Liver,mouse liver,1
2774,Mouse mammary tumor virus,mouse mammary tumor,1
2775,Mouse Model,mouse model,4
2776,Mouse Ovary,mouse ovary,1
2777,Mouse Prostate Gland,mouse prostate,1
2778,Mouse Protein,mouse proteins,1
2779,Mouse Skin,mouse skin,1
2780,Mouse Strains,mouse strain,1
2781,Mouse Testis,mouse testis,3
2782,Movement,movement,3
2783,MPP4 gene,MPP4,1
2784,mRNA synthesis,mRNA synthesis,1
2785,MTA1 gene,MTA1,2
2786,MTOR gene,mTOR,8
2787,MTX1 gene,metaxin 1,7
2788,MTX1 gene,Metaxin 1,1
2789,MTX2 gene,metaxin 2,11
2790,MTX2 gene,Metaxin 2,2
2791,MUC20 gene,MUC20,6
2792,Multigene Family,multigene family,1
2793,Multiple Sclerosis,multiple sclerosis,1
2794,Multiprotein Complexes,multiprotein complexes,1
2795,Muridae,murine genes,1
2796,Murine,murine,39
2797,Murine,Murine,2
2798,Mus,mouse,86
2799,Mus,Mouse,2
2800,Muscle,muscle,8
2801,Muscle,muscle tissue,1
2802,muscle cell differentiation,muscle differentiation,4
2803,Muscle Cells,muscle cells,3
2804,Muscle Cells,muscle cell,1
2805,Muscle Cells,myocytes,5
2806,Muscle Development,muscle development,2
2807,Muscle Fibers,muscle fibers,2
2808,Muscle Fibers,muscle fiber,1
2809,Muscle Fibers,muscle fibres,1
2810,Muscle function,muscle function,1
2811,"Muscle, Smooth, Vascular",vascular smooth muscle,2
2812,"Muscle, Striated",striated muscle,2
2813,"Muscular Dystrophies, Limb-Girdle",limb-girdle muscular dystrophies,1
2814,Muscular Dystrophy,muscular dystrophies,1
2815,Muscular Dystrophy,muscular dystrophy,1
2816,"MUSK protein, human",muscle-specific,4
2817,Mutagenesis Process,Mutagenesis,1
2818,mutant,mutants,17
2819,mutant,mutant,35
2820,mutant,Mutant,3
2821,Mutant Proteins,mutant protein,2
2822,Mutant Proteins,mutant proteins,2
2823,Mutation,mutations,30
2824,Mutation,Mutations,17
2825,Mutation,genetic alterations,1
2826,Mutation Abnormality,mutation,23
2827,Mutation Abnormality,Mutation,4
2828,Mutation Abnormality,mutated,6
2829,mutation analysis,Mutational analysis,1
2830,MYC Family Protein,protein Myc,1
2831,Mycobacterium avium infection,Mycobacterium avium infection,2
2832,Mycobacterium Infections,mycobacterial infection,1
2833,MYEF2 gene,MEF-2,5
2834,Myelin Sheath,myelinated,1
2835,MYL4 gene,GT1,5
2836,Myoblasts,myoblast,1
2837,Myoblasts,myoblasts,6
2838,Myoblasts,muscle precursor cells,1
2839,Myocardial degeneration,myocardial regeneration,2
2840,Myocardial Infarction,myocardial infarction,1
2841,Myocardium,cardiac muscle genes,1
2842,Myocardium,myocardium,2
2843,MYOCD gene,Myocardin,1
2844,MYOCD gene,myocardin,3
2845,myocyte enhancer factor 2C,MEF2C transcription factor,1
2846,"Myocytes, Cardiac",cardiomyocytes,15
2847,"Myocytes, Cardiac",heart muscle cells,1
2848,"Myocytes, Cardiac",cardiomyocyte,6
2849,"Myocytes, Cardiac",Cardiomyocytes,1
2850,"Myocytes, Cardiac",cardiac myocytes,2
2851,"Myocytes, Cardiac",Cardiomyocyte,1
2852,"Myocytes, Smooth Muscle",smooth muscle cells,4
2853,"Myocytes, Smooth Muscle",SMCs,1
2854,MYOD1 gene,MyoD,7
2855,MYOD1 gene,myogenic differentiation,1
2856,Myofilaments,myofilaments,1
2857,Myogenesis,myogenesis,3
2858,Myogenin,myogenic,1
2859,Myogenin,myogenin,1
2860,Myopathy,skeletal muscle disease,1
2861,myosin-binding protein C,myosin-binding protein,1
2862,"N,N-dimethylarginine",asymmetric dimethyl arginine,1
2863,Na(+)/H(+) Exchange Regulatory Cofactor NHE-RF3,PDZ domain-containing protein family,1
2864,Name Given at Birth,birth,3
2865,National reporting jurisdiction:Loc:Pt:^Event:Nom,event,2
2866,Native (qualifier value),native,3
2867,Natural Killer Cells,natural killer cells,1
2868,NCF1 gene,Ncf1,3
2869,NCI Thesaurus Property,property,1
2870,NCKAP1 gene,Nck-associated protein 1,1
2871,NCKAP1 gene,Nap1,4
2872,NCOA1 gene,steroid receptor coactivator 1,1
2873,NCOA1 gene,SRC-1,6
2874,NCOA1 gene,steroid receptor coactivator,2
2875,NCOA1 gene,SRC,3
2876,NCOA1 gene,nuclear receptor coactivator level,1
2877,"NCOA1 protein, human",NCoA-1,2
2878,NCOA2 gene,glucocorticoid receptor-interacting protein 1,2
2879,NCOA2 gene,GRIP1,41
2880,NCSTN gene,nicastrin,5
2881,NDE1 gene,NUDE,2
2882,NDE1 gene,Nde1,2
2883,NDE1 gene,NDE1,2
2884,NDEL1 gene,mNudE-L,4
2885,NDEL1 gene,NudEL,1
2886,NDEL1 gene,NudE-like protein,1
2887,NDEL1 gene,Ndel1,10
2888,NDEL1 gene,NDEL1,13
2889,NDEL1 gene,Nudel,7
2890,NDFIP1 gene,Ndfip1,2
2891,Neck,neck,1
2892,Negative,negative,10
2893,Negative Charge,negative charge,1
2894,negative regulation of excitatory postsynaptic potential,excitatory postsynaptic membrane,1
2895,Negative Regulation of G2 to M Transition,G2/M,2
2896,NEIL2 gene,Neh2,1
2897,Neocortex,neocortex,3
2898,Neonatal (qualifier value),neonatal,4
2899,Neonatal (qualifier value),newborn,1
2900,Neoplasms,tumors,1
2901,Neoplastic Cell Transformation,tumorigenesis,4
2902,Neoplastic Cell Transformation,oncogenesis,1
2903,Nerve Degeneration,neurodegeneration,3
2904,Nerve Growth Factor,nerve growth factor,1
2905,Nerve Growth Factor,NGF,2
2906,nerve supply,innervation,1
2907,Nerve Tissue,neural tissues,2
2908,nervous system disorder,neurological disorders,2
2909,Nervous system structure,nervous systems,1
2910,nestin protein,nestin,1
2911,Network,protein networks,1
2912,Network,networks,7
2913,neural,neural,2
2914,Neural Crest,neural crest,2
2915,neural crest cell migration,cranial neural crest cell migration,1
2916,neural crest cell migration,neural crest cell migration,1
2917,Neural Crest Cells,neural crest cells,3
2918,Neural Network Simulation,neural-network models,1
2919,Neural Plate,neural plate,1
2920,Neural Stem Cells,neural stem cells,2
2921,Neural Stem Cells,NSCs,3
2922,Neural tube,neural tube,2
2923,neural tube closure,neural tube unclosure,1
2924,Neural Tube Defects,neural tube defects,1
2925,Neuregulin Receptor,neuregulin receptor,1
2926,Neuregulins,neuregulins,4
2927,Neuregulins,NRG,2
2928,Neurites,neurites,5
2929,Neuroblast,neuroblasts,2
2930,neurocognitive,neurocognitive,1
2931,NEUROD2 gene,neuroD2,3
2932,Neurodegenerative Disorders,neurodegenerative disorder,1
2933,Neurodegenerative Disorders,neurodegenerative diseases,3
2934,neurodevelopment,neurodevelopment,1
2935,Neuroepithelial,mouse neuroepithelial,1
2936,Neuroepithelium,neuroepithelium,3
2937,Neurofibrillary degeneration (morphologic abnormality),neurofibrillary tangles,1
2938,Neurogenesis,neurogenesis,6
2939,Neurogenesis,neural development,2
2940,Neurogenesis,neuronal growth cones,1
2941,Neuroglia,glial cells,7
2942,Neuroglia,mouse neuroglial cells,1
2943,Neuroglia,non-neuronal cells,1
2944,Neuroglia,glia,1
2945,Neuroglia,glial,1
2946,Neurologic (qualifier value),neurologic,1
2947,Neurologic Deficits,motor deficits,1
2948,Neurological observations,nervous system,6
2949,neuron component,neuronal components,1
2950,neuron development,neuronal development,7
2951,neuron differentiation,neural differentiation,2
2952,neuron migration,neuronal cell migration,1
2953,neuron migration,mild neuronal migration,1
2954,neuron structure,neuronal structures,1
2955,neuronal,neuronal,5
2956,Neuronal Differentiation,neuronal differentiation,3
2957,Neuronal Outgrowth,neurite outgrowth,1
2958,Neuronal Outgrowth,neuritic outgrowth,1
2959,Neuronal Plasticity,neuronal plasticity,1
2960,Neuronal Plasticity,synaptic plasticity,3
2961,neuronal signal transduction,neuronal motility signal transduction,1
2962,Neurons,Neuron 7,1
2963,Neurons,neurons,49
2964,Neurons,neuron,1
2965,Neurons,neural cells,2
2966,Neuropathology,neuropathologies,1
2967,Neuropeptides,neuropeptide,1
2968,Neuroprotection,neuroprotection,1
2969,Neuroprotective Effect,neuroprotective effects,2
2970,Neurosecretory Systems,neuroendocrine,1
2971,Neurotransmitter Receptor,neurotransmitter receptors,2
2972,neurotransmitter release,Neurotransmitter release,1
2973,Neurulation,neural tube formation,1
2974,neutrophil,neutrophils,3
2975,Never (frequency),never,1
2976,New,novel,9
2977,NFE2L2 gene,NF-E2-related-factor 2,1
2978,NFE2L2 wt Allele,Nrf2,23
2979,NFE2L2 wt Allele,nrf2,1
2980,NFE2L2 wt Allele,Nrf2 protein,1
2981,NFI Transcription Factors,nuclear factor,2
2982,NF-kappa B,NF-kappa,1
2983,NFS1 gene,Nfs1,1
2984,"Night blindness, congenital stationary",congenital stationary night blindness,1
2985,Night time,night,1
2986,Ninein,ninein,1
2987,Nisoldipine,nisoldipine,2
2988,Nitric Oxide Synthase,nitric oxide synthase-2,1
2989,nitric-oxide synthase inhibitor activity,inhibitory activity,2
2990,N-Methylaspartate,N-methyl-D-aspartate,1
2991,N-Methyl-D-Aspartate Receptors,NMDA receptor,2
2992,N-Methyl-D-Aspartate Receptors,N-methyl-D-aspartate receptor,1
2993,N-Methyl-D-Aspartate Receptors,NMDAR,3
2994,N-Methyl-D-Aspartate Receptors,NMDARs,1
2995,No effect,no effect,1
2996,No incoordination,coordinated,1
2997,No reaction,reactions,1
2998,No structural defects,structural defects,1
2999,Nocodazole,nocodazole,1
3000,Non-Clinical Postnatal Trial Phase,postnatal,6
3001,Nongranular leukocyte,mononucleated,1
3002,"Normal, Unit of Concentration",normal,10
3003,North,Northern,1
3004,Northern Blot,Northern blots,1
3005,Northern Blotting,Northern blot analysis,7
3006,Northern Blotting,Northern blot,3
3007,Northern Blotting,RNA blot analysis,1
3008,Northern Blotting,Northern blotting,1
3009,"NOS3 protein, human",constitutive,3
3010,"NOTCH1 protein, human",Notch1,1
3011,Nothing,nothing,1
3012,"NR3C2 protein, human",mineralocorticoid receptor,1
3013,NR4A2 gene,Nurr1,1
3014,NR4A3 gene,Minor,1
3015,"NRBP protein, human",nuclear receptor-binding,1
3016,NRG1 gene,neuregulin gene,1
3017,"NRG1 protein, human",Neuregulin-1,1
3018,"NRG1 protein, human",Nrg1,2
3019,NTHL1 wt Allele,Nth1,1
3020,NUAK1 wt Allele,Omphk1,3
3021,nuclear,nuclear,4
3022,Nuclear accumulation,nuclear accumulation,1
3023,Nuclear Export Signals,nuclear export signal motif,1
3024,Nuclear Export Signals,nuclear export signal,1
3025,nuclear hormone receptor activity,nuclear hormone receptor,1
3026,Nuclear Hormone Receptors,nuclear hormone receptors,1
3027,Nuclear Lamina,nuclear lamina,1
3028,Nuclear LIM Interactor-Interacting Factor 2,CTD,2
3029,Nuclear Localization Signals,nuclear localization signal,1
3030,Nuclear Magnetic Resonance,NMR,1
3031,nuclear migration,nuclear movements,1
3032,nuclear migration,nuclear migration,1
3033,nuclear periphery,nuclear periphery,1
3034,nuclear pore distribution,nuclear distribution gene,1
3035,nuclear pore distribution,nuclear distribution,1
3036,nuclear pore localization,nuclear localization,6
3037,nuclear pore localization,Nuclear localization,1
3038,Nuclear Proteins,nuclear proteins,3
3039,Nuclear Proteins,nuclear pore proteins,1
3040,Nuclear Receptor Coactivators,p160 nuclear receptor coactivators,1
3041,"Nuclear Receptor Subfamily 1, Group F, Member 1",orphan nuclear receptor RORalpha,1
3042,"nuclear receptor subfamily 1, group H, member 3",receptor-alpha,1
3043,"Nuclear Receptor Subfamily 4, Group A, Member 1",Nur77,1
3044,Nuclear Translocation,nuclear translocation,1
3045,nucleic acid biosynthesis,nucleic acid biosynthesis,1
3046,nucleocytoplasmic transport,nucleocytoplasmic transport,1
3047,Nucleosomes,nucleosomes,1
3048,Nucleotides,nucleotides,2
3049,Nucleotides,nucleotide,2
3050,Null Allele,null allele,5
3051,Null Value,,1
3052,Numb (emotional response),Numb,1
3053,Numbers,numbers,2
3054,"Numerical Analysis, Computer-Assisted",computer-assisted analysis,1
3055,Numerous,multiple,3
3056,Numerous,Multiple lines,1
3057,Nutrients,nutrient,2
3058,Nutrients,Nutrient,1
3059,NYAP1 gene,NYAP1,1
3060,NYAP2 gene,NYAP2,1
3061,O(6)-Methylguanine-DNA Methyltransferase,EC 2.1.1.63,1
3062,Obesity Adverse Event,obesity,5
3063,Obesity Adverse Event,Obesity,1
3064,Object Attribute,attributes,1
3065,objective (goal),goal,1
3066,Observation - diagnostic procedure,observation,3
3067,Observation in research,observations,10
3068,Observation parameter,parameters,3
3069,Observed,observed,3
3070,Obstetric Delivery,parturition,4
3071,Obstructed,obstructed,1
3072,Obstruction,blocked,6
3073,Off,OFF,1
3074,Olfactory Neuroblastoma,olfactory neuroepithelium,1
3075,Olfactory Pathways,olfactory pathway,1
3076,Oligodendroglia,primary oligodendrocytes,2
3077,Oligodeoxyribonucleotides,Degenerate oligodeoxyribonucleotide,1
3078,Oligodeoxyribonucleotides,oligo,1
3079,Oligonucleotide Primers,primer,1
3080,Oligonucleotide Synthesis,synthetic oligonucleotide,1
3081,Oligonucleotides,oligonucleotides,1
3082,Oncogene ETS,Ets,1
3083,Oncogene MAX,Max,1
3084,Oncogenes,oncogenes,2
3085,Oocytes,oocytes,2
3086,Open,opens,1
3087,Open,open,1
3088,Open Reading Frames,coding sequence,4
3089,Open Reading Frames,open reading frame,2
3090,Open Reading Frames,coding region,1
3091,Open Reading Frames,ORF,3
3092,Open Reading Frames,coding sequences,1
3093,Open Reading Frames,protein-coding sequences,1
3094,Open Reading Frames,CDSs,2
3095,Operator gene,gene promoters,1
3096,"Opitz GBBB Syndrome, X-Linked",Opitz syndrome,1
3097,Opposite,opposite,2
3098,Optimization,optimization,1
3099,Options,option,1
3100,orders - HL7PublishingDomain,orders,1
3101,Organ,organs,5
3102,Organ,organ,1
3103,Organelles,organelles,2
3104,Organism,organisms,2
3105,Organism,organism,1
3106,Organized,disorganization,1
3107,Organized,organize,2
3108,Organized,disorganized,3
3109,Organogenesis,organogenesis,2
3110,Orofaciodigital syndrome 9,Oral-facial-digital type 1,1
3111,Orofaciodigital syndrome 9,OFD1,3
3112,Orphan Nuclear Receptor ROR-gammaT,RORgammat,7
3113,Orthologous Gene,ortholog,1
3114,Oscillator Device Component,oscillator,3
3115,osteoblast differentiation,osteoblastic differentiation,1
3116,Osteoblasts,osteoblasts,1
3117,Osteoblasts,mouse osteoblasts,1
3118,osteoclast differentiation,osteoclast differentiation,3
3119,Osteoclastogenesis,osteoclastogenesis,3
3120,Osteoclasts,osteoclasts,5
3121,Osteoclasts,mouse osteoclasts,2
3122,Osteofibrous Dysplasia,Osteofibrous dysplasia,1
3123,Osteofibrous Dysplasia,OFD,3
3124,Osteogenesis,osteogenesis,2
3125,Osteoplasty,bone repair,1
3126,Other Toxicity Studies: Dependence,dependence,2
3127,outer membrane,outer membrane,2
3128,Outlines (document),outlines,1
3129,Outpatient Physical Therapy Improvement in Movement and Assessment Log (OPTIMAL) Survey,optimal,1
3130,Overlap,overlap,1
3131,Oxidants,oxidants,1
3132,Oxidative,oxidative,2
3133,Oxidative Stress,oxidative stress,2
3134,Packing (action),Packaging of,1
3135,Packing Dosage Form,Packing,1
3136,PAF1 gene,PAF1,2
3137,PAF1 gene,Paf1,1
3138,PAFAH1B1 gene,LIS1 genes,1
3139,PAFAH1B1 gene,LIS-1,2
3140,PAFAH1B1 gene,murine lissencephaly-1,1
3141,PAFAH1B1 gene,Lis1 gene,5
3142,PAFAH1B1 gene,LIS1 gene,4
3143,PAFAH1B1 gene,PAFAH1B1,2
3144,PAFAH1B1 gene,Pafah1b1,1
3145,PAFAH1B1 gene,pafah1b1,1
3146,PAFAH1B1 gene,Pafah1b1 gene,1
3147,PAFAH1B1 wt Allele,mLis1,4
3148,PAFAH1B2 gene,Pafah1b2,1
3149,PAFAH1B3 gene,Pafah1b3,1
3150,PAFAH2 gene,PAF-AH,4
3151,Page (document),PAGE,1
3152,Paint,paints,1
3153,PAK2 gene,Pak2,6
3154,PAK2 kinase,gamma-PAK,3
3155,Pakistan,PAK,5
3156,Palmitoylation,palmitoylation,1
3157,Paracrine Communication,paracrine signalling system,1
3158,Paralogous Gene,paralog,1
3159,paranodal junction,paranodal junction,1
3160,Paraxial Mesoderm,paraxial mesoderm,1
3161,PARK2 gene,Parkin,8
3162,PARK2 gene,PARKIN,2
3163,Parkinson Disease,Parkinson disease brains,1
3164,Partial,partial,2
3165,Participant,participant,2
3166,participation,participation,1
3167,participation,participate,2
3168,Participation Type - origin,origin,2
3169,Particle,particles,1
3170,Partner in relationship,partners,4
3171,"PASD1 protein, human",domain-containing proteins,2
3172,"PASD1 protein, human",domain-containing,1
3173,"PASD1 protein, human",hand domain-containing protein,1
3174,Pathogenesis,pathogenesis,3
3175,Pathogenic,pathogenic,1
3176,Pathogenic organism,pathogens,1
3177,Pathologic,pathological,5
3178,Pathologic,pathologic,1
3179,Pathologic Complete Response,PCR,6
3180,Pathologic Neovascularization,vascularization,2
3181,Pathologic Neovascularization,pathologic angiogenesis,1
3182,Pathological aspects,pathology,2
3183,Patient Care Bundles,bundles,1
3184,Patients,patients,18
3185,Patients,patient,5
3186,Patients,Patients,1
3187,PATJ gene,CIPP,2
3188,Patterns,patterns,6
3189,Patterns,pattern,15
3190,PAWR gene,Par-4,2
3191,PCDHB11 gene,ME2,3
3192,PCNT gene,pericentrin,4
3193,PD 98059,PD-98059,1
3194,PD 98059,PD98059,1
3195,"PDK1 protein, human",PDK1,1
3196,PDLIM5 gene,LIM,1
3197,PDZ Domains,PDZ domain,1
3198,Peak level,peak,2
3199,peptidase activity,protease activity,1
3200,Peptide Elongation Factor 1,EF,2
3201,Peptide Hydrolases,peptidases,1
3202,Peptide Initiation Factors,initiator factors,1
3203,Peptide Initiation Factors,translation initiation factor,1
3204,Peptides,peptides,1
3205,PER2 gene,PER2,1
3206,PER3 gene,PER3,1
3207,Pericentriolar Material 1 Protein,PCM-1,2
3208,perinuclear endoplasmic reticulum,perinuclear,1
3209,Period (temporal qualifier),period,5
3210,periodate-oxidized adenosine,adenosine dialdehyde,1
3211,Periodicity,rhythmic,3
3212,Periodicity,rhythmicity,2
3213,Periodicity,periodicity,1
3214,Periosteal Route of Administration,periosteal,1
3215,Periosteum,periosteum,2
3216,Peripheral,peripheral,1
3217,peripheral membrane protein 43K,rapsyn,1
3218,Persistent,persistent,1
3219,Persons,persons,1
3220,Pervasive Development Disorder,autistic spectrum disorders,1
3221,Pharmacokinetics: Distribution,distribution,13
3222,Pharmacokinetics: Metabolism,metabolism,4
3223,pharmacological,pharmacological,6
3224,Pharmacology,pharmacologically,1
3225,pharyngeal development,pharyngeal development,1
3226,Pharyngeal pouch,pharyngeal pouches,1
3227,Pharyngeal Stripping Wave Absent,absent,3
3228,Pharyngeal structure,pharyngeal,2
3229,Phase,stage,2
3230,Phase,phase,2
3231,Phase 2,phase 2,1
3232,Phase 3 Clinical Trials,3,1
3233,Phenotype,phenotypes,13
3234,Phenotypic abnormality,phenotypic abnormalities,1
3235,Phenylephrine,Phenylephrine,1
3236,PHF10 gene,BAF45a,1
3237,Phorbol,phorbol,1
3238,Phorbol Esters,phorbol ester,1
3239,Phosphatidate Phosphatase,phosphatidic acid phosphohydrolase,1
3240,Phosphatidate Phosphatase,PAP,1
3241,phosphatidylinositol 3-kinase binding,phosphoinositide 3-kinase,1
3242,Phosphatidylinositol 3-Kinases,PI 3-kinase,1
3243,"Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatase 1",SH2-domain-containing inositol 5\'phosphatase,1
3244,"Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatase 1",SHIP-1,4
3245,phosphatidylinositol-3-phosphate binding,cellular phosphatidylinositol 3-phosphate,1
3246,Phosphatidylinositols,phosphatidylinositol 3,2
3247,Phosphatidylinositols,phosphatidylinositol,1
3248,Phosphatidylinositols,polyphosphatidylinositol,1
3249,Phosphatidylinositols,phosphoinositide,1
3250,Phospholipase,phospholipase,1
3251,Phospholipase C,phospholipase C,1
3252,Phospholipase C,PLC,1
3253,Phospholipase C gamma,phospholipase C-gamma,1
3254,Phospholipase C gamma,PLC-gamma,3
3255,Phospholipids,phospholipids,1
3256,Phosphopeptides,phosphopeptides,8
3257,Phosphopeptides,phosphopeptide,2
3258,Phosphoproteins,phosphoproteins,2
3259,Phosphoproteins,phosphoprotein,1
3260,phosphoric monoester hydrolase activity,phosphatase activity,1
3261,Phosphoric Monoester Hydrolases,phosphatase,3
3262,Phosphorylation,phosphorylation,104
3263,Phosphorylation,phosphorylated,22
3264,Phosphorylation,Phosphorylation,4
3265,Phosphorylation,phosphorylation state,2
3266,Phosphorylation,phosphorylates,5
3267,Phosphorylation,phosphorylations,1
3268,Phosphorylation,Phosphorylated,1
3269,Phosphorylation,phosphorylate,1
3270,Phosphorylation Site,phosphorylation site,1
3271,Phosphoserine,phosphoserine,1
3272,Phosphotransferases,kinases,4
3273,Phosphotransferases,kinase,6
3274,Phosphotyrosine,phosphotyrosine,4
3275,phosphotyrosine binding,phosphotyrosine-binding,1
3276,phosphotyrosine binding,PTB,6
3277,Phosphotyrosine Binding Domain,PTB domain,1
3278,Phosphotyrosine Binding Domain,phosphotyrosine binding domain,1
3279,photoreceptor disc membrane,photoreceptor membranes,1
3280,Photoreceptors,photoreceptors,2
3281,Physical,physical,1
3282,Physical Examination,examination,1
3283,Physical Examination,Examination,1
3284,Physical shape,morphology,5
3285,Physiologic Coordination,coordination,2
3286,Physiologic hypertrophy,physiological hypertrophy,1
3287,Physiologic hypertrophy,physiologic hypertrophy,1
3288,Physiologic Organization,organization,11
3289,Physiological,physiologically,1
3290,Physiological,physiological,11
3291,physiological aspects,brain physiology,3
3292,physiological aspects,physiology,2
3293,Physiological Processes,physiological processes,3
3294,Pick Disease of the Brain,frontotemporal dementia,1
3295,Pick Disease of the Brain,FTD,2
3296,Picture,picture,1
3297,PIK3C3 wt Allele,Vps34,1
3298,"PIM1 protein, human",PIM1,1
3299,PINK1 gene,PINK1,1
3300,Pituitary Gland,pituitary gland,4
3301,Pituitary Gland,Pituitary gland,1
3302,Pituitary hormone preparation,pituitary,2
3303,PKN2 gene,PAK-2,5
3304,PLA2G1B gene,PlA2,1
3305,"PLA2G7 protein, human",acetylhydrolase,4
3306,"PLA2G7 protein, human",brain platelet-activating factor acetylhydrolase 1b,1
3307,Placement action,placement,1
3308,Placenta,placental,2
3309,Placenta,placentas,1
3310,Plasma,plasma,1
3311,Plasma Cells,plasma cell,1
3312,Plasma membrane,plasma membrane,10
3313,Plasma membrane,plasmalemmal,1
3314,Plasmids,plasmid,3
3315,Plasticity,plasticity,7
3316,Platelet Activating Factor,brain platelet-activating factor,1
3317,Platelet Activating Factor,PAF,18
3318,Platelet Activating Factor,bovine platelet-activating factor,1
3319,Platelet Activating Factor,Platelet-activating factor,1
3320,Platelet Activating Factor,1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine,1
3321,Platelet Activation,platelet activating,1
3322,Platelet Activation,platelet activation,1
3323,Platelet aggregation measurement,platelet function,1
3324,Platelet Count measurement,platelet counts,1
3325,Platelet Count measurement,platelet numbers,1
3326,Platelet Glycoprotein GPIIb-IIIa Complex,alphaIIbbeta3,2
3327,Platelet Membrane Glycoprotein IIb,integrin alpha IIb,1
3328,Platelet Size,platelet size,1
3329,Platelet-Activating Factor Acetylhydrolase IB Subunit Alpha,PAF-AH Ib alpha,1
3330,Platelet-Derived Growth Factor,PDGF,1
3331,Pleckstrin Homology Domains,domains,16
3332,PLEK gene,pleckstrin,1
3333,Pliability,flexibility,1
3334,Pliability,inflexibility,1
3335,Plication,folding,1
3336,PLK1 gene,Plk1,1
3337,PLK3 gene,PLK3,1
3338,PLK3 gene,Plk3,5
3339,Pluripotent,pluripotent,2
3340,Pluripotent,pluripotent state,1
3341,Pluripotent Stem Cells,pluripotent stem cell state,1
3342,"Pneumonia, Interstitial",interstitial pneumonia,1
3343,Point Mutation,point mutations,1
3344,Polyadenylation,polyadenylation,1
3345,Polyclonal antibody,polyclonal antibody,1
3346,Polycomb,Polycomb,4
3347,Polymerase Chain Reaction,polymerase chain reaction,3
3348,Polymerization,polymerization,2
3349,Polymerization,polymerized,1
3350,Polymers,polymer,2
3351,Polymorphism,polymorphism,1
3352,Polynucleotides,polynucleotides,1
3353,Polypeptides,polypeptides,3
3354,Polypyrimidine Tract-Binding Protein 3,differential regulation,1
3355,Polyubiquitination,polyubiquitination,5
3356,Polyubiquitination,polyubiquitinated,1
3357,Population Group,subpopulation,3
3358,Population Group,subpopulations,1
3359,population migration,migration,27
3360,PORPHOBILINOGEN SYNTHASE,5-aminolevulinate dehydratase,1
3361,Positioning - therapy,positioning,2
3362,Positioning Attribute,positions,2
3363,Positive Charge,positive,6
3364,Positive Transcriptional Elongation Factor B,transcription elongation factor b,1
3365,Positive Transcriptional Elongation Factor B,P-TEFb,8
3366,post-Golgi vesicle-mediated transport,post-Golgi transport,1
3367,Postmortem period,postmortem,1
3368,Postpartum Period,postpartum,2
3369,Post-Synaptic Density,postsynaptic,8
3370,Post-Synaptic Density,post-synaptic density,1
3371,Post-Synaptic Density,post-synaptic density fraction,1
3372,Post-Synaptic Density,postsynaptic density area,1
3373,Post-Synaptic Density,post-synaptic density protein,1
3374,Post-Synaptic Density,post-synaptic density fractions,1
3375,Post-Synaptic Density,postsynaptic density,2
3376,Post-Synaptic Density,PSD,2
3377,Post-Synaptic Density,postsynaptic density preparation,1
3378,Post-Synaptic Density,post-synaptic density preparation,1
3379,Post-Synaptic Density,synaptic density,1
3380,Post-Synaptic Density,post-synaptic density preparations,1
3381,Post-Synaptic Density,post-synaptic,1
3382,postsynaptic density proteins,postsynaptic density proteins,1
3383,Postsynaptic Membrane,postsynaptic membrane,3
3384,Postsynaptic Membrane,postsynaptic membranes,1
3385,Post-Translational Protein Processing,post-translational modifications,1
3386,Post-Translational Protein Processing,protein post-translational modifications,1
3387,Post-Translational Protein Processing,posttranslational modifications,1
3388,Post-Translational Protein Processing,posttranslational modification,1
3389,Potassium Ion,K+,1
3390,potential,potential,7
3391,PPARGC1A gene,PGC-1alpha,2
3392,PPARGC1A gene,PGC-1alpha\'s,1
3393,PPAT gene,glutamine phosphoribosylpyrophosphate amidotransferase,1
3394,PPIA gene,Cyclophilin A,1
3395,PPIA gene,CyPA,5
3396,PPIase activity,peptidyl-prolyl cis-trans isomerase activity,1
3397,PPIase activity,PPIase,1
3398,PPIase activity,PPIase activity,1
3399,PPP1R13B wt Allele,p85,3
3400,PPP2R4 gene,phosphatase PP2A,2
3401,PPP3CA gene,calcineurin A,1
3402,PPP3CB gene,Ppp3cb,1
3403,PRB2 gene,PS,1
3404,PRDM16 gene,Prdm16,4
3405,Precocious,precocious,1
3406,Precursor,precursor,1
3407,prediction,predicted,3
3408,prediction,prediction,1
3409,Predominate,predominate,1
3410,Pregnancy,pregnancy,1
3411,Premature aging syndrome,premature aging,1
3412,prerequisite,prerequisite,1
3413,Presenilins,presenilin,2
3414,presynaptic density protein 95,postsynaptic density-95,1
3415,presynaptic density protein 95,PSD-95,17
3416,presynaptic grid,presynaptic,3
3417,pre-synaptic ribbon,ribbon,1
3418,Presynaptic Terminals,axon terminals,1
3419,Prevalence aspects,prevalence,1
3420,Preventing (action),prevents,5
3421,Primary,principal,1
3422,Primary,primary,3
3423,Primary Cell Culture,primary cultures,1
3424,Primary Cell Culture,primary cell cultures,1
3425,Primary congenital glaucoma,Primary congenital glaucoma,1
3426,Primary congenital glaucoma,PCG,4
3427,Priming,priming,1
3428,Primitive,primitive,2
3429,Primitive Streak,primitive streak,2
3430,Privacy Level - Isolation,isolation,7
3431,PRL gene,Prolactin,1
3432,PRL gene,prolactin,1
3433,PRMT1 gene,PRMT1,1
3434,Probability Distribution Type - beta,beta,4
3435,ProbabilityDistributionType - T,T,1
3436,Probes,probe,4
3437,Probes,probes,1
3438,PROC gene,Proc,2
3439,Procedural approach,approaches,1
3440,Process,process,13
3441,Process,processed,1
3442,Process of secretion,secretion,4
3443,Processing (action),processing,1
3444,product,product,8
3445,product,products,5
3446,product,protein products,1
3447,production,production,9
3448,production,Production,2
3449,Profile (lab procedure),profile,2
3450,Prognosis bad,poor prognosis,1
3451,Program,program,1
3452,Progression,progression,3
3453,Progressive,progressive,3
3454,Project,project,7
3455,Prokaryote,prokaryotic,1
3456,Proliferating Cell Nuclear Antigen,cyclin,4
3457,Proliferation,proliferation,20
3458,Proliferation,proliferate,3
3459,Proliferation,proliferation rate,1
3460,Proliferation,proliferating,1
3461,Proliferation,Proliferating,1
3462,Proliferation (morphologic abnormality),proliferative,1
3463,Proline,proline,1
3464,Proline-Rich Domain,proline-rich region,1
3465,Prolonged,prolonged,2
3466,Prominent,prominent,4
3467,promoter,promoter,10
3468,promoter,promoters,6
3469,"Promoter Regions, Genetic",promoter regions,1
3470,"Promoter Regions, Genetic",promoter region,1
3471,Promotion (action),promote,8
3472,Promotion (action),promoting,2
3473,PROP1 gene,Prop1,1
3474,PROP1 gene,PROP1,1
3475,Prophase,prophase,2
3476,Proportion,proportion,2
3477,Proposal (document),proposal,1
3478,Prosencephalon,forebrain,3
3479,Prostate,prostate,1
3480,Prostate carcinoma,prostate cancer,1
3481,Prostatic epithelium,prostate epithelium,1
3482,pro-survival,pro-survival,1
3483,Protease Inhibitors,peptide inhibitors,1
3484,proteasome complex disassembly,proteasomal degradation,4
3485,Proteasome Pathway,proteasome,2
3486,Protection,protection,4
3487,Protein Acetylation,acetylation,15
3488,Protein Acetylation,protein acetylation,1
3489,Protein Binding,binding protein,1
3490,Protein Binding Motif,binding motif,1
3491,Protein Biosynthesis,translation,4
3492,Protein Biosynthesis,protein synthesis,1
3493,Protein complex,protein complex,2
3494,"Protein Conformation, beta-Strand",D beta-strands,1
3495,"Protein Conformation, beta-Strand",beta strands,1
3496,protein C-terminus binding,carboxy-terminus,1
3497,protein C-terminus binding,COOH-terminal,1
3498,protein desumoylation,desumoylation,1
3499,Protein Dimerization,protein dimerization,1
3500,Protein Domain,motif,11
3501,protein expression,expressed,118
3502,protein expression,protein expression,2
3503,Protein Expression Analysis,expression analysis,1
3504,Protein Family,protein family,3
3505,protein folding,protein folding,1
3506,Protein Fragment,long protein fragment,1
3507,Protein Function,Protein function,1
3508,Protein Import,preprotein import,1
3509,Protein Import,protein import,1
3510,Protein Isoforms,isoform,7
3511,Protein Isoforms,long isoforms,1
3512,Protein Isoforms,isoforms,32
3513,Protein Isoforms,beta isoforms,1
3514,protein K63-linked ubiquitination,K63-linked ubiquitination,1
3515,Protein Kinases,protein kinases,1
3516,Protein Kinases,protein kinase,2
3517,Protein Kinases,PKA,6
3518,Protein level - finding,protein level,1
3519,Protein methylation,protein methylation,1
3520,Protein methylation,Protein methylation,1
3521,protein methyltransferase activity,protein methyltransferase activity,1
3522,protein monoubiquitination,monoubiquitylation,2
3523,protein N-linked glycosylation,N-linked glycosylation sites,2
3524,protein oligomerization,oligomerization,2
3525,Protein Overexpression,Overexpression,16
3526,Protein Overexpression,overexpressed,4
3527,Protein Overexpression,overexpression,19
3528,Protein Overexpression,overexpressing,2
3529,Protein p53,p53 protein,1
3530,Protein p53,tumour suppressor protein p53,1
3531,Protein phosphatase,protein phosphatases,1
3532,protein protein interaction,protein-protein interactions,3
3533,protein protein interaction,protein-protein interaction,1
3534,protein protein interaction,protein-protein interaction area,1
3535,protein reconstitution,reconstitution,1
3536,protein self-association,self-associate,1
3537,protein self-association,self-association,2
3538,Protein Sequence Determination,protein sequencing,1
3539,Protein Sorting Signals,sorting signals,1
3540,Protein Splicing,splicing proteins,1
3541,Protein Stability,protein stability,4
3542,"Protein Structure, Secondary",protein secondary structure,1
3543,"Protein Structure, Secondary",secondary structure,1
3544,Protein Subunits,subunit,14
3545,Protein Subunits,subunits,13
3546,Protein Subunits,subunit protein of,1
3547,protein succinylation,succinylation,2
3548,Protein translocation,translocation,7
3549,Protein translocation,translocates,4
3550,Protein translocation,translocated,3
3551,Protein translocation,translocate,1
3552,Protein translocation,protein translocation,1
3553,protein transport,Protein transport,1
3554,protein transport,trafficking proteins,1
3555,protein transport,trafficking protein,1
3556,Protein Truncation Abnormality,truncations,1
3557,Protein Truncation Abnormality,truncation,2
3558,Protein Tyrosine Kinase,tyrosine kinases,3
3559,Protein Tyrosine Kinase,tyrosine kinase,4
3560,Protein Tyrosine Kinase,protein-tyrosine kinase family,1
3561,Protein Tyrosine Kinase,protein-tyrosine kinases,1
3562,Protein Tyrosine Kinase,protein tyrosine kinase,1
3563,Protein Tyrosine Kinase,PTK,2
3564,Protein Tyrosine Kinase,protein-tyrosine,1
3565,Protein Tyrosine Kinase,Met tyrosine kinases,1
3566,Protein Tyrosine Phosphatase,PTPs,1
3567,"Protein Tyrosine Phosphatase, Receptor Type B",VE-PTP,8
3568,"Protein Tyrosine Phosphatase, Receptor Type B",Vascular endothelial protein tyrosine phosphatase,1
3569,Protein-Arginine N-Methyltransferase,protein arginine methyltransferase family,1
3570,Proteins,protein,43
3571,Proteins,proteins,79
3572,Proteins,gene product,2
3573,Proteins,gene 3 product,1
3574,Proteins,Proteins,1
3575,Proteins,Protein,1
3576,Proteins,E proteins,5
3577,Protein-Serine-Threonine Kinases,serine/threonine protein,1
3578,Protein-Serine-Threonine Kinases,serine/threonine protein kinase,1
3579,Protein-Serine-Threonine Kinases,serine-threonine kinase family,1
3580,Proteolysis,proteolysis,1
3581,Proteolytic Enzyme,proteolytic,2
3582,Proteomics,proteomic,4
3583,Proteomics,proteomics,6
3584,Protocol Forms Template,template,1
3585,Protocols documentation,protocols,1
3586,Protomers,protomers,1
3587,Proto-Oncogene Protein c-met,c-met protein,1
3588,Proto-Oncogene Protein c-met,affinity c-Met receptor tyrosine kinase,1
3589,Proto-Oncogene Proteins c-akt,Akt,8
3590,Proto-Oncogene Proteins c-akt,AKT,7
3591,Proto-Oncogene Proteins c-myc,MYC,4
3592,Proto-Oncogene Proteins c-myc,Myc,6
3593,Proto-Oncogenes,proto-oncogene,3
3594,Protoplasm,intracellular,11
3595,Providing presence (regime/therapy),presence,9
3596,Proximal,proximal,2
3597,Proximal,neighboring gene,1
3598,Proximal Interphalangeal Joint 3,PIP3,1
3599,PRRT2 gene,PKC,1
3600,PSEN1 gene,PS1,3
3601,PSENEN wt Allele,PEN-2,3
3602,PSENEN wt Allele,PEN2,1
3603,Psychologic Displacement,displacement,5
3604,PTEN activity,Pten activity,1
3605,PTEN gene,Pten gene,1
3606,PTEN Phosphohydrolase,MMAC1 protein,1
3607,PTEN Phosphohydrolase,PTEN protein,3
3608,"PTEN protein, human",PTEN,23
3609,"PTEN protein, human",Pten,2
3610,PTEN wt Allele,MMAC1,2
3611,PTPN11 gene,Shp2,1
3612,"PTPRB protein, human",endothelial protein-tyrosine phosphatases,1
3613,"PTPRB protein, human",VE-PTP gene,2
3614,Publications,publications,1
3615,Publications,literature,1
3616,Published Database,data bases,1
3617,Published Database,Data Bases,1
3618,Publishing,published,2
3619,Pulmonary Valve Insufficiency,PI,1
3620,Punctate,punctate,2
3621,Purifying,purified,2
3622,Purifying,purification,2
3623,Purine Nucleotides,purine nucleotide cycle,1
3624,Purines,purine,3
3625,Purkinje Cells,Purkinje,2
3626,Purkinje Cells,Purkinje cell bodies,1
3627,PURPOSE (pharmacologic preparation),PURPOSE,1
3628,PWWP2A gene,PWWP2A,9
3629,PWWP2B gene,PWWP2B,1
3630,Pyramidal Cells,pyramidal cells,1
3631,Pyruvate Dehydrogenase Complex,pyruvate dehydrogenase complex,1
3632,QDPR gene,DHPR,3
3633,Qualitative mobility,mobility,2
3634,Quality,quality,1
3635,quality control,quality control,1
3636,Quantitation,quantify,1
3637,Quantitative,quantitative,4
3638,Quantitative Reverse Transcriptase PCR,quantitative reverse transcriptase-polymerase chain reaction,1
3639,Quantity,amounts,1
3640,Question (inquiry),question,2
3641,rab GTP-Binding Proteins,Rab GTPases,3
3642,RAB13 gene,Rab13,1
3643,RAB39B gene,Rab39b,1
3644,RAB5A gene,Rab5,1
3645,Rabbits,rabbit,5
3646,Racial Segregation,segregate,1
3647,RAD54L2 gene,Arip4,6
3648,radial glia,radial glia,1
3649,Radiolabeled,radiolabeled,1
3650,Radiolucent,radiolucent,1
3651,RAI1 gene,RAI1,9
3652,RAI1 gene,Rai1,11
3653,Raised intraocular pressure,elevated intraocular pressure,1
3654,Rana <genus>,frog,1
3655,Randomization,random,2
3656,Rapid,rapid,1
3657,RARB gene,HAP,1
3658,Ratio,ratio,1
3659,Rattus,rat,8
3660,Rattus,Rat 1,1
3661,RBL2 wt Allele,p130,1
3662,RBM14 gene,coactivator,4
3663,RBM14 gene,activator,2
3664,React,react,1
3665,Reaction,reaction,2
3666,Reaction,reactivity,1
3667,Reaction,Reaction,1
3668,Reactivation,reactivation,1
3669,Reactive,reactive,1
3670,reactive oxygen intermediate,reactive oxygen intermediates,1
3671,Reactive Oxygen Species,reactive oxygen species,1
3672,Reactive Oxygen Species,ROS,3
3673,Reagents,reagents,1
3674,receptor,FGF-R,2
3675,receptor,receptors,13
3676,receptor,receptor,19
3677,receptor,FGFR-1,12
3678,receptor,Met receptor,1
3679,receptor,FGFRs,2
3680,receptor,receptors\',1
3681,receptor,MET receptor,3
3682,Receptor Activation Process,receptor activation,2
3683,receptor activator activity,receptor activator,1
3684,Receptor Protein-Tyrosine Kinases,putative receptor tyrosine kinase,2
3685,Receptor Protein-Tyrosine Kinases,tyrosine kinase receptor,3
3686,Receptor Protein-Tyrosine Kinases,receptor tyrosine kinases,9
3687,Receptor Protein-Tyrosine Kinases,RTKs,3
3688,Receptor Protein-Tyrosine Kinases,receptor tyrosine kinase,9
3689,Receptor Protein-Tyrosine Kinases,RTK,6
3690,Receptor Protein-Tyrosine Kinases,Receptor tyrosine kinases,2
3691,Receptor Protein-Tyrosine Kinases,receptor-tyrosine kinase,1
3692,receptor recycling,receptor recycling,1
3693,Receptor Signaling,signalling receptor,1
3694,Receptor Tyrosine Kinase Gene,receptor tyrosine kinase gene family,1
3695,"Receptor Tyrosine-Protein Kinase ErbB-4, human",ErbB4,50
3696,"Receptor Tyrosine-Protein Kinase ErbB-4, human",erbB4,2
3697,"Receptor Tyrosine-Protein Kinase ErbB-4, human",Erbb4,2
3698,"Receptor Tyrosine-Protein Kinase ErbB-4, human",ERBB4,10
3699,"Receptor Tyrosine-Protein Kinase ErbB-4, human",ErbB4 protein,1
3700,"Receptor Tyrosine-Protein Kinase ErbB-4, human",ErbB4 ligand,1
3701,"Receptor, Serotonin, 5-HT2A",5-HT(2A) receptor,2
3702,"Receptor, Serotonin, 5-HT2C",5-HT(2C) receptor,4
3703,"Receptor, Serotonin, 5-HT2C",5-HT(2C) receptors,2
3704,"Receptor, Serotonin, 5-HT2C",5-HT(2C) receptor binds,1
3705,"Receptor, TIE-2",Angiopoietin receptor Tie-2,1
3706,"Receptor, TIE-2",Tie-2 receptor,4
3707,"Receptor, TIE-2",Tie2 receptor,2
3708,"Receptors, Cell Surface",cell surface receptors,2
3709,"Receptors, Cell Surface",mouse cell surface receptor,1
3710,"Receptors, Cell Surface",cell surface receptor tie,1
3711,"Receptors, Cell Surface",cell surface receptor,1
3712,"Receptors, Dihydropyridine",dihydropyridine receptor,1
3713,"Receptors, Eph Family",Eph receptors,2
3714,"Receptors, Nuclear",nuclear receptors,7
3715,"Receptors, Nuclear",NR,5
3716,"Receptors, Nuclear",nuclear receptor,1
3717,"Receptors, Nuclear",Nuclear receptors,1
3718,"Receptors, Nuclear",NRs,4
3719,"Receptors, Steroid",steroid receptor,2
3720,"Receptors, Steroid",steroid receptors,1
3721,Recognition (Psychology),recognition,3
3722,Recombinant DNA,construct,1
3723,Recombinant Interleukin-1,interleukin-1,1
3724,Recombinant Interleukin-4,Interleukin-4,1
3725,Recombinant Interleukin-4,IL-4,6
3726,Recombinant melatonin,melatonin,1
3727,Recombinant Proteins,recombinant protein,1
3728,Recombinant Vascular Endothelial Growth Factor,vascular endothelial cell growth,1
3729,Recombinants,recombinant,9
3730,Recombinants,Recombinant,1
3731,recovery - adjustment,recovery,1
3732,Recycling,recycling,1
3733,Recycling,recycle,1
3734,Redistribution,redistribution,1
3735,Reduced,reduced,49
3736,Reduced,decreased,20
3737,Reduced,reducing,2
3738,Reduced,Reduced,1
3739,Reduction (chemical),reduction,20
3740,Reduction (chemical),Reduction,2
3741,Redundancy,redundancy,2
3742,Reeler,reeler,1
3743,Reelin Signaling Pathway PID,reelin signaling pathway,2
3744,Refractive surgery enhancement,enhancement,5
3745,REG1A gene,PTP,1
3746,regenerated,regenerate,1
3747,Regenerating muscle fiber,muscle regeneration,1
3748,Region of chromosome,chromosomal regions,1
3749,regional,regional,2
3750,regional,region,11
3751,Regulation,regulation,29
3752,Regulation,regulated,11
3753,Regulation,Regulation,2
3754,Regulation of biological process,physiological regulation,1
3755,regulation of developmental process,developmental regulation,1
3756,regulation of metabolism,regulating metabolism,1
3757,regulation of mitophagy,mitophagy regulator,1
3758,Regulator,regulator,24
3759,Regulators (device),regulators,8
3760,Regulatory Pathway,regulatory pathways,1
3761,regulatory proteins,regulatory proteins,1
3762,"Regulatory Sequences, Nucleic Acid",regulatory regions,1
3763,Regulatory T-Lymphocytes,Treg cells,4
3764,Regulatory T-Lymphocytes,Regulatory T cells,1
3765,Relative ratio,relative ratio,1
3766,Relaxation,relaxation,1
3767,Release - action (qualifier value),releasing,1
3768,Release - action (qualifier value),released,1
3769,release of sequestered calcium ion into cytoplasm,calcium influx,3
3770,release of sequestered calcium ion into cytoplasm,calcium mobilization,2
3771,Relevance,relevance,2
3772,RELN gene,RELN,1
3773,RELN gene,reelin,1
3774,RELN gene,Reelin,3
3775,Renal function,kidney functions,1
3776,reorganization,reorganization,2
3777,Reorientation,reorientation,2
3778,Reparative closure,closure,1
3779,Repeat,repeats,12
3780,Repeat,repeat 5,1
3781,Replicate Specimen,replicate,1
3782,Report (document),report,7
3783,Report (document),reports,4
3784,Reporter (occupation),reporter,1
3785,Reporter (occupation),reporters,2
3786,Repositioning (procedure),repositioning,1
3787,representational difference analysis,genomic representational difference analysis,1
3788,"Repression, Psychology",repression,2
3789,Reproductive function,reproductive functions,1
3790,Reproductive process,reproductive process,1
3791,Reprogram,programming,1
3792,Reprogram,reprogramming,1
3793,Requirement,requisite,1
3794,Research Personnel,researchers,1
3795,research study,experiments,8
3796,research study,Experiments,4
3797,research study,experiment,2
3798,Resident (physician),resident,1
3799,Residue after Decontamination Medical Device Problem,residue,4
3800,"Resistance, Natural",natural resistance,1
3801,Resolution,resolution,4
3802,Resources,resource,1
3803,Resources,resources,1
3804,Respiratory Failure,respiratory failure,1
3805,Response process,responses,6
3806,Response process,Ab responses,1
3807,ResponseLevel - modification,modification,4
3808,ResponseLevel - modification,modifications,5
3809,Restricted,restricted,6
3810,Result,outcome,1
3811,Retarded,retarded,1
3812,Retention - dental,retention,1
3813,Retina,retina,2
3814,Retina,retinal,2
3815,retina layer formation,retinal lamination,1
3816,Retinal Bipolar Cells,bipolar cells,1
3817,Retinal Cone,cone photoreceptors,1
3818,Retinal Cone,cones,1
3819,Retinal Ganglion Cells,retinal ganglion cells,4
3820,Retinal Ganglion Cells,RGCs,1
3821,Retinal Neurons,retinal neuron,1
3822,Retinoblastoma,retinoblastoma,1
3823,"Retinoic Acid Receptor Alpha, human",retinoic acid receptor alpha,1
3824,Retinoic Acid Receptor RXR-Alpha,retinoid X receptor alpha,1
3825,Retinoids,retinoid acid,1
3826,Retrograde approach,retrograde,3
3827,Rett Syndrome,Rett syndrome,1
3828,reuptake,reuptake,1
3829,Revealed,revealed,1
3830,Reverse Transcriptase Polymerase Chain Reaction,Reverse transcriptase-polymerase chain reaction,1
3831,Reverse Transcriptase Polymerase Chain Reaction,RT-PCR,8
3832,Reverse Transcriptase Polymerase Chain Reaction,reverse transcription polymerase chain reaction,1
3833,Reverse Transcriptase Polymerase Chain Reaction,reverse transcriptase-polymerase chain reaction analysis,1
3834,Reverse Transcriptase Polymerase Chain Reaction,Reverse transcriptase polymerase chain reaction,1
3835,Reverse Transcriptase Polymerase Chain Reaction,reverse transcription-polymerase chain reaction products,1
3836,Reversible,reversible,1
3837,rho GTP-Binding Proteins,Rho GTPase,1
3838,rho GTP-Binding Proteins,Rho GTPases,2
3839,rhoA GTP-Binding Protein,RhoA,2
3840,Rhythm,rhythm,1
3841,Ribbon synapse,synaptic ribbons,1
3842,Ribosomal Protein S6 Kinase Beta-1,p70S6K,1
3843,Ribosomal RNA,ribosomal RNA,1
3844,Ribosomal RNA,rRNA,1
3845,Ribosomal RNA Genes,rRNA genes,1
3846,Ribosomal RNA Genes,ribosomal RNA gene,1
3847,Right ventricular structure,right ventricle,1
3848,RIPK1 gene,androgen receptor-interacting protein 4,1
3849,Risedronate,rise,1
3850,Risk,risk,5
3851,Risk Codes - Aggressive,aggressive,1
3852,Risk Evaluation and Mitigation Strategies Requirement,requirement,5
3853,Risk Evaluation and Mitigation Strategies Requirement,requirements,1
3854,risk factors,risk factor,1
3855,RNA,RNA,12
3856,RNA,RNAs,2
3857,RNA biosynthesis,RNA synthesis,1
3858,RNA destabilization,destabilization,1
3859,RNA Interference,RNA interference,7
3860,RNA Polymerase I,RNA polymerase I,1
3861,RNA Polymerase II,RNA polymerase II,3
3862,RNA Polymerase II,RNAPII,1
3863,RNA Processing,RNA processing,2
3864,RNA Splicing,splicing,10
3865,RNA Splicing,RNA splicing,2
3866,"RNA, Messenger",mRNA,36
3867,"RNA, Messenger",mRNAs,6
3868,"RNA, Small Interfering",small interfering RNA,1
3869,"RNA, Small Interfering",siRNA,4
3870,"RNA, Untranslated",non-protein-coding,1
3871,RNA-Binding Motifs,DNA-binding domain,3
3872,RNA-Binding Motifs,binding domains,1
3873,RNA-Binding Motifs,RNA-binding domain,1
3874,RNA-Binding Proteins,RNA-binding protein,2
3875,RNASE1 gene,Rac1,9
3876,RNF2 gene,RNF2,6
3877,Robust,robust,3
3878,ROCK1 gene,Rho kinases,1
3879,ROCK1 gene,ROCK1,5
3880,ROCK1 wt Allele,p160ROCK,1
3881,ROCK2 gene,ROCK2,1
3882,Role Class - content,content,2
3883,Roof physical object,roof,1
3884,Rostral,rostral,3
3885,Routine Signature,signature,2
3886,RPL41 gene,L41,3
3887,rRNA Promoter,rRNA promoter,4
3888,rRNA synthesis,rRNA synthesis,1
3889,ruffle membrane,membrane ruffles,1
3890,Ryanodine Receptors,ryanodine receptors,2
3891,S Phase,S phase,7
3892,Saccharomyces cerevisiae,S. cerevisiae,1
3893,Saccharomyces cerevisiae,Saccharomyces cerevisiae,3
3894,S-acyltransferase activity,protein S-acyltransferase activity,1
3895,SAFB gene,SAFB1,3
3896,SAFB gene,scaffold attachment factor B,1
3897,SAFB wt Allele,SAF-B,1
3898,Sample pool,pool,3
3899,Sarcolemma,sarcolemma,3
3900,Sarcoplasmic Reticulum,SR,6
3901,Sarcoplasmic Reticulum,sarcoplasmic reticulum,1
3902,Scaffold,scaffold,1
3903,Scaffold,scaffolding,1
3904,Scaffold protein,scaffold protein,2
3905,Scaffold protein,scaffolding proteins,1
3906,Scaffold protein,scaffold proteins,2
3907,Scattered,scattering,1
3908,scenario,scenario,1
3909,Schizophrenia,schizophrenia,3
3910,Schizosaccharomyces,Schizosaccharomyces,1
3911,Schizosaccharomyces pombe,pombe,1
3912,Scientific Study,studies,19
3913,Scientific Study,study,34
3914,Scientific Study,Studies,1
3915,Sclerotome device,sclerotome,1
3916,SCRIB gene,Scrib,3
3917,SCYL1 gene,p105,1
3918,"SDHD protein, human",succinate dehydrogenase,1
3919,Sebaceous Glands,sebaceous glands,1
3920,second (number),secondary,1
3921,Secondary Immunization,secondary immunizations,1
3922,Secondary Immunization,secondary immunization,1
3923,Secondary Neoplasm,metastatic disease,1
3924,Seizures,seizures,1
3925,selectin activity,selectivity,2
3926,"SELP protein, human",P-selectin,4
3927,SEMA3A gene,semD,1
3928,SEMA4C gene,Sema4C,5
3929,SEMA5A gene,semF,2
3930,SEMA5A gene,SemF,1
3931,SEMA5A gene,Sema5A,14
3932,SEMA5A gene,Sema5a gene,1
3933,SEMA5A gene,Semaphorin 5A,1
3934,SEMA5A gene,SEMA5A,1
3935,SEMA5B gene,Sema5B,2
3936,Semaphorins,semaphorins,5
3937,Semaphorins,Semaphorins,2
3938,Semaphorins,semaphorin,2
3939,Seminiferous tubule structure,seminiferous tubules,1
3940,SENP3 gene,Ulp1,1
3941,Sense of identity (observable entity),identity,11
3942,Sense Organs,sense organs,1
3943,Sensitive,sensitive,4
3944,sensor (device),sensors,2
3945,sensor (device),sensor,1
3946,Sepsis,systemic infection,1
3947,SEPT4 gene,septin 4,1
3948,SEPT4 gene,44808,6
3949,Sequence - TransmissionRelationshipTypeCode,sequenced,6
3950,Sequence - TransmissionRelationshipTypeCode,sequence,31
3951,Sequence - TransmissionRelationshipTypeCode,Sequence,1
3952,Sequence - TransmissionRelationshipTypeCode,core sequence,2
3953,Sequence Analysis,Sequence analysis,3
3954,Sequence Analysis,sequence analysis,1
3955,Sequence Analysis,sequence analyses,1
3956,Sequence Data Type,list,1
3957,Sequence Similarity,sequence similarities,1
3958,Sequence Similarity,sequence similarity,1
3959,Sequential - Sequence/Results Flag,sequential,1
3960,Series - set of composite instances,series,2
3961,Serine,serine,6
3962,Serotonin,serotonin,2
3963,Serotonin,5-HT,8
3964,Serpin B9,AP-3,1
3965,Serum,serum,2
3966,"Serum Albumin, Bovine",BSA,1
3967,Serum amyloid A protein,amyloid precursor,1
3968,Serum Response Factor,serum response factor,1
3969,Serum Response Factor,SRF,2
3970,Service Request Relationship - Compound,compound,1
3971,Service Request Relationship - Simultaneous,simultaneous,1
3972,Service Request Relationship - Simultaneous,Simultaneous,1
3973,Set (Psychology),SET,2
3974,SET gene,gene set,1
3975,Set of polysomal ribosomes,polysomes,1
3976,SETD5 gene,SETD5,9
3977,Seventh,seventh,2
3978,Severe (severity modifier),severe,17
3979,Severities,severity,3
3980,Severity of illness,disease severity,1
3981,Sf21 Cells,Sf21 insect cells,1
3982,SGCG gene,type,1
3983,SH2 Domain,SH2 domain,4
3984,SH2 Domain,SH2 domains,1
3985,SH2 Domain,SH2 domain mutant,1
3986,SH3 and Multiple Ankyrin Repeat Domains Protein 3,SHANK3,6
3987,SH3 and Multiple Ankyrin Repeat Domains Protein 3,Shank3,3
3988,SH3GL2 gene,endophilin A1,1
3989,Sharing (Social Behavior),shares,2
3990,SHB gene,Shb,1
3991,SHH gene,Sonic hedgehog,1
3992,SHH gene,Shh,2
3993,SHISA6 gene,Shisa6,6
3994,SHISA7 gene,Shisa7,5
3995,SHISA7 gene,Shisa7 gene,1
3996,Shock,collapse,1
3997,Short,short,3
3998,Short Hairpin RNA,small hairpin RNAs,1
3999,Short Hairpin RNA,small hairpin RNA,1
4000,short-term,short-term,2
4001,Signal,signal,5
4002,Signal Pathways,signaling pathway,2
4003,Signal Pathways,signaling pathways,7
4004,Signal Peptides,signal peptide,1
4005,Signal Peptides,signal sequence,1
4006,"Signal Processing, Computer-Assisted",signaling processing,1
4007,signal transducer activity,signal transducer,1
4008,Signal Transduction,signals,6
4009,Signal Transduction,Signal transduction,1
4010,Signal Transduction,signal transduction,5
4011,Signal Transduction,signal transduction portion,1
4012,Signal Transduction,signalling pathways,1
4013,Signal Transduction Pathways,signal-transduction pathways,1
4014,Signal Transduction Pathways,signal transduction pathways,2
4015,Signal Transduction Pathways,multiple signal transduction pathways,1
4016,Signaling Molecule,signaling molecules,1
4017,Signaling Molecule,signalling molecules,1
4018,Signaling Protein,signaling proteins,2
4019,Significant,significant,1
4020,Significant,no significant,1
4021,Significant,significance,2
4022,Significant,SIGNIFICANCE,1
4023,Signs and Symptoms,clinical findings,1
4024,Signs and Symptoms,finding,3
4025,simian virus,simian virus,1
4026,Similarity,similarity,5
4027,Simplex styrene-methylmethacrylate,simplex,1
4028,Simultaneous,concomitant,2
4029,Simultaneous,simultaneously,2
4030,Single-pass plasma transmembrane protein,single-pass transmembrane protein,1
4031,Sirolimus,rapamycin,2
4032,SIRT1 gene,SIRT1,9
4033,SIRT5 gene,SIRT5,3
4034,Site,site,13
4035,Site,sites,20
4036,Sixth,sixth,2
4037,size,size,11
4038,Skeletal bone,bone,1
4039,skeletal muscle cell differentiation,skeletal muscle differentiation,1
4040,Skeletal muscle structure,skeletal muscle,7
4041,Skeletal muscle structure,skeletal muscles,2
4042,Skeletal Myocytes,myotubes,3
4043,Skin,skin,3
4044,SLC22A18 wt Allele,HET,1
4045,SLC30A9 gene,GAC63,5
4046,SLC3A2 gene,heavy chains,2
4047,SLC3A2 gene,heavy chain,1
4048,SLC4A1 wt Allele,WD,1
4049,SLC6A4 wt Allele,SERT,4
4050,"SLC8A1 protein, human",Na(+)/Ca(2+)-exchanger proximal,1
4051,"SLC8A1 protein, human",Na(+)/Ca(2+)-exchange,1
4052,"Sleep Disorders, Circadian Rhythm",sleep-wake cycle,1
4053,Slow,slowly,2
4054,Slow,slowing,1
4055,SLTM gene,SLTM,6
4056,Small brain,small brain,1
4057,Small cerebral cortex,small cerebral cortex,1
4058,SMARCA4 wt Allele,Brg1,1
4059,SMCR8 gene,SMCR8,1
4060,Smith-Magenis syndrome,Smith-Magenis syndrome,2
4061,Smith-Magenis syndrome,SMS,10
4062,SMN Complex Proteins,associated proteins,2
4063,Smooth muscle (tissue),smooth muscle,1
4064,Social Behavior,social behaviors,1
4065,Social engagement,engagement,1
4066,Social engagement,Engagement,1
4067,Social Interaction,interaction,69
4068,Social Interaction,Interaction,1
4069,Social Interaction,social interactions,1
4070,Social Networks,network,5
4071,social resistance,resistance,4
4072,Social Role,roles,1
4073,Sodium Chloride,NaCl,1
4074,soluble,soluble,5
4075,Solutions,solution,1
4076,Somatic,somatic,1
4077,Somatostatin Receptor,SSTR,1
4078,somatostatin receptor 1,SSTR1,1
4079,somatostatin receptor 1,Somatostatin receptor type II,1
4080,somatostatin receptor 2,SSTR-2,6
4081,somite development,somite development,1
4082,Somites,somites,6
4083,Somites,Somites,1
4084,Somites,somite,1
4085,somitogenesis,somitogenesis,1
4086,Sonic Hedgehog Pathway,Hedgehog pathway,1
4087,Sorting - Cell Movement,sorting,1
4088,sorting endosome,endosomal sorting,2
4089,Source,sources,1
4090,Southern Blot result,Southern blot analysis,2
4091,SOX18 gene,Sox18,2
4092,SOX18 gene,SOX18 proteins,2
4093,SOX18 gene,SOX18,2
4094,SOX2 gene,Sox2,1
4095,SOX3 gene,SOX3,2
4096,SOX3 gene,Sox3,1
4097,SP1 wt Allele,Sp1,1
4098,SPARC gene,cysteine-rich,1
4099,"SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE",sacs,1
4100,Special,specialized,5
4101,Species,species,3
4102,Specification,specification,1
4103,Specificity,specificity,10
4104,Specimen Source Codes - Respiratory,respiratory,1
4105,Specimen Source Codes - Spermatozoa,spermatozoa,2
4106,Specimen Source Codes - Tissue lung,lung tissue,1
4107,Specimen Type - Fibroblasts,fibroblasts,6
4108,Specimen Type - Lymphocytes,Lymphocytes,1
4109,Spectrum,spectrum,2
4110,sperm chromatin condensation,chromatin condensation,1
4111,Spermatid,spermatids,2
4112,Spermatocytes,spermatocytes,2
4113,Spermatogenesis,spermatogenesis,4
4114,Spermatogonia,spermatogonia,3
4115,Spermatozoa Cell Count,sperm,7
4116,Spermiogenesis,spermiogenesis,2
4117,Spinal Cord,spinal cord,2
4118,Spindle Poles,spindle poles,1
4119,Spleen,spleen,4
4120,Splice Acceptor Site,splice acceptor site,1
4121,Sporadic (qualifier value),sporadic,1
4122,Spreading (qualifier value),spreading,1
4123,SPSB1 gene,SSB-1,2
4124,SPSB2 gene,SSB-2,2
4125,SPSB3 gene,SSB-3,1
4126,SPSB4 gene,SSB-4,2
4127,Squamous cell carcinoma,mouse squamous cell carcinoma cells,1
4128,SR1001,SR1001,4
4129,SRC gene,Src,3
4130,src-Family Kinases,Src kinases,1
4131,SRF gene,MCM1,2
4132,SRSF3 gene,Srp20,1
4133,SSRP1 gene,SSRP1,2
4134,SSTR2 gene,SSTR2 gene,1
4135,SSTR2 gene,SSTR2,1
4136,ST7 wt Allele,HelG,4
4137,Stabilization,stabilization,4
4138,Stabilized (qualifier value),stabilize,2
4139,Stable status,stable,1
4140,Stage,stages,5
4141,Starvation,starvation,1
4142,Stat (do immediately),immediate,1
4143,STAT protein,STAT,1
4144,"STAT5A protein, human",STAT5A,17
4145,"STAT5A protein, human",STAT5A serine,2
4146,STAT5A wt Allele,Stat5,5
4147,STAT5A wt Allele,STAT5,3
4148,Statement,STATEMENT,1
4149,statistical cluster,clustering,5
4150,Statistical Frequency,frequency,1
4151,Statistical sensitivity,sensitivity,7
4152,status - In progress,progress,1
4153,Stem Cell Self-Renewal,self-renewal,3
4154,Stem cells,progenitors,2
4155,Stem cells,progenitor cells,2
4156,Stem cells,stem cells,2
4157,Stem cells,Progenitor cells,1
4158,Stem of Organ,stem,1
4159,steroid hormone receptor,steroid hormone receptors,1
4160,steroid receptor coactivator AIB1,ACTR,2
4161,Steroids,steroid,3
4162,Stimulant,stimulants,1
4163,Stimulation (motivation),stimulated,5
4164,Stimulation (motivation),stimulate,3
4165,Stimulation of Cell Proliferation,mitogenesis,3
4166,stimulation of growth,growth stimulation,1
4167,Stimulation procedure,stimulation,22
4168,Stimulation procedure,Stimulation,2
4169,Stimulus,stimuli,1
4170,Stimulus,stimulus,1
4171,Stoichiometry,stoichiometry,1
4172,Stomach,stomach,1
4173,Stool seat,tools,1
4174,Streams,stream,1
4175,Stress,stress,3
4176,Stress Fibers,stress fibers,1
4177,Structural protein,structural protein,1
4178,structure,structure,15
4179,structure,structural,6
4180,structure,structures,3
4181,Structure of allantois,allantois,1
4182,Structure of amnion,amnion,3
4183,Structure of amnion,amniotic,1
4184,Structure of corpus luteum of ovary,corpora lutea,1
4185,Structure of cortex of lens,cortical layer,1
4186,Structure of dentate gyrus,dentate gyrus,2
4187,Structure of interstitial cell of Leydig,interstitial cells,1
4188,Structure of myotome,myotomes,1
4189,Structure of myotome,myotome,1
4190,Structure of olfactory bulb,olfactory bulb,4
4191,Structure of olfactory bulb,OB,2
4192,Structure of renal segment,segments,1
4193,Study Element,element,4
4194,study of epigenetics,epigenetic,1
4195,Subcellular Fractions,subcellular,3
4196,Subcellular Fractions,subcellular fractions,1
4197,Subcutaneous Fat,subcutaneous fat,1
4198,Subgroup,subgroup,4
4199,Subject -direct target,subject,2
4200,subrhabdomeral cisterna,SMC,1
4201,Substitution - change,substitution,1
4202,Substitution - change,substitutions,1
4203,Substitution - change,Substitution,2
4204,Substrate,substrate,8
4205,Subtraction process,subtraction,2
4206,Subtractive Hybridization Techniques,cDNA subtractive hybridization,1
4207,Subtype (attribute),subtypes,10
4208,Subventricular Zone,subventricular zone,1
4209,Sufficient,sufficient,1
4210,Sulfhydryl Compounds,thiols,3
4211,Sulfhydryl Compounds,thiol,1
4212,sulforafan,sulforaphane,2
4213,SUMO2 gene,SUMO2,1
4214,SUMO3 gene,SUMO3,1
4215,Sumoylation,Sumoylation,1
4216,Sumoylation,sumoylation,4
4217,Superficial,superficial,1
4218,Suppressed,suppresses,1
4219,Suppressed,suppressed,9
4220,Suppressed,suppress,5
4221,Suppressed,suppressing,1
4222,Suppressor of Cytokine Signaling Proteins,SOCS box proteins,1
4223,Surface,surface,7
4224,Surgical construction,creation,1
4225,Surgical construction,construction,1
4226,Surgical Replantation,cell replacement,1
4227,Surveys,surveys,1
4228,Survival Rate,survival rate,1
4229,survive,survive,1
4230,Survivors,survivors,1
4231,Susceptibility (property) (qualifier value),susceptibility,4
4232,Sustain,sustain,1
4233,Sustained,sustaining,2
4234,SWI/SNF complex,mSWI/SNF complex,1
4235,Swiss 3T3 Cells,Swiss mouse 3T3 cells,1
4236,Switch Device Component,switch,2
4237,Symptomatic,symptomatic,1
4238,synapse maturation,synapse maturation,1
4239,Synapses,synapses,9
4240,Synapses,synapse,4
4241,Synapses,cone synapses,1
4242,Synaptic cleft,synaptic cleft,1
4243,Synaptic connectivity,synaptic connectivity,1
4244,Synaptic Transmission,synaptic transmission,5
4245,Synaptic Transmission,neurotransmission,1
4246,synaptic vesicle localization,synaptic localization,1
4247,Synaptic Vesicles,synaptic vesicle fraction,1
4248,Synaptic Vesicles,synaptic vesicle,1
4249,Synaptic Vesicles,synaptic vesicles,1
4250,synaptogenesis,synapse formation,2
4251,Synaptosomes,synaptosomal,2
4252,Synaptosomes,synaptosomes,2
4253,Synchronous,synchronized,1
4254,Synchronous,synchronization,1
4255,SYNRG gene,gamma-synergin,1
4256,Synthesis,synthesized,4
4257,Systemic arterial pressure,arterial blood pressure,1
4258,T cell apoptotic process,T-cell apoptosis,1
4259,Table Frame -box,box,1
4260,Table Rules - groups,groups,1
4261,Tail,tails,2
4262,Talin,talin,1
4263,Tandem Mass Spectrometry,tandem mass spectrometry,2
4264,TARDBP gene,TAR DNA binding protein,1
4265,Target,targeted,8
4266,Target,Targeted,2
4267,Target Cell Count,target cells,1
4268,Target Lesion Identification,target,22
4269,TATA Box,TATA box,1
4270,TATA-Box Binding Protein,TATA-box,1
4271,TATA-Box Binding Protein,TATA-box-binding protein,1
4272,Tau - Statistical Technique,tau,1
4273,TBATA gene,spatial,5
4274,TBC1D21 gene,TBC1D21,5
4275,TBC1D21 gene,Tbc1d21,1
4276,T-Cell Activation,T-cell activation,1
4277,T-Cell Immunoreceptor with Ig and ITIM Domains,domain-containing transmembrane protein,1
4278,T-Cell Proliferation,T-cell proliferation,1
4279,T-Cell Receptor,TCR,1
4280,TCF12 gene,helix-loop-helix transcription factor,1
4281,TCF12 gene,HEB,3
4282,TCF3 gene,immunoglobulin transcription,1
4283,TCF4 gene,TCF4,3
4284,TCF4 gene,Tcf4,1
4285,TCF4 wt Allele,ITF-2,3
4286,TCF4 wt Allele,SEF-2,6
4287,TCF7L2 gene,Tcf-4,8
4288,TCF7L2 gene,Tcf7l2,2
4289,Techniques,technique,1
4290,Techniques,techniques,2
4291,Technology,technology,2
4292,Technology,technologies,1
4293,TEK gene,tek,2
4294,TEK gene,Tie-2,10
4295,TEK gene,Tek,12
4296,TEK gene,tek gene,2
4297,TEK gene,tie-2,8
4298,TEK gene,TEK,5
4299,TEK gene,tie2,3
4300,TEK gene,tie2 protein,1
4301,TEK gene,Tek receptor tyrosine kinase,1
4302,TEK gene,Tie2,23
4303,TEK gene,Tie-2 gene,1
4304,TEK gene,Tie-2 protein,1
4305,Telephone Extension Number,extension,1
4306,Temporal - Regional site descriptor,temporal,3
4307,teratologic,anomalies,2
4308,Teratoma,teratomas,1
4309,Teratozoospermia,teratozoospermia,1
4310,Term Source,source,1
4311,terminal differentiation,Terminal differentiation,1
4312,Terminally Ill,terminally,1
4313,termination - ActReason,termination,1
4314,"Terminator Regions, Genetic",terminal sequences,1
4315,Test Method,method,3
4316,Test Result,results,43
4317,Testicular Tissue,testicular tissue,2
4318,Testiculo-,testicular,4
4319,Testis,testis,10
4320,Testis,testes,1
4321,Testis-Specific Gene 10 Protein,testis-specific,1
4322,Tests (qualifier value),tested,4
4323,Tethered,tethering,1
4324,Tetrodotoxin,tetrodotoxin,1
4325,TEX101 gene,TEX101,1
4326,TFAP4 gene,AP-4,1
4327,"TFF1 protein, human",PS2,1
4328,TGFB1I1 gene,androgen receptor activator,1
4329,Thalamic structure,thalamus,2
4330,Therapeutic - Location Service Code,therapeutic,6
4331,Therapeutic procedure,therapies,2
4332,Therapeutic procedure,therapeutics,1
4333,thiol-dependent ubiquitin-specific protease activity,deubiquitinase,2
4334,thiol-dependent ubiquitin-specific protease activity,DUB,3
4335,Three-dimensional,three-dimensional fold,1
4336,Three-dimensional,three-dimensional,1
4337,Three-dimensional,three-dimensional matrices,1
4338,Threonine measurement,threonine,1
4339,Threshold,threshold,1
4340,Thrombosis of blood vessel,thrombosis,2
4341,Thymine DNA Glycosylase,thymine glycol DNA glycosylase,1
4342,thymocyte,Thymocytes,1
4343,thymocyte,thymocytes,1
4344,Thymus Gland,thymus,1
4345,THYROID HORMONE PLASMA MEMBRANE TRANSPORT DEFECT,defect,4
4346,Thyroid Hormone Receptor Alpha-1,thyroid receptor alpha,1
4347,Tibial Arteries,tibialis arteries,1
4348,TIE1 gene,tie,1
4349,TIE1 gene,Tie,1
4350,TIE1 gene,TIE,1
4351,Time,time,1
4352,Timing,timing,1
4353,TIMM8A gene,MTs,1
4354,Tip,tip,1
4355,Tissue Adhesions,adhesion,2
4356,Tissue Donors,donor,1
4357,Tissue fiber,fibers,2
4358,tissue homeostasis,tissue homeostasis,2
4359,Tissue membrane,membranes,1
4360,tissue regeneration,tissue regeneration,2
4361,Tissue Specificity,tissue specificity,1
4362,Tissue-Specific Splicing,tissue-specific,7
4363,TLE4 wt Allele,lymphocyte gene,1
4364,T-Lymphocyte,T cells,3
4365,T-Lymphocyte,T cell,1
4366,"TM4SF1 protein, human",L6,2
4367,"TNFSF11 protein, human",RANKL,1
4368,TNIK gene,Tnik,2
4369,TNIK gene,TNIK,4
4370,TNS1 gene,tensin,1
4371,Toll-like receptors,Toll-like receptor,1
4372,TOMM20 gene,TOMM20,2
4373,Tongue,tongue,1
4374,Topical Dosage Form,top,1
4375,TOR signaling,signaling cascades,2
4376,tortuous aorta,tortuous aorta,1
4377,Total Peripheral Resistance,peripheral vascular resistance,1
4378,Toxic,toxic,1
4379,Toxicity aspects,toxicity,1
4380,TP53 gene,p53,17
4381,"TP53INP1 protein, human",stress-induced,2
4382,TPM3 wt Allele,TM3,1
4383,TPM3 wt Allele,TM5,1
4384,trabecula formation,trabeculation,1
4385,Trabecular meshwork structure,trabecular meshwork,1
4386,Tract,tracts,2
4387,Traffic,traffic,1
4388,trafficking,trafficking,3
4389,trafficking,Trafficking,1
4390,Transaction counts and value totals - day,day,11
4391,"Trans-Activation, Genetic",transactivation,6
4392,"Trans-Activation, Genetic",transactivation activity,2
4393,Trans-Activators,trans-activates,1
4394,Trans-Activators,trans-activation,1
4395,Transcript,transcripts,26
4396,Transcript,transcript,7
4397,Transcript,no transcripts,1
4398,Transcript,gene transcripts,1
4399,Transcription Activator-Like Effectors,effectors,1
4400,Transcription Coactivator,transcriptional coactivator proteins,1
4401,Transcription Coactivator,transcriptional coactivator,3
4402,Transcription Coactivator,activator of transcription,1
4403,Transcription Coactivator,nuclear transcriptional coactivator,1
4404,Transcription Coactivator,co-,1
4405,Transcription Coactivator,transcriptional activators,1
4406,Transcription Coactivator,transcriptional coactivators,1
4407,Transcription Coactivator,transcriptional activator,1
4408,Transcription Elongation,transcriptional elongation,2
4409,TRANSCRIPTION FACTOR,transcription factors,20
4410,TRANSCRIPTION FACTOR,transcription factor,7
4411,TRANSCRIPTION FACTOR,Transcription factor,1
4412,TRANSCRIPTION FACTOR,TFs,2
4413,Transcription Factor 3,E2A,1
4414,Transcription Factor AP-2 Alpha,AP-2,3
4415,transcription factor S-II,transcription elongation factor,1
4416,Transcription Factor TFIIB,basal transcription factor TFIIB,1
4417,Transcription Factor TFIID,mouse transcription factor IID,1
4418,Transcription Factor TFIID,TFIID,1
4419,"Transcription Factors, General",general transcription factors,1
4420,"Transcription Factors, General",general transcription factor,1
4421,transcription from mitochondrial promoter,mitochondrial gene transcription,1
4422,Transcription Initiation,transcription initiation,1
4423,Transcription Repressor/Corepressor,transcriptional corepressor,2
4424,"Transcription, Genetic",transcription,40
4425,"Transcription, Genetic",Transcription,1
4426,"Transcription, Genetic",transcriptional,4
4427,"Transcription, Genetic",gene transcription,7
4428,"Transcription, Genetic",transcriptionally,1
4429,"Transcription, Genetic",active gene transcription,1
4430,Transcriptional Activation,transcriptional activation function,1
4431,Transcriptional Activation,transcriptional activation,10
4432,Transcriptional Activation Domain,transcriptional activation domain,1
4433,Transcriptional Regulation,transcriptional control,2
4434,Transcriptional Regulation,transcriptional regulation,4
4435,Transcriptional Regulation,transcriptional regulators,2
4436,Transcriptional Regulation,Transcriptional regulation,1
4437,Transcriptional Repression,repress transcription,1
4438,Transcriptional Repression,transcriptional repression,2
4439,"Transcriptional Repressor Protein YY1, human",YY-1,1
4440,Transcriptome,transcriptome,1
4441,Transcytotic Pathways,cellular pathways,1
4442,Transducers,transduces,2
4443,Transducers,transduce,1
4444,Transfection,Transfection,3
4445,Transfection,transfection,1
4446,Transferrin measurement,transferrin,2
4447,Transforming Growth Factor Beta 2,Tgfb2,1
4448,Transforming Growth Factor Beta-1-Induced Transcript 1 Protein,HIC-5,4
4449,transforming growth factor beta3,Tgfb3,1
4450,Transforming Growth Factors,transforming growth factor,1
4451,Transgenes,transgene,1
4452,Transgenes,Transgenes,1
4453,trans-Golgi Network,trans-Golgi network,1
4454,trans-Golgi Network,TGN,3
4455,Transition (action),transition,8
4456,Transition (action),transitions,1
4457,Transitory,Transient,1
4458,Transjugular intrahepatic portosystemic shunt procedure,tips,3
4459,Translating,translated,1
4460,Translation Initiation,translation initiation,1
4461,Translational Repression,Translational repression,1
4462,Translational Repression,translational repression,1
4463,Transmembrane Domain,transmembrane domain,1
4464,Transmembrane Domain,transmembrane region,1
4465,transmission process,transmitted,1
4466,Transmitted by,transmit,1
4467,Transplanted tissue,transplanted,1
4468,Transport Device Component,transport,4
4469,trans-synaptic signaling by trans-synaptic complex,trans-synaptic,1
4470,Traumatic injury,injury,1
4471,Treating,treated,1
4472,Treating,treated with,5
4473,Treating,treating,3
4474,Treatment Study,treatment,13
4475,Treatment Study,Treatment,4
4476,Tretinoin,retinoic acid,1
4477,Tretinoin,RA,1
4478,Tretinoin,Retinoic acid,1
4479,Trial Inclusion and Exclusion Criteria Submission Domain,Ti,8
4480,Trial Phase 3B,3b,1
4481,Trial Screening,screening,9
4482,trichostatin A,trichostatin A,1
4483,trichostatin A,TSA,1
4484,Triggered by,initiator,2
4485,Triggered by,precipitated,1
4486,Triggered by,evoked,1
4487,"TRIM25 protein, human",estrogen-responsive,1
4488,Trisomy,trisomy,3
4489,Triton X-100,Triton X-100,1
4490,trophoblast,trophoblast,1
4491,Trophoblast cell,trophoblast cells,1
4492,"tropomyosin-related kinase-B, human",tropomyosin-related kinase B,1
4493,"tropomyosin-related kinase-B, human",TrkB,2
4494,Troponin I,inhibitory subunit,3
4495,TRPM1 gene,TRPM1,1
4496,"TRPM3 protein, human",transient receptor potential melastatin 1,1
4497,Truncated BID,truncated,2
4498,Trunk structure,trunk,1
4499,TSC2 gene,tuberin,2
4500,Tuberculosis,tuberculosis,2
4501,Tuberous Sclerosis,Tuberous sclerosis,1
4502,Tuberous Sclerosis,tuberous sclerosis complex,2
4503,Tuberous Sclerosis,TSC,1
4504,TUBEROUS SCLEROSIS 1 (disorder),TSC1,4
4505,TUBEROUS SCLEROSIS 1 (disorder),Tsc1,11
4506,TUBEROUS SCLEROSIS 2 (disorder),tuberous sclerosis 2,2
4507,TUBEROUS SCLEROSIS 2 (disorder),Tsc2,6
4508,tuberous sclerosis complex 2 protein,TSC2,9
4509,tuberous sclerosis complex 2 protein,TSC2 protein,1
4510,Tubulin,tubulin,3
4511,tubulogenesis,tubulogenesis,1
4512,Tumor Angiogenesis,tumor angiogenesis,1
4513,Tumor Cell Invasion,invasion,2
4514,"Tumor cells, malignant",cancer cells,5
4515,"Tumor cells, malignant",Cancer cells,1
4516,tumor growth,tumor growth,1
4517,Tumor Necrosis Factor-alpha,tumor necrosis factor alpha,3
4518,Tumor Necrosis Factor-alpha,Tumor necrosis factor alpha,1
4519,Tumor Necrosis Factor-alpha,TNF alpha,1
4520,Tumor Necrosis Factor-alpha,TNF,5
4521,Tumor Suppressor Genes,tumour suppressor gene,3
4522,Tumor Suppressor Genes,tumour suppressor,2
4523,Tumor Suppressor Genes,tumor suppressor genes,2
4524,Tumor Suppressor Genes,tumor suppressor gene,1
4525,Tumor Suppressor Genes,tumor suppressors,3
4526,Tumor tissue sample,tumor samples,1
4527,Turnover technique,turnover,2
4528,Two-Hybrid System Techniques,two-hybrid,1
4529,Type 2,type II,1
4530,Type of bridge device,bridge,1
4531,Type of restoration,restoration,1
4532,tyrosine binding,bind tyrosine,1
4533,Tyrosine Kinase Domain,tyrosine kinase domains,1
4534,Tyrosine measurement,tyrosine,21
4535,Tyrosine measurement,Tyrosine,1
4536,Tyrosine measurement,tyrosines,2
4537,tyrosine receptor,receptor tyrosine,1
4538,"Tyrosine-Protein Kinase ABL1, human",p150,1
4539,Ubiquitin,ubiquitinated,2
4540,ubiquitin activity,ubiquitin,3
4541,Ubiquitin Ligase Gene,ubiquitin ligase,3
4542,Ubiquitinated Proteins,ubiquitinated proteins,1
4543,Ubiquitination,ubiquitination,15
4544,Ubiquitination,protein ubiquitination,1
4545,Ubiquitination,ubiquitylation,4
4546,ubiquitin-like protein conjugating enzyme activity,E2,2
4547,ubiquitin-protein ligase,E3 ubiquitin-protein ligases,1
4548,ubiquitin-protein ligase,ubiquitin ligases,2
4549,ubiquitin-protein ligase,E3 ubiquitin ligase,1
4550,ubiquitin-protein ligase,E3 ubiquitin ligase activity,1
4551,ubiquitin-protein ligase,E3 ligase,3
4552,ubiquitin-protein ligase,E3 ligases,1
4553,UHRF1 gene,Uhrf1,3
4554,Ultrastructure,ultrastructure,2
4555,Ultrastructure,ultrastructural,1
4556,undefined,undefined,1
4557,Undetectable,undetectable,1
4558,Undifferentiated,undifferentiated,3
4559,Unidentified - modifier,unidentified,2
4560,Unilateral,unilateral,1
4561,Unique,unique,8
4562,United Arab Emirates,TC,1
4563,United States,USA,2
4564,Units Of Measure - Gilbert,Gilbert,1
4565,Unrelated (finding),unrelated,1
4566,Untranslated Regions,untranslated region,1
4567,Unusual,unusual,2
4568,Upper,superior,1
4569,Up-Regulation (Physiology),up-regulated,3
4570,Up-Regulation (Physiology),upregulation,3
4571,Up-Regulation (Physiology),up-regulation,1
4572,Upstream,upstream,5
4573,Uroporphyrinogen III Synthetase,uroporphyrinogen III synthase,1
4574,Ursidae Family,bear,1
4575,Usage,employ,1
4576,USP1 gene,Usp7,4
4577,USP7 gene,herpesvirus-associated ubiquitin-specific protease,1
4578,USP7 gene,HAUSP,4
4579,USP7 gene,Hausp,5
4580,USP7 gene,hausp,2
4581,USP7 gene,USP7,8
4582,USP7 gene,ubiquitin-specific protease 7,1
4583,Usual,typical,1
4584,Uterine Tachysystole,Hypercontractility,1
4585,Utility (animal life circumstance),utility,2
4586,utilization qualifier,utilization,1
4587,UTS2R gene,UTR,1
4588,Vaccinia virus,vaccinia virus,1
4589,Vacuolar Protein Sorting,vacuolar protein sorting,1
4590,Value Below Reference Range,low,11
4591,Values,values,1
4592,Variable (uniformity),variable,1
4593,Variable expressivity,variable expressivity,1
4594,Variant,variant,6
4595,Variant,variants,13
4596,Variant,variation,3
4597,Vascular anomaly,vascular malformations,1
4598,Vascular constriction (function),vasoconstriction,2
4599,vascular cord development,vascular development,6
4600,Vascular Endothelial Cells,vascular endothelial cells,3
4601,Vascular Endothelial Growth Factor A,VEGF,1
4602,Vascular Endothelial Growth Factor Receptor-2,VEGFR-2,1
4603,Vascular plexus,vascular plexus,2
4604,Vascular Remodeling,vascular remodeling,1
4605,Vascular System,vascular system,5
4606,Vascularization,vascularized,1
4607,Vasculature,vasculature,4
4608,vasculogenesis,vasculogenesis,4
4609,Vasoactive Intestinal Peptide,vasoactive intestinal peptide,1
4610,VAX1 gene,ventral anterior homeobox,1
4611,VAX2 gene,Vax2,1
4612,"VCL protein, human",vinculin,1
4613,Vegetable marrow,marrow,1
4614,Venous system,venous systems,1
4615,Version,versions,1
4616,Vertebral column,vertebral column,1
4617,Vertebral column,spines,1
4618,Vertebrates,vertebrates,8
4619,Vertebrates,vertebrate,7
4620,Vesicle (morphologic abnormality),vesicles,5
4621,Vesicle (morphologic abnormality),vesicle,1
4622,vesicle coat,vesicle coat,1
4623,vesicle-mediated transport,vesicular transport,1
4624,Viable,viable,1
4625,View,view,1
4626,Viral,viral,1
4627,Viral Genome,viral genome,1
4628,Virus Diseases,viral infections,1
4629,Virus Physiological Phenomena,antiviral activity,1
4630,virus tail structure,tail structure,1
4631,Vision,vision,1
4632,Vision,visual function,1
4633,Visual learning,spatial learning,2
4634,Visual Suppression,suppression,7
4635,Visual Suppression,Suppression,1
4636,Vitamin D3 Receptor,vitamin D receptor,1
4637,VLDLR gene,VLDLR receptor,1
4638,voltage,voltage,2
4639,von Willebrand factor,von Willebrand factor,3
4640,von Willebrand factor,VWF,2
4641,VPS45 gene,H1,1
4642,WASF1 gene,WAVE,1
4643,WASF1 gene,WAVE1,3
4644,WASF2 wt Allele,WAVE2,2
4645,WASH1 gene,WASH,11
4646,WASL gene,N-WASP,1
4647,WD40 Repeats,tryptophan-aspartate,1
4648,WD40 Repeats,WD40 domain,1
4649,WDR41 gene,WDR41,1
4650,Weakness,weak,1
4651,Weight Gain,weight gain,1
4652,Well Differentiated,differentiated,4
4653,Well Differentiated,differentiate,1
4654,West (direction),Western,1
4655,Western Blot,western blot,1
4656,Western Blot,Western blot analysis,2
4657,WFDC5 gene,whey acidic protein,1
4658,What subject filter - Status,status,1
4659,White Adipose Tissue,white adipose tissue,2
4660,Whole Transcriptome Sequencing,RNA-Seq,1
4661,Wild Type,wild type,3
4662,Williams Syndrome,Williams syndrome,1
4663,Wiskott-Aldrich Syndrome Protein,Wiskott-Aldrich syndrome protein,2
4664,Wiskott-Aldrich Syndrome Protein,WASP,2
4665,With configuration,arrangement,4
4666,With staging,staging,1
4667,Withdrawal (dysfunction),serum withdrawal,2
4668,Wnt Signaling Pathway,(Wg)/Wnt signaling pathway,1
4669,Wnt Signaling Pathway,Wnt signaling pathway,2
4670,Wnt Signaling Pathway,Wnt pathway,1
4671,Wnt1 Protein,Wnt-1,1
4672,Wound Healing,wound healing,1
4673,Wound Healing,healing,1
4674,Wound Healing,repair,2
4675,X^o^rX^o^r blood group phenotype,phenotype,21
4676,xanthine,xanthine,1
4677,Xenopus oocyte,Xenopus oocytes,1
4678,Xenopus subgenus,Xenopus,2
4679,XML Bound,bound,1
4680,Y 27632,Y-27632,1
4681,year,A,1
4682,year,years,2
4683,Yeast Cell Measurement,yeast cells,3
4684,Yeast Two-Hybrid System Techniques,yeast two-hybrid system,5
4685,Yeast Two-Hybrid System Techniques,two-hybrid system,1
4686,Yeast Two-Hybrid System Techniques,yeast two-hybrid,7
4687,Yeast Two-Hybrid System Techniques,Yeast two-hybrid assays,1
4688,Yeast Two-Hybrid System Techniques,yeast two-hybrid assay,1
4689,Yeasts,yeast,6
4690,Yeasts,yeast gene,1
4691,yolk,yolk,4
4692,Young,young,2
4693,YWHAE gene,YWHAE,1
4694,YWHAE gene,Ywhae,1
4695,ZBTB8OS gene,arch,1
4696,ZDHHC5 gene,DHHC5,5
4697,Zebrafish,zebrafish,3
4698,Zinc,zinc,1
4699,Zinc Fingers,zinc finger,1
4700,ZNF451 gene,SRCs,8
4701,ZNF451 gene,Steroid receptor coactivators,1
4702,ZNF451 gene,ZNF451,1
